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Abstract: Exploring Non-transgenic CRISPR-Cas9 gRNA 
Delivery Using Transactivation in Nicotiana benthamiana 
 
Sarah Garland 
 
Gene editing via CRISPR-Cas9 (Clustered, Regularly Interspaced, Short Palindromic 
Repeats – CRISPR-associated protein 9) is a powerful tool in biotechnology. The method 
involves an endonuclease Cas9 forming a complex with a guide RNA (gRNA) that matches a 
distinct DNA target sequence, causing double-stranded breaks in the DNA site. The break 
induces imperfect DNA repair resulting in insertions or deletions that render the target gene 
non-functional. It is also possible to mutate the Cas9 protein so that it loses its cutting function, 
but can still sit on the target DNA when in a complex with gRNA. This deactivated Cas9 
(dCas9) can be fused with transcriptional activators or repressors to adjust the expression of a 
target gene.  
While CRISPR-Cas9 is already widely used in plants, there are limitations to the 
system’s delivery and efficiency. The aims of the research in this thesis were to generate a 
dCas9-activator-reporter system and to use the system to explore the possibility of two different 
non-transgenic methods of delivering gRNA. 
The system consists of two plant expression plasmids. One encodes a constitutively 
expressed dCas9 fused to a transcriptional activator and a reporter gene driven by a minimal 
promoter. The second contains the gRNA, designed to target the minimal promoter. When the 
constructs are co-expressed, the gRNA-bound dCas9-activator sits on the minimal promoter 
and drives increased reporter expression.  
Transient assays in N. benthamiana established the functionality of the system, showing 
increased reporter levels when the two constructs were co-expressed compared to the activator-
reporter construct alone. Stable transgenic N. benthamiana lines of the separate constructs were 
generated and taken to the T2 generation. 
To explore non-transgenic gRNA introduction methods, I tested viral delivery and 
grafting. Tobacco Rattle Virus (TRV) engineered to contain gRNA for the system was able to 
activate the reporter. However, the results suggest that viral recombination of the gRNA insert 
may cause the effect to be lost over time.  
The positive readout transactivation system developed in this thesis will be a valuable 
tool for future CRISPR development in plants. In addition, the data reported present 
opportunities for further exploration on potential delivery methods, spatial specificity of 
CRISPR, and the mobility characteristics of synthetic gRNA compared to various endogenous 
RNAs.  
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Chapter 1: Introduction 
Developing sustainable agricultural practices is an urgent global priority due to the 
effects of climate change, pest migration, and population increase (FAO 2016). In addition to 
being threatened by these phenomena, current agricultural practices are also contributing to the 
problem by causing a substantial amount of global greenhouse gas emissions as well as harm 
to land and water resources (Foley et al. 2011). The challenge of sustainability is to maintain 
high enough agricultural yield to support humans while also preserving the planet.  
Plant science has responded to these issues by prioritizing the development of 
sustainable traits such as plants engineered to require fewer external nutrient inputs or to be 
resistant to drought and flood (Jez et al. 2016). Cutting-edge biotechnologies are allowing an 
unprecedented rate of discovery in these areas.  
In recent years, a main focus of plant biotechnology has been gene editing. From 
disease resistance to yield improvement, nutritional value to fruit ripening, gene editing 
specific traits in plants is at the forefront of technology that has the capability to transform the 
crops grown around the world. The potential of gene editing has been catalysed by the 
discovery of the CRISPR/Cas9 system (Jinek et al. 2012, Khatodia et al. 2016). While it is 
already widely used in plant research and industry, CRISPR in plants is still limited compared 
to its use in animal systems (Cunningham et al. 2018).  
In this introduction, I will first describe CRISPR/Cas9 gene editing and the challenges 
to its use in plants. I will then discuss systemic movement of infectious and endogenous RNAs 
in plants and how their mobility has been manipulated for biotechnology. Bringing these 
concepts together, I will introduce my project, which focuses on using mobile RNA for 
improvement of CRISPR/Cas9 gene editing in plants.  
 
1.1 What is gene editing? 
Gene editing is the precise modification of target DNA sequences. The first step in gene 
editing involves a nuclease creating a double-stranded break (DSB) in DNA (Figure 1.1). Once 
this break is created, the introduction of insertions or deletions into the DNA disrupt or alter 
the function of the targeted gene (Sander and Joung 2014).  
There are two ways in which these broken genes can be repaired – Non-Homologous 
End Joining (NHEJ) and Homology Directed Repair (HDR). NHEJ occurs when the DNA 
repair mechanisms join the two ends of the break. However, before the process is complete, 
the DNA usually degrades or extra bases are added, causing a repair that is not perfectly 
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identical to the original sequence. These changes often include reading frame shifts or the 
introduction of stop codons, rendering the gene non-functional. This technology is valuable in 
research because studying the loss of a gene often reveals its function. NHEJ is also useful for 
applications for which it is known that the removal of a certain gene confers a desirable trait. 
In contrast, HDR requires that a DNA template be artificially introduced at the same 
time that the gene editing occurs. In this case, the DNA repair mechanisms insert this template 
code in between the ends of the break site, allowing for the precise manipulation of an 
endogenous sequence or the addition of an engineered sequence at a specific genomic location. 
 
 
 
 
 
 
 
  
Figure 1.1 Mechanism of gene editing. Gene editing is triggered by a nuclease-induced 
double-stranded DNA break. Knock outs are caused via non-homologous end joining 
(NHEJ) in which imperfect DNA repair causes random insertions or deletions at the break 
site, rendering the gene non-functional. Precise insertion of engineered sequence at the 
break site can also be achieved via homology directed repair (HDR) in which a template 
DNA strand must also be provided synthetically. Image from Sander and Joung (2014). 
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1.2 Targeted nucleases for gene editing 
Most gene editing techniques involve inducing DSBs at a defined genomic location 
using sequence-specific nucleases (SSNs), which recognise and cleave the target DNA (Voytas 
and Gao 2014). 
Zinc-finger nucleases (ZFNs) were the first SSNs to be used for gene editing. It was 
observed that the FokI type IIS restriction enzyme had a zinc-finger DNA binding domain and 
a cleavage domain that could be separated (Carroll 2011). Replacing the binding domain 
allowed targeting of different DNA sequences (Kim et al. 1996). ZFNs therefore consist of the 
non-specific DNA cleaving domain from FokI fused with engineered zinc-finger proteins, 
which recognise the target DNA (Gaj et al. 2013). Individual amino acids on the zinc-finger 
interact with individual DNA bases (Klug 2010). Therefore, to create high specificity, multiple 
zinc-finger domains are usually artificially linked together in combination with the FokI 
domains which requires complicated design and validation (Doudna and Charpentier 2014).  
The next SSNs applied to gene editing were transcription activator-like effector 
nucleases (TALENs). Similar to ZFNs, TALENs use the FokI domain for cleavage but, unlike 
zinc-fingers, they bind to DNA using repeated domains from TALE proteins (Gaj et al. 2013), 
which are native to the Xanthomonas bacteria. Each repeat domain corresponds to one DNA 
base pair and specificity is determined by two amino acids in the domain (Joung and Sander 
2013). TALENs do not require manipulating linkage like ZFNs, however complexity is added 
regarding the cloning of repeat sequences (Gaj et al. 2013). While TALENs are faster to 
generate than ZFNs, they still are limited by the reliance on protein engineering for DNA target 
specificity (Doudna and Charpentier 2014).  
 
1.3 Along came CRISPR 
1.3.1 CRISPR as a native bacterial adaptive immune system 
CRISPR (Clustered, Regularly Interspaced, Short Palindromic Repeats) is the newest 
SSN gene editing technology and is derived from the process of forming targeted double-
stranded DNA breaks during the process of natural bacterial adaptive immunity. Findings on 
short repeats separated by other sequences in Escherichia coli were first published in 1987 
(Doudna and Charpentier 2014, Ishino et al. 1987). Twenty years later, Barrangou et al. (2007) 
showed that these repeats were involved in a mechanism for prokaryotic viral defence.  
Different species of bacteria use CRISPR systems with varying characteristics. These 
systems are grouped in two classes; Class 1 requires multiple CRISPR-associated (Cas) 
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proteins to achieve nucleic acid cleavage while Class 2 only requires one (Wright et al. 2016). 
Biotechnology favours the simplicity of Class 2 systems; frequently used CRISPR nucleases 
Cas9, Cpf1, and C2c2 are all part of Class 2 (Xu and Qi 2018). The CRISPR-Cas9 Class 2 
system of Streptococcus pyogenes was the first to be exploited for biotechnology (Jinek et al. 
2012) and is still the most extensively used form of CRISPR (Wright et al. 2016). 
The CRISPR locus in the S. pyogenes genome contains encodes four proteins involved 
in the CRISPR process: Cas9, Cas1, Cas2, and Csn2 (Wright et al. 2016). It also includes the 
sequence for a transactivating CRISPR RNA (tracrRNA) and a CRISPR array, in which short 
20-50 bp repeat sequences are separated by short unique spacer sequences (Figure 1.2). When 
foreign DNA enters S. pyogenes, small pieces of it are cut and incorporated into the CRISPR 
array as spacers. The exact mechanism for acquiring these spacer sequences is not well 
understood and is a field of ongoing research (Wright et al. 2016). Current studies (Heler et al. 
2015, Wei et al. 2015) suggest that Cas9 is able to recognise a protospacer-associated motif 
(PAM) with the sequence NGG in the invading DNA and then recruits Cas1, Cas2, and Csn2. 
These proteins form a complex which acquires the spacer sequence from the foreign DNA and 
integrates it into the CRISPR array (Wright et al. 2016). 
The CRISPR array is transcribed resulting in a long precursor CRISPR RNA (pre-
crRNA) (Figure 1.2). The tracrRNA, transcribed independently from the pre-crRNA, anneals 
to the pre-crRNA at a complementary region of the repeat sequence (Jiang and Doudna 2017). 
After the base pairing of the pre-crRNA and tracrRNA, endogenous RNase III cleaves the pre-
crRNA in the non-annealed repeat sequence. The 5’ end of the crRNA is trimmed by an 
unknown nuclease to a 20nt sequence complementary to the region immediately adjacent to 
the PAM on the original foreign DNA (Wright et al. 2016).  
After cleavage of the repeat and 5’ trimming, the mature CRISPR RNA (crRNA) is still 
annealed to the tracrRNA, and they form a complex with endonuclease Cas9. The crRNA-
tracrRNA guides the Cas9 to the region of the invading DNA complementary to the 20 nt 
crRNA spacer sequence. Once the complex has found the target foreign DNA, each of the two 
nuclease domains of Cas9 (HNH and RuvC) cuts a strand of the DNA, creating a double-
stranded break. This system is able to protect bacteria by adapting to the specific sequences of 
invasive viral or plasmid DNA.  
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Figure 1.2 CRISPR-Cas9 as a bacterial adaptive immune system in S. pyogenes. The 
bacterial CRISPR locus encodes transactivating CRISPR RNA (tracrRNA), four CRISPR-
associated (Cas) proteins, and a CRISPR array containing repeats separated by unique 
spacers. When foreign DNA enters the bacterial cell, small regions are incorporated into the 
CRISPR array as spacers, guided by a complex of Cas1, Cas2, and Csn2. The CRISPR array 
is transcribed into pre-CRISPR RNA (pre-crRNA) which is then annealed with tracrRNA 
and processed. The mature crRNA-tracrRNA forms a complex with endonuclease Cas9 and 
precisely cuts the invading foreign DNA at a target site adjacent to a protospacer-associated 
motif (PAM) in a sequence-specific manner. Image from Jiang and Doudna (2017). 
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1.3.2 Advantages of CRISPR for biotechnology 
To simplify the system for biotechnology, Jinek et al. (2012) engineered the crRNA 
and tracrRNA into a single guide RNA (gRNA). Therefore, CRISPR gene editing has two 
components: the Cas9 nuclease and a gRNA complementary to the target DNA sequence 
(Figure 1.3). In 2013, multiple publications demonstrated that the CRISPR-Cas9 system could 
be used for gene editing in eukaryotes (Doudna and Charpentier 2014). 
CRISPR has distinct advantages over the other SSN gene editing methods because the 
specificity determinant is via base pairing of an RNA rather than through a protein with more 
complex DNA targeting rules. Creating a gRNA is faster, easier and less expensive than protein 
engineering (Cunningham et al. 2018). In addition, multiple genes can be targeted at the same 
time if more than one gRNA is introduced into the system (Cunningham et al. 2018). This 
property is beneficial for studying or engineering traits that are controlled by a gene network 
instead of a single gene.   
 
1.3.3 Modifications to CRISPR for transcriptional regulation 
It is also possible to mutate Cas9’s catalytic residues (D10A and H840A) so that it can 
still form a complex with the gRNA and sit on the target DNA sequence, but not cut it (Qi et 
al. 2013, Bikard et al. 2013). This version is called deactivated Cas9 (dCas9) (Figure 1.4). 
When dCas9 is bound to DNA, it can block other enzymes such as transcription factors or 
polymerases from reaching the DNA, therefore impairing the transcription of the target gene. 
This technique was the first form of CRISPR interference (CRISPRi), in which dCas9 is used 
for transcriptional repression (Qi et al. 2013, Bikard et al. 2013). Gilbert et al. (2013) improved 
the effect of CRISPRi by fusing dCas9 to known transcriptional repressors such as the zinc 
finger KRAB domain which is involved in epigenome modification (Wiznerowicz et al. 2007).  
Similarly, CRISPR activation (CRISPRa) using dCas9 fused to a transcriptional 
activator to increase target gene expression has also been established (Gilbert et al. 2013, 
Maeder et al. 2013, Perez-Pinera et al. 2013). These studies used transcriptional activator 
VP64, a tetrameric repeat of the Viral Protein 16 (VP16) activation domain from Herpes 
Simplex Virus (Beerli et al. 1998). Other activator domains have also been shown to function 
for CRISPRa (Gilbert et al. 2013, Piatek et al. 2015, Li et al. 2017), but most advancement of 
CRISPRa has continued to use dCas9-VP64 as the main transcriptional activator fusion 
component (Dominguez et al. 2016). Only recently has CRISPRa been applied for epigenetic 
modification, and these studies are discussed in Chapter 6.  
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Figure 1.3 CRISPR system for biotechnology. Instead of a separate crRNA and tracrRNA, 
they have been fused into a single guide RNA (gRNA) that combines with Cas9 to target a 
specific sequence. This simplification allows for a two-component gene editing system. 
Image from Sander and Joung (2014). 
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A)#Cas9#nuclease:#gene/editing
C)#dCas9/activator:#CRISPRa
B)#dCas9:#CRISPRi
Figure 1.4 Modifications to Cas9 for CRISPRi and CRISPRa. A) A functional Cas9 
endonuclease interacting with gRNA to cause a double-stranded DNA break at a target site. 
B) deactivated Cas9 (dCas9) can sit on target DNA matching the gRNA sequence, but is 
unable to cut. The dCas9 can block proper transcription by RNA polymerases (Pol II shown 
in green) or inhibit the binding of essential transcription factors (Txn). This is a method of 
transcriptional repression and is called CRISPR interference (CRISPRi). C) Shows how 
fusion of a transcriptional activator to dCas9 can turn the system into CRISPR activation 
(CRISPRa) in which the expression of a gene downstream of the gRNA target site is 
increased. Figures adapted from Dominguez et al. (2016). 
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1.3.4 Current limitations to CRISPR in plants 
In order to achieve the goal of using CRISPR gene editing to develop crops for 
sustainable agriculture, it is essential that the process works efficiently in plants. Unfortunately, 
there are still considerable technical obstacles to effective implementation (Altpeter et al. 
2016).  
Most CRISPR applications in plants include stably transforming the genes encoding 
Cas9 and gRNA into the plant in order to induce the gene editing process (Figure 1.5). Methods 
to integrate these genes include callus bombardment, protoplast transformation, and 
transformation with Agrobacterium tumefaciens (Belhaj et al. 2015). The transgenic plants 
regenerated from these methods express the Cas9 and gRNA, allowing the CRISPR mechanism 
to target the desired gene. The plants are then backcrossed and progeny are selected in which 
the transgenes are absent, but the targeted CRISPR mutation remains.  
The transformation methods involved in the CRISPR process all rely on tissue culture, 
whether it be a protoplast, callus, or explant. Tissue culture is known to be associated with 
unanticipated genetic and epigenetic mutation, causing trait variability which then needs to be 
further selected (Stroud et al. 2013). This side effect of tissue culture is detrimental to the goal 
of the precision CRISPR gene editing.  
In addition to the unpredictability of tissue culture, it is a long process. It can take more 
than six months to create the desired plant with a CRISPR mutation. With current methods, 
every time there is a new editing target, the whole process must be repeated.  
It has been identified that tissue culture steps are a bottleneck for CRISPR gene editing 
in plants, especially crop species (Altpeter et al. 2016). New delivery mechanisms are needed 
to reduce reliance on tissue culture and decrease time required for the process in order for 
CRISPR to be a transformative tool in plant biotechnology. 
A considerable step toward overcoming this limitation would be to introduce the gRNA 
and Cas9 separately. Whenever a new target is selected the only variable component is the 
gRNA. If the gRNA can be delivered in trans, then only one tissue culture step would be 
necessary to stably transform the Cas9 or dCas9. The same Cas9 or dCas9 transgenic line could 
be used for every application while only changing the gRNA delivered in trans, reducing the 
effects caused by repeated tissue culture. In addition, using a line hemizygous for the 
Cas9/dCas9 would allow easy segregation in the progeny, generating transgene-free mutants. 
The next sections focus on harnessing the capabilities of natural biological processes to 
generate new methods of introducing gRNA for CRISPR in plants.  
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Figure 1.5 Current CRISPR method in plants. Once the gene target has been selected 
and gRNA designed, the constructs must be delivered to the plant. Current methods all 
conclude with a form of tissue culture followed by screening for mutations in the target 
sequence. Figure from Belhaj et al. (2015). 
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1.4 RNA mobility in plants: natural systems and use in biotechnology 
In order to deliver the gRNA in trans and still cause heritable mutations, the gRNA 
would either need to be delivered directly to pre-germline cells expressing the nuclease or be 
produced in other cells and trafficked into pre-germline cells. With the aim of reducing tissue 
culture, the latter is a more feasible approach and would require exploiting natural systems for 
RNA mobility in plants to transport the gRNA.  
 
1.4.1 Phloem transport 
Classes of both endogenous and pathogenic RNAs are mobile in plants, and move long 
distances through the phloem vasculature (Ham and Lucas 2017). The phloem is responsible 
for transporting nutrients from photosynthetically productive leaves (source tissues) into 
developing tissues and roots (sink tissues). Phloem’s unique structure consists of companion 
cells (CC) which have full cellular function connected via plasmodesmata (PD) to specially 
differentiated enucleate sieve elements (SE) (Figure 1.6). Cell files of SEs are joined to each 
other by open sieve plate pores (SPP) instead of plasmodesmata, allowing a continuous flow 
throughout the plant. Molecules for transport are loaded from the companion cells into the 
sieve element cell and then move with the phloem pressure gradient to sink tissues (Melnyk et 
al. 2011, Ham and Lucas 2017).   
  
Figure 1.6. Phloem structure schematic. RNA and proteins generated in companion cells 
(CC) that have a nucleus (N) move into the enucleate phloem sieve elements (SE) via 
expandable channels called plasmodesmata (PD). Specially differentiated sieve plate pores 
(SPP) allow for flow through the phloem tube. Figure from Ham and Lucas (2017).  
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1.4.2 RNA movement for infection and use of viral vectors 
1.4.2.1 Viroids 
Viroids are perhaps the most mysterious plant pathogen. They are single-stranded, 
circular, noncoding RNAs ranging from 239-401nt in length and their origins are unknown 
(Kovalskaya and Hammond 2014, Takeda and Ding 2009). They exploit long-distance 
systemic transport via the phloem for infection. Viroids do not encode any proteins of their 
own, so they have to rely entirely on host machinery (Kovalskaya and Hammond 2014). The 
secondary structure of viroid RNA, comprised of helices and loops, is essential to the 
interaction with the proteins of host plants. Site-directed mutagenesis in specific structural 
domains in Potato spindle tuber viroid (PSTVd) showed that various sequence motifs played 
important roles in viroid replication, movement, and infection (Takeda and Ding 2009, 
Kovalskaya and Hammond 2014). 
Various RNA-binding proteins (RBPs) in plants have been identified which interact 
with viroids to enable systemic movement. For example, PHLOEM PROTEIN 2 (PP2) has 
been shown to be a viroid RBP, shuttling viroid RNA through the phloem in a grafted system 
(Kehr and Kragler 2018, Ham and Lucas 2017, Kovalskaya and Hammond 2014). Since it is 
sequence non-specific and functions by increasing the plasmodesmata size exclusion limit, it 
is likely that PP2 and other viroid RBPs are also RBPs for many categories of RNA (Ham and 
Lucas 2017).   
 
1.4.2.2 Plant viruses 
Plant viruses also move through the phloem for systemic spread (Heinlein 2015). They 
rely on viral movement proteins (MP) encoded in their genomes which expand the 
plasmodesmata to allow cell-to-cell passage. These MPs are sequence independent, and there 
is therefore ongoing research on how the MP associates specifically with viral nucleic acid 
(Heinlein 2015). Current work suggests that the MPs associate with viral replication complexes 
(VRCs) which would cause the MP to only bind to the viral genome. It seems some VRCs 
unload viral RNA-coat protein complexes through plasmodesmata, while other viruses may 
move as intact VRCs (Heinlein 2015).    
Biotechnology has benefitted from the use of viruses as vectors to deliver sequences of 
interest to plants for applications such as expressing recombinant proteins or inducing post-
transcriptional gene silencing. These techniques became especially widespread after the 
discovery that viral genomes could be expressed as in a T-DNA binary vector for 
agroinfiltration (Grimsley et al. 1986) instead of previous methods which involved mechanical 
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inoculation (Peyret and Lomonossoff 2015). Different families of plant viruses are beneficial 
for different applications.   
The genus Tobravirus contains an RNA genome that can be easily manipulated for 
delivery of RNA sequences in trans (Macfarlane 2010). A member of the genus, Tobacco Rattle 
Virus (TRV), has become especially popular for Virus Induced Gene Silencing (VIGS), a 
technique of triggering the plant’s RNA silencing-based immune system against an 
endogenous gene by using the virus to introduce a bit of RNA that matches the target sequence 
(Figure 1.7). During the process of viral replication, the plant’s RNA silencing machinery 
recognises the double-stranded RNA, and DICER-like proteins cut it into small dsRNA 
fragments which become small interfering (siRNAs). The siRNAs generated from the sequence 
inserted in the viral vector target the endogenous gene and cause post-transcriptional gene 
silencing (Becker and Lange 2009). 
TRV vectors have also been used for gene editing. Meristem invasion capability 
(Martin-Hernandez and Baulcombe 2008) and the ability to infect a wide variety of plant 
species are traits that make TRV a desirable vector choice for genetic engineering. Marton et 
al. (2010) used TRV to deliver the coding sequence of a ZFN to Nicotiana benthamiana, 
Nicotiana tabacum, and Petunia hybrida. The infected plants were edited, and ZFN-induced 
mutations were detected in the next generation. 
At the beginning of my PhD, there were three examples of Virus Induced Gene Editing 
(VIGE) for the CRISPR system, but none were able to reliably demonstrate inheritance of the 
induced mutation. Ali et al. (2015) showed editing in infected plants using a TRV vector to 
introduce gRNA to transgenic Cas9 N. benthamiana and claimed two lines of mutant progeny. 
However, the observed inheritance was disputed due to the minimal reported mutation rate 
compared to expected inheritance calculations (Yin et al. 2015).  
 Geminiviruses have also been used for VIGE. The geminivirus Cabbage Leaf Curl 
Virus (CaLCV) was employed by Yin et al. (2015) to deliver gRNA to transgenic Cas9 
expressing N. benthamiana. The infected plant exhibited targeted mutations. Unlike TRV, 
CaLCV does not move to the germline (Yin et al. 2015). The study’s proposed inheritance 
pathway involves regenerating edited plants from infected systemic tissues. Geminiviruses are 
excluded from the plant during the regeneration process (Yin et al. 2015), so the cultured plants 
would be virus-free.  
 Baltes et al. (2014) also chose a geminivirus vector for gene editing. Their 
deconstructed bean yellow dwarf virus (BeYDV) vector, engineered to overcome insert size 
limits by removing the coat and movement proteins, was non-mobile but able to deliver the 
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Cas9 protein and gRNA simultaneously in N. tabacum. The local expression of this system 
does not lend itself to inheritance in the progeny and would also require tissue culture to 
generate the desired plant. However, the strong benefit of this system is that no transgenes are 
required for editing since all components are included in the viral vector.   
 
 
  
Figure 1.7 Schematic of Virus Induced Gene Silencing (VIGS). A) Shows how the 
designed RNA is inserted into a vector containing viral genome cDNA and is inoculated to 
the plant via agroinfiltration. B) Illustrates the process of post-transcriptional gene silencing 
caused by the siRNA encoded by the viral construct. Figure from Becker and Lange (2010).  
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1.4.3 Endogenous RNA movement and use of grafting 
1.4.3.1 Classes of mobile endogenous RNA 
Analyses of phloem sap from various plant species revealed that most categories of 
endogenous RNAs exist in the phloem, including messenger RNA (mRNA), small interfering 
RNA (siRNA), and microRNA (miRNA) (Ham and Lucas 2017). Since the sieve element cells 
do not have nuclei, the RNA must be produced elsewhere and trafficked into the phloem. 
Grafting assays allow for deeper study of which RNAs are mobile by spatially separating the 
production of RNAs from the destination sink tissue.  
For example, Thieme et al. (2015) grafted together different ecotypes of Arabidopsis 
thaliana with distinct transcript variation and used sequencing data to distinguish mRNAs 
mobile across a graft junction. They found that mRNA moved both from scion to stock and 
also from root to shoot, especially to the flowers. The selection of which mRNAs enter phloem 
transport is contested; notably Calderwood et al. (2016) suggest that abundance of a certain 
mRNA in the companion cells is the major factor in determining whether it enters the phloem, 
not its function. No matter how they are chosen for long distance movement, it has been shown 
using grafting that mRNA in the phloem can have considerable phenotypic effects on the 
destination tissue, like leaf shape in tomato (Haywood et al. 2005, Kim et al. 2001) (Figure 
1.8a). 
Both microRNAs (miRNA) and small interfering RNAs (siRNA) are found in phloem 
sap (Yoo et al. 2004, Buhtz et al. 2008). The long distance mobility and function of both kinds 
of these small RNAs (sRNAs) have also been demonstrated in grafting assays, showing 
silencing phenotypes in destination sink tissues (Figure 1.8b) (Molnar et al. 2010, Lewsey et 
al. 2016, Pant et al. 2008, Dunoyer et al. 2010:retracted).  
 
1.4.3.2 Mechanisms of movement 
There is a limit to the size of molecules that can pass freely through plasmodesmata, 
but under specific signalling, the plasmodesmata can expand in order to let larger molecules 
through (Melnyk et al. 2011). There is evidence that endogenous RNAs combine with RNA-
binding proteins (RBPs) which act similarly to viral movement proteins, binding RNA in a 
non-sequence-specific manner and increasing the size exclusion limit of the plasmodesmata in 
order to allow the RNA to be loaded into the phloem (Ham and Lucas 2017) (Figure 1.9).  
The first mRNA RBP to be discovered was Cucurbita maxima PHLOEM PROTEIN 
16 (CmPP16). It was observed to behave similarly to a viral movement protein in the way it 
increases plasmodesmata size exclusion limit (Xoconostle-Càzares et al. 1999). It also binds 
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RNA in a non-sequence specific manner, like viroid RBP PP2, mentioned above (Ham and 
Lucas 2017). C. maxima RNA-BINDING PROTEIN 50 (CmRBP50) was demonstrated to 
form a complex with CmGAIP mRNA, one of the long-distance mobile mRNAs previously 
functionally studied via grafting (Haywood et al. 2005). Interestingly, grafting assays showed 
an intact CmRBP50 ribonucleoprotein (RNP) complex in the phloem sap of destination tissue 
(Ham et al. 2009), suggesting that CmRBP50 does not just participate in loading the mRNA 
into the phloem, but that the complete RNP moves systemically. 
sRNAs are also known to be associated with RBPs for long distance systemic 
movement (Ham and Lucas 2017). For example, C. maxima PHLOEM SMALL-RNA 
BINDING PROTEIN 1 (CmPSRP1) binds to single-stranded sRNA and increases 
plasmodesmata size exclusion limit like other known RBPs (Yoo et al. 2004). It does not bind 
mRNA or double-stranded sRNA. Interestingly, in order to function upon reaching destination 
tissues, sRNA would need to dissociate from a movement protein in order to bind to proteins 
involved in the silencing mechanism. Indeed, it was found that the CmPSRP1 RNP complex 
destabilised when exposed to sink tissue phloem sap, but not source tissue phloem sap (Ham 
et al. 2014). This finding suggests that the single-stranded sRNA can separate from phloem 
movement proteins upon reaching sink tissues in order to function in its silencing capacity.  
sRNA may also be able to move as a double-stranded duplex without an RBP. The 
phloem sap is RNAse-free, so the sRNA could be stable in its double-stranded form as it moves 
systemically (Melnyk et al. 2011). Once outside of the vasculature, one of the strands is 
destroyed in order for the single stranded sRNA to load into the silencing protein complex 
(Melnyk et al. 2011).  
 
1.4.3.3 Grafting in biotechnology 
Basic research has shown that RNA can provide a function in trans via a graft. This 
knowledge is beginning to be applied to crop improvement through transgrafting, in which a 
genetically engineered root stock is grafted with a wild type scion with the purpose of inducing 
certain traits in the commercial product (Haroldsen et al. 2012). This method of RNA delivery 
holds promise for many beneficial purposes such as increasing nutrient uptake and resistance 
to disease and pests (Haroldsen et al. 2012, Nawaz et al. 2016). Graft delivery of gRNA to the 
CRISPR system has not yet been reported.  
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A)
B)
Figure 1.8 Demonstrations of function mobile RNAs. A) Haywood et al. 2005 showed 
via in situ RT-PCR that mutant mRNA transcripts (shown in green) accumulate in the apices 
of wild type scions grafted onto mutant stock. In maturity, the leaves from these scions 
showed a mutant phenotype, demonstrating that the mRNA was both mobile and functional 
upon arriving at the destination tissue. B) Molnar et al. 2010 demonstrated the mobility and 
function of siRNAs from shoot to root by grafting a GFP silencing line scion to a GFP 
expressing root. siRNAs moved across the graft junction and silenced GFP in the root. 
Figures from Haywood et al. (2005) and Molnar et al. (2010). 
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Figure 1.9 Schematic mobile mRNA trafficking into the phloem. When plasmodesmata 
(PD) are closed, it is difficult for RNA molecules to move from the companion cells (CC) 
to the sieve elements (SE) of the phloem. RNA binding proteins (RBPs) can increase the 
size exclusion limit of the PD and allow RNAs into the phloem. In the figure, non-cell 
autonomous (NCA) mRNAs shown in red and blue either bind with sequence specific RBPs 
(S-RBP) or non-specific RBP (NS-RBP) to get channeled into the phloem. The mRNA 
shown in black is cell autonomous (CA) and represents how sheer abundance of certain 
mRNAs in CCs may cause them to be trafficked into the phloem and do not actually have a 
reason to be mobile, based on the reporting of Calderwood et al. (2016). Figure modified 
from Ham and Lucas (2017). 
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1.5 Project goals 
This work in this thesis focused on addressing the challenges of using CRISPR gene 
editing in plants by exploring non-transgenic gRNA delivery methods based on natural systems 
of mobile RNA. The project had three main objectives: 
Objective 1: Generate a CRISPRa system in plants optimised for testing gRNA delivery 
in trans. 
I chose to work with CRISPRa transcriptional activation in order to have a positive 
readout assay that could be easily analysed. At the time of starting this project, there were only 
two demonstrations of CRISPRa in plants (Lowder et al. 2015, Piatek et al. 2015). These 
systems were designed either only for transient expression or stable transformation of all 
components of the system in the same construct. Therefore, my first goal was to create a 
CRISPRa system in plants designed specifically for exploring various methods of gRNA 
delivery.  
Objective 2: Test viral delivery of gRNA to transactivate the CRISPRa system. 
Next, I set up experiments to test the efficiency of delivering gRNA in trans via a viral 
vector. While there had already been attempts at Viral Induced Gene Editing (VIGE) when this 
project began (Ali et al. 2015, Yin et al. 2015, Baltes et al. 2014), none were able to reliably 
achieve heredity of the CRISPR mutation to the next generation. My transactivation system 
was designed to be able to analyse where the flaw was occurring, in order to improve VIGE as 
a potential useful method in the future. 
Objective 3: Explore graft delivery of gRNA to the CRISPRa system. 
 Since grafting is already a commonly used technique for commercial crop production, 
graft delivery of gRNA for CRISPR would be a useful technical advance. In addition, there is 
evidence for most classes of endogenous RNAs to be mobile in the phloem, but there has been 
no study to date on whether gRNA can move systemically in plants. Exploration of gRNA 
movement would add to the ongoing body of work on the mobility of different classes of RNAs 
by testing a synthetic RNA that may not be designed to interact with host proteins.  
 
1.5.1 Model plant species selection 
Nicotiana benthamiana is an advantageous model organism for all three objectives of 
this project. First, it is frequently used for its ability to express transgenes transiently upon 
agroinfiltration (Bally et al. 2018, recently used for CRISPRa by Piatek et al. 2015, Lowder et 
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al. 2015) and was therefore a logical choice for testing the constructs of my CRISPRa system 
developed under Objective 1.  
N. benthamiana has also become the standard species for plant-virus studies such as 
VIGS and, more recently, VIGE. A mutation in a gene directly involved in plant immune 
response (RNA-dependent RNA polymerase 1 Rdr1) causes N. benthamiana to be highly 
susceptible to infection (Yang et al. 2004, Bally et al. 2018). This characteristic made it a 
suitable model plant for Objective 2 of my project. In addition, there are many examples of 
successful grafting of N. benthamiana which is beneficial for the grafting work included in 
Objective 3.  
Finally, since it is a member of the family Solanaceae, which also includes important 
crop plants such as tomato, pepper, potato, and aubergine, the findings of gene editing assays 
in N. benthamiana could be easily translated to crop applications in the future. 
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Chapter 2: Materials and Methods 
 
2.1 Bacteria 
2.1.1Bacterial strains used: 
Strain Antibiotics Competency/source 
E. coli dH5a N/A Chemical/Lab stock 
E. coli One Shot Top10 N/A Chemical/Invitrogen 
E. coli One Shot ccdB Survival 2 T1R N/A Chemical/Invitrogen 
A.tumefaciens C58C1(pSoup) Rif, Tet, Gent Electro/Lab stock 
A. tumefaciens GV3101 (pSoup) Rif, Tet, Gent Electro/Lab stock 
Lab stocks were prepared by James Barlow. 
 
2.1.2 Chemical Transformations (E. coli) 
For dH5a prepared in the lab, 50µL of cells were thawed on ice until just thawed. 2-
4µL of plasmid was added to the cells, gently flicked to mix, and then kept ice for 20 minutes 
before a heat shock at 42°C for 60 seconds and immediately returning to ice for 2 minutes. 
950µL of room temperature SOC medium was added to the cells and mixed by inverting. The 
mixture was incubated at 37°C with shaking for an hour and then spread on LB-agar plates 
with the appropriate antibiotics. 
For transformation of chemically competent One Shot Top10 and One Shot ccdB 
Survival 2 T1R, the manufacturer’s protocol was followed. 
 
2.1.3 Electroporation (A. tumefaciens) 
First, sterile water, SOC media, and 1mm cuvettes were chilled on ice. Pre-prepared 
50µL aliquots of electro-competent A. tumefaciens were thawed on ice. In a sterile hood, the 
competent cells were diluted using 200µL of cold sterile water for every 50µL tube of cells 
and mixed. The cell dilutions were divided into 50µL aliquots.  1µL of purified plasmid was 
added to the 50µL cell dilution. The mixtures were transferred into labelled cuvettes, taking 
care to not cause any air bubbles. Each cuvette was inserted into the Bio-Rad GenePulser Xcell 
and electroporated with the pre-set A. tumefaciens programme (voltage 2400V, capacitance 25 
µF, resistance 200W, 1mm cuvette). 950µL cold SOC medium was quickly added to the cuvette 
and mixed with the electroporated cells before transferring back into the corresponding 
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Eppendorf tubes on ice. The tubes were shaken at 28°C for 2-4 hours to allow the cells to 
recover before spreading 50-100µL of the culture on plates with appropriate antibiotics. 
Colonies could be observed 48 hours after transformation.  
 
2.1.4 Glycerol stocks 
Glycerol stocks were made by mixing 800µL of the overnight bacterial culture with 
600µL autoclaved 100% glycerol in a Nunc CryoTube Vial (Thermo Scientific). Stocks were 
stored at -80°C. 
 
2.1.5 Bacterial plates and liquid growth conditions 
Plates for all bacterial applications were made by mixing heated 2X LB broth and 2% 
(w/v) Agar, adding appropriate selection antibiotics, and pouring into 90mm round petri plates. 
E. coli from glycerol stocks were grown in LB broth with appropriate antibiotics at 
37°C with shaking overnight.  
A. tumefaciens from glycerol stocks were grown in LB broth with appropriate 
antibiotics at 28°C for 48 hours. 
 
LB broth, agar, and antibiotics were all prepared by lab technician James Barlow. 
 
2.2 N. benthamiana  
2.2.1 Stable transformations 
A. tumefaciens C58C1 (pSoup) was cultured in 10mL LB broth with appropriate 
antibiotics for 48 hours, then pelleted and re-suspended in infiltration medium to an OD of 0.4 
at 600nm. Using a needle-less 1mL syringe, leaves of 4-week old N. benthamiana were 
completely infiltrated with the culture. 3 days later, the leaves were harvested and cut into 
squares after large veins had been removed. The squares were placed in stainless steel mesh 
infusion balls and surface sterilise in 70% (v/v) ethanol for 5 minutes. Next, the infusion balls 
were immersed in 20% (v/v) sodium hypochlorite and Tween for 10 minutes. They were then 
rinsed four times in in sterile water, 10 minutes per rinse. Flame-sterilised curved forceps were 
used to place individual leaf squares onto shooting medium plates with selection antibiotics 
adaxial side up, leaving space between the squares. The plates were sealed with a double layer 
of of micropore tape and placed in a growth chamber at 24°C with 16h days.  
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Explants were transferred to fresh selection plates as needed, and shoots began to 
appear around 4 weeks later. Shoots were cut with a flame-sterilsed scalpel, and transferred 
into rooting medium with selection antibiotics. Around 2 weeks later, roots began to appear 
and plantlets were transferred to sterilised peat blocks. When the plantlets seemed stable, they 
were moved to non-sterile soil and kept under propagation lids for the first few days before 
gradual decrease in humidity.  
Agroinfiltration medium 
Ingredient Stock  Amount added for 10 mL Final Concentration 
100 mM MgCl2/100 mM MES 
pH 5.6 
1 mL 10 mM/10 mM 
H2O 9 mL  
150 mM acetosyringone 
(Sigma-Aldrich) 
10 µL 150 µM 
 
Shooting Medium 
Ingredient Stock Amount added for 1 L Final Concentration 
Murashige and Skoog with 
Gamborg B5 vitamins 
2.2 g 2.2 g/L 
Sucrose 10 g 1% (w/v) 
Agargel 5 g 0.5% (w/v) 
pH 5.7   
After autoclaving and while still 
molten, add the following: 
  
BAP at 1 g/L 2 mL 2 mg/L 
NAA at 0.1 g/L 0.5 mL 0.05 mg/L 
Cefotaxime at 500 mg/L 2 mL 1 mg/L 
Timentin at 320 mg/L 1 mL 0.32 mg/L 
Selection: Kanamycin at 100 mg/L 2 mL 0.2 mg/L 
 
Rooting Medium 
Ingredient Stock Amount added for 1 L Final Concentration 
Murashige-Skoog basal salt 
mixture 
2.15 g 2.15 g/L 
Sucrose 5 g 0.5% (w/v) 
Gelrite/Gelzan 2.5 g 0.25% (w/v) 
pH 5.8   
After autoclaving and while still 
molten, add the following: 
  
NAA at 0.1 g/L 0.5 mL 0.05 mg/L 
Cefotaxime at 500 mg/L 2 mL 1 mg/L 
Timentin at 320 mg/L 1 mL 0.32 mg/L 
Selection: Kanamycin at 100 mg/L 2 mL 0.2 mg/L 
 
Protocol from Temur Yenusov, The Sainsbury Lab Cambridge University.  
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2.2.2 Crossing 
It was important to ensure that flowers had not yet been self-pollinated before crossing. 
Flowers that had not yet bloomed and were still slightly green were opened using forceps and 
the immature anthers removed. The petals were cut so that the stigma was just exposed. Pollen 
from mature open flowers was harvested into the cap of a 2mL tube. The pollen in the cap was 
then pressed onto the exposed stigma. The pollinated flower was marked with string to denote 
it was the product of a cross. 
 
2.2.3 Grafting 
The technique used for full plant grafting of N. benthamiana was based on the 
conditions of available growth chambers. First, N. benthamiania seeds were sown in 24-pot 
trays which allowed the plants to shoot up competing for the light instead of staying close to 
the soil. Five weeks after sowing, the plants were moved to larger individual pots to prepare 
for grafting. Plants were grafted using a V-cut at six weeks post sowing and held together with 
a grafting clip. Before the actual grafting, apical meristems and all leaves except two were 
removed from the plants in order to encourage healing (Figure 2.1). The newly grafted plants 
were placed in a tray layered with a heating pad set to 22°C, watertight plastic, capillary mat, 
and plastic with holes (Figure 2.2). The capillary mat extended past the ends of the tray into 
reservoirs of water on either end, to ensure it stayed wet. Once the grafts were in the tray, they 
were covered with propagation lids and white plastic to keep moisture in and protect them from 
the light. Two weeks after grafting, the clips were removed and plants were kept under the 
white plastic for partial humidity 2-3 days before moving them into full light with no covering. 
Two weeks after moving them to full light, tissue was sampled and frozen.  
The steps of the grafting procedure are summarised in Figure 2.1. 
 
2.2.4 Growth conditions 
Wild type N. benthamiana for transient expression assays were provided by the lab of 
Sebastian Schornack and grown in a glasshouse environment. 
Transgenic N. benthamiana for transient expression and viral infection were grown in 
controlled chambers at 20°C and 60% humidity. 
Transgenic and wild type N. benthamiana for grafting were grown in a controlled 
chamber with 16h day length, 22°C day, 18°C night, 70% humidity. 
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A B C
D E
Figure 2.1. Grafting procedure. Six week old N. benthamiana (A) have apical meristems 
removed and all leaves cut off except for two (B). The stems are cut , V-grafted to a different 
plant, and held together with a grafting clip (C). The new grafts are placed in the grafting 
tray under propogation lids (D) and the whole system is covered by white plastic to protect 
the plants from harsh light (E). 
Figure 2.2. Grafting tray set up. Grafted N. benthamiana were placed in a humid, low 
light environment to heal. To created the necessary conditions, a heating pad set to 22ºC 
was placed in a plant growth tray and covered with a layer of impermeable plastic. On top 
of it, a moist capillary mat lined the tray and extended into reservoirs of water on either side 
to keep it continually saturated. Thin perforated plastic laid on top of the capillary mat. Once 
the plants were in the tray, propogation lids were placed on top to keep in the humidity. 
Finally, white plastic covered the whole enclosure to protect the plants from too much light. 
 Chapter 2 
 
26 
2.3 Agroinfiltrations for transient expression and virus assays 
LB broth, Mg2SO4 1M, and Acetosyringone were prepared by Lab Technician James Barlow. 
0.5M MES pH 5.6 was prepared by me. 
2.3.1 Infiltration medium recipe 
Ingredient Stock Amount added for 100 mL Final Concentration 
Mg2SO4 1M 1 mL 10 mM 
MES 0.5M pH 5.6 2 mL 10 mM 
H2O 97 mL  
Acetosyringone 0.1M 150 µL 150 µM 
 
2.3.2 A. tumefaciens for Transient expression  
To prepare for transient expression assays, A. tumefaciens GV3101 glycerol stocks 
were grown in LB broth for 48 hours in 28°C with shaking. The liquid cultures were pelleted 
and re-suspended in Infiltration Medium to an OD of 0.4 measured at wavelength 600nm. The 
re-suspended A. tumefaciens were mixed to the desired combination for the assay and then 
recovered in 28°C with shaking for 2-4 hours. 
3-4 week old N. benthamiana leaves were infiltrated with the cultures in localised spots 
using a needle-less syringe, avoiding major veins. Tissue from infiltrated leaves was sampled 
3dpi. 
 
2.3.3 A. tumefaciens for viral infection  
To prepare for viral assays, A. tumefaciens GV3101 glycerol stocks were grown in LB 
broth for 48 hours in 28°C with shaking. The liquid cultures were pelleted and re-suspended in 
Infiltration Medium to an OD of 1.0 measured at wavelength 600nm. The re-suspended A. 
tumefaciens were mixed to the desired combination for the assay and then recovered in 28°C 
with shaking for 2-4 hours. 
3-4 week old N. benthamiana leaves were entirely infiltrated with the cultures using a 
needle-less syringe, two leaves per plant. Tissue from infiltrated leaves was sampled 3 dpi and 
from systemic leaves at 14 dpi. 
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2.4 Nucleic acid purification 
2.4.1 Plasmid purification 
Plasmid DNA minipreps were performed using Qiagen QIAprepâ Spin Miniprep Kit 
following the manufacturer’s instructions. DNA was eluted in DNase/RNase-free water heated 
to 50°C. 
 
2.4.2 Genomic DNA extraction 
Genomic DNA was extracted using DNeasy Plant Mini Kit (Qiagen), following the 
manufacturer’s instructions. DNA was eluted in DNase/RNase-free water. 
 
2.4.3 RNA purification 
Tissue was ground using a mortar and pestle with liquid nitrogen or in a tissue lyser 
using 3mm glass beads. RNA purification was then performed using either the Direct-Zol RNA 
MiniPrep kit (Zymo Research) following manufacturer’s instructions, or using TRIzol and 
ethanol precipitation (method below).  
In a chemical hood, 1.5mL of TRIzol (Ambion) was added to the frozen ground tissue 
sample and mixed vigorously by vortexing followed by centrifugation at 10,000RPM for 10 
minutes at 4°C. The supernatant was transferred to a new tube and incubated at room 
temperature for 5 minutes. 300µL of chloroform was then added. The mixture was vortexed 
for 15 seconds and incubated at room temperature for 3 minutes before centrifugation for 15 
minutes at 10,000RPM at 4°C. ~750µL of the aqueous phase was transferred to a new tube, 
careful not to disrupt the interphase. 750µL of isopropanol was added and the mixture was 
incubated at -20°C from 2 hours to overnight. The sample was then centrifuged for 10 minutes 
at 10,000 RPM at 4°C and supernatant discarded. The pellet was washed twice with 80% (v/v) 
ethanol for 5 minutes at 4°C. After the second wash, the pellet was dried for 15 minutes and 
then re-suspended in RNase-free H2O. Purified RNA was stored in -20°C. 
 
2.4.4 Nucleic acid quantification 
Purified DNA and RNA was quantified using either Qubit or Nanodrop equipment according 
to manufacturer’s instructions.  
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2.5 Polymerase Chain Reaction 
2.5.1 DNA PCR (genomic and plasmid) 
DNA PCRs were performed either using the Phire Plant Direct PCR Kit (Thermo Scientific) 
or using Phusion High-Fidelity DNA Polymerase (Thermo Scientific). 
The Phusion mix used for one sample is as follows: 
Ingredient Volume 
H2O 13.4 µL 
5X Phusion HF Buffer 4 µL 
dNTP mix 0.4 µL 
Forward primer 0.5 µL 
Reverse primer 0.5 µL 
Phusion polymerase 0.2 µL 
Template DNA 1 µL 
 
The cycling protocol used for Phusion reactions was: 
98°C, 30 sec 
98°C, 10 sec 
60°C, 30 sec 
72°C, 15 sec 
72°C, 10 min 
4°C, forever 
 
2.5.2 Colony PCR 
Colonies to be screened via PCR were picked and re-streaked onto a numbered and gridded 
plate in order to create a stock for future applications. PCR master mix was prepared using 
PCRBIO Taq for 50µL reactions using the following recipe:      
Ingredient Volume 
5x PCRBIO Reaction Buffer 10 µL 
Forward primer (10 µM) 2 µL 
Reverse primer (10 µM) 2 µL 
PCRBIO Taq 0.5 µL 
H2O 15.5 µL 
 
35 cycles 
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The master mix was divided into a 96 well plate, and pipette tips were used to touch the colony 
on the numbered gridded plate and place it in the corresponding numbered well. A 
multichannel pipette was used to mix the bacteria and the master mix in the well.  The plate 
was sealed and run using the following PCR programme: 
95°C, 3 min 
94°C, 30 sec 
57°C, 30 sec  
72°C, 1 min 
72°C, 5 min 
4°C forever 
 
2.5.3 cDNA synthesis and RT-PCR 
One-Step RT-PCR (Qiagen) was carried out according to manufacturer’s instructions 
and using this cycling protocol: 
50°C, 30 min 
95°C, 15 min 
94°C, 1 min 
57°C, 1 min 
72°C, 1 min 
72°C, 10 min 
4°C, forever 
 
For two step RT-PCR, cDNA was synthesised using SuperScript IV Reverse 
Transcriptase (Invitrogen) and a mixture of Oligo d(T) and random hexamer primers according 
to the manufacturer’s protocol. The samples were incubated at 23°C for 10 min, 52°C for 10 
min, and 80°C for 10 min. cDNA was then used as template in a PCR with Phusion polymerase.  
 
2.5.4 Gel electrophoresis 
1% - 2% (w/v) electrophoresis gels were prepared by mixing agarose and 1X TBE buffer. 
Ethidium bromide or Midori Green Advance (Nippon Genetics) dye was added to the gel 
before pouring. Orange DNA loading dye (New England Biolabs) was added to the PCR 
samples and gels were run using 80-110V charge. 
 
1X TBE prepared by Lab Technician James Barlow. 
 
  
35 cycles 
30 cycles 
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2.6 Molecular cloning techniques 
2.6.1 Restriction digestions of DNA 
Typical restriction reaction for a New England Biolabs High Fidelity restriction enzyme: 
Ingredient Volume 
DNA 500 ng 
Cutsmart Buffer (NEB) 2.5 µL 
High Fidelity Restriction Enzyme 0.5 µL 
H2O To 25 µL  
 
2.6.2 DNA Dephosphorylation   
Dephosphorylation was performed using Antarctic Phosphatase (New England 
Biolabs). 3µL Antarctic Phosphatase Reaction Buffer and 2µL Antarctic Phosphatase were 
added to a 25µL restriction reaction and incubated for 30 minutes at 37°C before heat 
inactivation at 80°C. 
 
2.6.3 Gel extraction and PCR purification 
DNA fragments from excised gel bands were extracted using QIAquick Gel Extraction 
Kit (Qiagen) according to manufacturer’s instructions. Samples were eluted in DNase/RNase-
free water. QIAquick PCR Purification Kit (Qiagen) was used for PCR purification according 
to manufacturer’s instructions. Samples were eluted in DNase/RNase-free water.  
 
2.6.4 DNA Ligations 
Ligations were performed using T4 DNA Ligase (either NEB or Thermo Fisher) 
following manufacturer’s instructions. 
 
2.6.5 Sanger sequencing 
Sanger sequencing was carried out by Source Bioscience. 
 
2.6.6 Gateway reactions 
Gateway reactions were performed using LR Clonase II (Thermo Fisher) for a single site 
reaction and LR Clonase II Plus (Thermo Fisher) for a multisite reaction according to 
manufacturer’s instructions. 
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2.6.7 Ligation into pGEM-T Easy vector  
If a PCR amplification was performed using a polymerase that does not add an A-tail 
to the end of the fragment, an A-tail must be added before ligation into the linear T-tailed 
pGEM-T Easy Vector via the following protocol: 
Ingredient Volume 
DNA from PCR or gel extraction 50 µL 
MgCl2 (25mM) 10 µL 
dATP (1mM) 4 µL 
PCRBIO Taq 1 µL 
H2O 15 µL 
Incubate at 72°C for 20 minutes 
After A-tail addition, the sample is cleaned via PCR purification (2.6.4). The sample is 
dried down until no liquid remains, and re-suspended in 6µL H2O. 3µL of the resuspension is 
used for ligation into pGEM-T Easy Vector  (Promega) according to manufacturer’s 
instructions. 
 
2.6.8 Golden Gate method 
 
The method used for Type II restriction cloning was based on the Golden Gate “Long protocol 
in ligase buffer” from The Sainsbury Laboratory. The following were added to a PCR tube and 
brought to a total volume of 20µL with H2O: 
100-200ng of acceptor plasmid 
Plasmids containing each part to be inserted 
(Use a 2:1 molar ratio of insert:acceptor) 
1.5µL T4 Ligase Buffer (NEB) 
1.5µL Bovine Serum Albumin 10x 
0.5µL T4 DNA Ligase 400U/µL (NEB) 
0.5µL BsaI 100U/µL (Thermo Fisher) 
 
The mixture was then cycled:  
37°C, 20 sec 
37°C, 3 min 
16°C, 4 min 
50°C, 5 min 
80°C, 5 min 
16°C, forever 
26 cycles 
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2.7 Cloning of specific constructs 
2.7.1 Cloning of pK-AR (Illustrated in Figure 3.3) 
I amplified the 2x35S promoter from pYL156 (Liu et al. 2002) using Phusion DNA 
polymerase with SacI and SpeI restriction sites on the tails of the primers (Figure 3.3 Step 1). 
Primer sequences are in Appendix I. I excised the band from the agarose gel, extracted the 
DNA, and ligated the fragment into a pGEM-T Easy vector. After successful transformation 
shown by blue/white screening, I further confirmed the correct insert with Sanger sequencing.  
Next, I performed SacI-HF and SpeI-HF double restrictions of pKGWFS7 (Karimi et 
al. 2002) and the pGEM-T Easy vector containing 2x35S promoter (Figure 3.3 Step 2). I used 
Antarctic Phosphatase to dephosphorylate the pKGWFS7 digest and then heat inactivated all 
the enzymes. To ligate together the 2x35S insert digest and the pKGWFS7 digest, I used T4 
ligase overnight and transformed the ligation into One Shot ccdB survival cells that could 
accommodate the toxic ccdB gene. I then selected positive clones of this transformation. The 
final product of this step was a Gateway destination vector containing 2x35S promoter before 
the attR1 site, followed by the ccdB gene, the attR2 site, and finally the GFP:GUS reporter.  
I PCR amplified the minimal Bs4 302bp promoter sequence from pGWB19-300 
(Schornack et al. 2005) using Phusion DNA polymerase (Figure 3.3 Step 3). The primers, listed 
in Appendix I, were designed with the appropriate restriction sites and 4bp overlaps to prepare 
for a Type II Restriction reaction with BsaI. I excised the band from the gel and extracted the 
DNA fragment. I then followed the Golden Gate “Long protocol in ligase buffer” from The 
Sainsbury Laboratory to insert the Bs4 minimal promoter into pYPQ143 (Lowder et al. 2015), 
a Golden Gate destination and Gateway entry vector. After transformation into dH5a E. coli, 
miniprep, and Sanger sequencing, I identified a positive clone. The result of these steps (Figure 
3.3 Steps 3-4) was a Gateway entry vector containing the Bs4 302bp minimal promoter 
followed by a Gateway cassette with attL5 and attL2 sites.  
A Gateway entry vector with attL1 and attR5 sites containing the dCas9-VP64 fusion 
and a transcriptional terminator already existed, generated by Lowder et al. (2015), called 
pYPQ152.  
The final step of the process to obtain a dCas9-activator-reporter construct was to 
perform a multisite Gateway including pYPQ152, pYPQ143+Bs4, and pKGWFS7+2x35S 
(Figure 3.3 Step 5). The reaction product was transformed into E. coli One Shot Top10 cells 
for selecting positive clones. I confirmed the correct construct via Sanger sequencing (primers 
in Appendix I). The full map and sequence of pK-AR can be found in Appendix II. 
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2.7.2 Cloning of gRNA constructs (Illustrated in Figure 3.4) 
Following the protocol in Schiml et al. (2016), I designed oligos for the three different 
gRNAs with proper overlaps for insertion into pEN-Chimera (Fauser et al. 2014). Oligo 
sequences can be found in Appendix I. I digested pEN-Chimera with BbsI, following the 
protocol from Schiml et al. (2016), and PCR purified the product. I annealed the gRNA oligos 
and ligated them into the digested pEN-Chimera, transformed the ligations into E. coli, and 
confirmed the positive clones via colony PCR and Sanger sequencing (Figure 3.4 Steps 1-3). 
The resulting pEN-Chimera+gRNA vectors were Gateway entry vectors with attL1 and attL2 
sites. 
Next, I combined pEN-Chimera+gRNA with a binary vector that was also a Gateway 
destination. The final step (Figure 3.4 Step 4) was a single site Gateway reaction between pEN-
Chimera+gRNA and pGWB401, pGWB401 (Nakagawa et al. 2007), an empty binary Gateway 
destination vector with Kanamycin resistance in plants. The reaction product was transformed 
into E. coli One Shot Top10 cells for selecting positive clones. 
 
2.7.3 Cloning of pYDg2 (TRV RNA2 gRNA vector) (Illustrated in Figure 4.5) 
First, I amplified sequences close to unique restriction sites (AatII and EcoRI) on either 
side of the deletion region using primers with overhangs that would cause the resulting 
fragments to have overlapping regions and gel extracted these fragments. Next, the two 
fragments were combined in a PCR using the outer two primers of the previous reaction, 
producing a combined fragment with the overlap region in the middle. The cycling method, 
based on Phusion Polymerase protocol and the overlap deletion method published by Lee et al. 
(2010) was: 
98°C, 30 sec 
98°C, 10 sec 
60°C, 30 sec 
72°C, 30 sec 
72°C, 10 min 
4°C, forever 
 
 I gel extracted the resulting fragment, cloned it into a pGEM-T Easy vector, and 
confirmed with Sanger Sequencing. Restriction of pYL156 and the pGEM-T Easy vector 
containing the overlap fragment with AatII and EcoRI was followed by dephosphorylation of 
the pYL156 restriction product to reduce the possibility of pYL156 re-ligating with its own 
insert. I combined the two restrictions in a ligation reaction, transformed the ligation into E. 
25 cycles 
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coli dH5a, and used Sanger Sequencing to confirm clones that had a successful deletion. I 
named the plasmid at this step “pYL_DEL.” 
Next, gRNA2 was amplified from the gRNA2-containing binary vector I had 
previously generated. The forward primer contained an EcoRI tail on the 5’ end, and I made 
use of an XbaI site already present in the gRNA2 vector as the 3’ restriction site. I extracted 
the resulting fragment from the gel and cloned it into a pGEM-T Easy vector. I confirmed 
positive clones with Sanger Sequencing. Finally, I inserted the gRNA into the MCS using 
restriction with EcoRI and XbaI followed by ligation. Positive clones were confirmed with 
Sanger sequencing. 
The full map and sequence of pYDg2 can be found in Appendix II. 
 
2.8 GUS histochemical and fluorometric assays 
Protocols for GUS assays were based on the method published by Jefferson et al. (1987) and 
Schornack et al. (2005). 
2.8.1 GUS histochemical staining 
GUS Stain: 
Ingredient Stock Amount added for 50 mL Final Concentration 
0.1 M Na3PO4 25 mL 50 mM 
10% (v/v) Triton-X  1000 µL 0.2% (v/v) 
0.1 M Potassium Ferrocyanide 1000 µL 2 mM 
0.1 M Potassium Ferricyanide 1000 µL 2 mM 
ddH2O 22 mL  
0.1 M X-GLUC in DMF 1000 µL 2 mM 
 
Incubate at 37°C overnight. Clear tissue in ethanol. 
 
2.8.2 GUS fluorometric assay 
Equal leaf spots were punched using the mouth of a 2mL microcentrifuge tube avoiding 
veins and wound sites, frozen in liquid nitrogen, and stored at -80°C. Frozen tissue punches 
were ground in a tissue lyser using 3-4 3mm glass beads for 2 minutes. 150µL Extraction 
Buffer were added to each tube and mixed thoroughly by vortex. Samples were centrifuged for 
10 minutes at 13,000 RPM at 4°C and 100µL of supernatant transferred to a new tube. 10µL 
of the sample was mixed with 90µL Assay Buffer and incubated at 37°C for an hour. 900µL 
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0.2 M Na2CO3 (pH 9.5) was added to each sample to stop the reaction. 300µL of each sample 
was loaded into a 96 well plate along with dilutions of 4-methyl-umbelliferone as standards 
and read in a plate reader. Plate readers used were: BMGlabtech CLARIOstar with pre-set 4-
MUG settings 360nm (excitation)/450nm (emission); or BMGlabtech FLUOstar Omega with 
settings 355nm (excitation)/460nm (emission). 
Extraction Buffer: 
Ingredient Stock Amount added for 20 mL Final Concentration 
1M Na3PO4  1 mL 50 mM 
b-mercaptoethanol 14 µL 10 mM 
10% (v/v) Triton X-100 200 µL 0.1% (v/v) 
10% (w/v) SDS 200 µL 0.1% (w/v) 
0.5M EDTA (pH 8) 400 µL 10 mM 
DI water 18.2 mL  
 
Assay Buffer: 
Ingredient Stock Amount added for 5 mL Final Concentration 
4-MUG 0.0088 g 5 mM 
Extraction Buffer 5 mL  
 
0.2 M Na2CO3: 
Ingredient Stock Amount added for 50 mL Final Concentration 
Na2CO3 1.06 g 0.2 M 
DI water 50 mL  
à pH to 9.5 
 
4-methyl-umbelliferone (MU) stock solution: 
Ingredient Stock Amount added for 10 mL Final Concentration 
MU salt 0.002 g 1 mM 
0.2M Na2CO3 (pH 9.5) 10 mL  
 
 
1M Na3PO4, 10% (v/v) Triton X-100, 10% (w/v) SDS, and 0.5M EDTA (pH 8) were prepared 
by James Barlow. 
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Chapter 3: Generation of a CRISPRa system in plants 
Introduction 
3.1 CRISPRa in plants 
CRISPR activation (CRISPRa) functions when deactivated Cas9 (dCas9) fused to a 
transcriptional activator forms a complex with gRNA and sits on a target DNA promoter 
region, inducing increased expression of the downstream gene (Gilbert et al. 2013, Maeder et 
al. 2013, Perez-Pinera et al. 2013). Unlike a CRISPR gene knock out, activation is not 
dependent on the mutation being out of frame, it is not dependent on degradation of the gene’s 
product protein before sampling, and an effect can be easily observed and quantified even if 
there is activity on only a single allele. This last quality allows CRISPRa to overcome the 
challenge of functional redundancy faced by knock out assays. I therefore decided to use 
CRISPRa as a tool for testing non-transgenic methods of gRNA delivery. At the time of 
designing this project, there were only two demonstrations of CRISPRa in plants (Piatek et al. 
2015, Lowder et al. 2015). 
 Piatek et al. (2015) generated three plant expression constructs to form their CRISPRa 
system (Figure 3.1A). The first contained a 2X35S CaMV promoter driving human codon 
optimised dCas9 fused to either the EDLL domain from the ERF/EREBP family of plant 
transcription factors or a TAL activation domain (TAD). The second construct contained a 
GFP:GUS fusion reporter driven by a Bs3 minimal promoter from Capsicum annuum, 
originally published by Römer et al. (2009), uncited by Piatek et al. (2015). For the gRNA, 
Piatek et al. (2015) cloned each gRNA driven by the Arabidopsis U6 promoter into the multiple 
cloning site of a Tobacco Rattle Virus RNA2 cDNA construct. When they agroinfiltrated all 
three constructs together using gRNA targeting the Bs3 minimal promoter, they were able to 
show activation of the GUS reporter gene with either the dCas9-EDLL or the dCas9-TAD. 
Lowder et al. (2015) set out to create a toolbox for transcriptional regulation in plants. 
For CRISPRa, they designed a system in which plant codon optimised dCas9 (pco-dCas9) 
fused to transcriptional activator VP64 combines with gRNA to target a synthetic minimal 
promoter driving an intron-containing GUS reporter gene. The synthetic minimal promoter 
contains multiple gRNA binding sites and was chosen in order to avoid the regulatory factors 
that interact with promoters of endogenous genes (Figure 3.1B).  
They first tested their synthetic system using transient expression in N. benthamiana by 
co-infiltrating two expression constructs: one containing the GUS reporter driven by the 
minimal promoter and one encoding dCas9-VP64 and three gRNAs. They observed activation 
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of the GUS upon co-expression compared to the reporter construct alone (Figure 3.1C). They 
then demonstrated endogenous gene activation in Arabidopsis stably transformed with dCas9-
VP64 and three gRNAs from a single T-DNA construct. One of the endogenous targets tested 
was a methylated promoter region, and the dCas9-VP64 was able to activate the downstream 
gene.  This result showed the possibility for using CRISPRa in plants for epigenetic analyses.  
The goal of the work presented in this chapter was to develop a system suitable for 
testing non-transgenic gRNA delivery into plants stably expressing an dCas9-activator and a 
reporter gene. My design differs from the previous methods (Lowder et al. 2015, Piatek et al. 
2015) because it is based on only the gRNA being kept separate, while the activator and 
reporter are together in one construct to allow a single transformation step to generate 
transgenic lines. 
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A)
B)
C)
Figure 3.1 Previously demonstrated systems of CRISPRa in plants. A) Schematic of the 
system used by Piatek et al. (2015) in which gRNAs were designed to target a minimal Bs3 
promoter to activate GFP:GUS expression when combined with a dCas9-activator. B) 
Schematic of the system used by Lowder et al. (2015) in which 3 gRNAs were designed to 
combine with dCas9-VP64 to target a synthetic minimal promoter driving an intron 
containing GUS reporter gene C) Transient expression assay by Lowder et al. (2015) 
demonstrating that co-expression of dCas9-VP64 and 3 gRNAs targeted to their synthetic 
minimal promoter can increase GUS expression. 
Figures adapted from Piatek et al. (2015) and Lowder et al. (2015) 
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Results 
3.2 Construct design 
3.2.1 dCas9-activator-reporter construct (K-AR) 
The design of the dCas9-activator-reporter vector was based on a combination of the 
systems described in Lowder et al. (2015) and Piatek et al. (2015), with important 
modifications. Instead of the human codon optimised dCas9 used by Piatek et al. (2015), I 
chose the plant codon optimised dCas9 from Lowder et al. (2015). I decided to use the VP64 
transcriptional activator because it been demonstrated in plants by Lowder et al. (2015) and 
there was continued development on the use of dCas9-VP64 in animal systems (Zalatan et al. 
2015, Konermann et al. 2015) which might allow for easy improvement of my system in plants 
in the future. 
For the gRNA, I used an expression method specifically designed for gRNA instead of 
cloning the AtU6 promoter driving gRNA into the MCS of a viral cDNA expression plasmid 
as in Piatek et al. (2015). This was an illogical design decision for their constructs because the 
system was not used for viral delivery. 
For transient expression assays in N. benthamiana, Lowder et al. (2015) used a single 
construct containing the dCas9-VP64 fusion and three gRNAs co-infiltrated with a construct 
expressing intron-containing GUS under a synthetic minimal promoter. In contrast, Piatek et 
al. (2015) kept all the components in separate constructs, one for the reporter, one for the 
dCas9-activator, one for gRNA. Unlike Lowder et al. (2015), a design feature of my system 
was keeping the gRNA separate from the dCas9-VP64 in order to be able to test its introduction 
in trans. My design is distinct from that of Piatek et al. (2015), however, because I made a 
single construct containing the dCas9-VP64 and the reporter gene in order to require only a 
single tissue culture step to stably transform both components.  
Following a similar strategy to the Bs3 minimal promoter used by Piatek et al. (2015), 
I chose to use the Bs4 minimal promoter from tomato (Schornack et al. 2005), which had been 
previously used in testing activation of a reporter gene by TAL effectors (Boch et al. 2009). 
Schornack et al. (2005) demonstrated that the Bs4 promoter in tomato can be truncated which 
causes minimal expression of the Bs4 gene. They showed that the 74bp truncation was not long 
enough to allow the Bs4 protein to function properly, but it was still viable to drive GUS and 
showed the lowest level of GUS expression. Therefore, I wanted to use the 74bp sequence. 
Unfortunately, this strategy was not feasible because no PAM sites exist within the 74bp 
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region. Therefore, I chose to use the next shortest truncation, 302bp in length, to drive the 
minimal expression of the reporter.  
 For the reporter, I chose to use a GFP:GUS fusion as was previously used for CRISPRa 
(Piatek et al. 2015) and for the original demonstration of the Bs4 minimal promoter (Schornack 
et al. 2005). The dCas9-VP64 needed to be under a constitutive promoter, and I chose the 
commonly used 2x35S promoter from Cauliflower Mosaic Virus. 
   
3.2.2 gRNA selection and construct design 
The gRNA constructs were designed to each contain one gRNA targeting the Bs4 
minimal promoter in a binary vector. Due to the short length of the 302bp truncated Bs4 
promoter, there were only a few options for gRNA target sites, which require the NGG PAM 
sequence (Jinek et al. 2012). I chose three positive sense sites at various locations in the 
promoter, shown in Figure 3.2A. 
 To drive the gRNA, I used the Arabidopsis thaliana AtU6-26 promoter, based on the 
system developed by Fauser et al. (2014). Arabidopsis U6 RNA is transcribed by RNA 
Polymerase III (Pol III) (Waibel and Filipowicz 1990). A Pol III promoter is commonly used 
for gRNA expression because the promoter elements are upstream of the transcribed region so 
they do not interfere with the RNA sequence, their specific transcription start site allows for a 
clean 5’ end of the gRNA, and they have a known termination sequence of a polyT stretch 
(Gao et al. 2018).  
While new evidence in mammalian cells suggests the Pol III transcription start site 
(TSS) might be more complicated than originally thought (Ma et al. 2014), it is generally 
accepted that gRNAs driven by animal and plant U6 promoters should be designed on the basis 
that Pol III prefers to recognise a G at the +1 position (Ran et al. 2013, Parry et al. 2016). None 
of the gRNA sites in the Bs4 302bp promoter began with a G. Therefore, I added a G onto the 
5’ end of each of my gRNAs because it can increase efficiency of the gRNA without affecting 
specificity (Ran et al. 2013, Parry et al. 2016) (Figure 3.2B).  
I only included one gRNA per binary vector because the methods of introducing the 
gRNA in trans in the later parts of my project were limited to the ability to use a single gRNA 
at a time. Therefore, I made three separate gRNA binary vectors to be able to test the proof of 
principle that the system can work with a single gRNA. 
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gRNA1 gRNA2
gRNA3
A)
B)
Figure 3.2. gRNA selection and design. A) Shows the sequence of the Bs4 302bp minimal 
promoter. Red boxes indicate the location of gRNAs selected and their adjacent PAM 
sequence. Figure modified from Schornack et al. (2005). B) Illustration of adding a G to the 
5’ end of gRNA in order to prepare it for transcription by Pol III, which prefers a G in the 
+1 location. Figure from ABM Inc. 
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3.3 Construct generation 
3.3.1 dCas9 activator reporter vector (K-AR) 
The activator-reporter construct was designed to contain a dCas9-VP64 fusion driven 
by 2X35S promoter in the same construct as a GFP:GUS fusion reporter driven by the Bs4 
minimal promoter. I generated this construct using a variety of molecular cloning techniques, 
culminating in a multisite Gateway reaction to combine three separate constructs. Gateway 
cloning matches recombination sequences called “attL/attR” sites (Hartley et al. 2000) and I 
needed to ensure correct assembly in the final reaction using correct sites in the three progenitor 
constructs (Figure 3.3).  
I began with the binary vector and Gateway destination vector pKGWFS7 (Karimi et 
al. 2002), which contains attR1 and attR2 sites followed by a GFP:GUS fusion reporter and 
confers kanamycin resistance in plants. In between the attR1 and attR2 sites of pKGWFS7, I 
inserted the sequence encoding the dCas9-VP64 fusion and the Bs4 minimal promoter to drive 
expression of the GFP:GUS reporter that was already downstream of the Gateway cassette. 
Insertion of a 2X35S promoter upstream of the Gateway cassette allowed expression of the 
dCas9-VP64. Since the backbone of this construct is pKGWFS7 and it contains the activator 
and reporter parts of my system, I named this construct “pK-AR.” The complete cloning 
strategy is illustrated in Figure 3.3 and described in Chapter 2. Primers are in Appendix I and 
the map and sequence of pK-AR can be found in Appendix II. 
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Step%1:%Amplify%2x35S%promoter%from%pYL156%with%SacI and%SpeI
overhangs
Step%2:%Insert%2x35S%promoter%into%pKGWFS7%(Karimi et#al.#2002)%
with%SacI and%SpeI restriction/ligation
2x35S&promoter
SpeI overhang
SacI overhang 2x35S&F
2x35S&R
LB RB
attR1 attR2 GFP:GUS Kanamycin&resistance
SacI SpeI T?DNA&region&of&pKGWSF7&
2x35S&promoter
SpeISacI
Step%3:%Amplify%Bs4%302bp%promoter%from%pGWB19N300%(Schornack et#al.#2005)%
with%overlaps%for%Type%II%restriction%reaction
302bp&Bs4&
promoter
TCTCACTAT Bs4&302&F
GACCACTCTBs4&302&R
Step%4:%Insert%Bs4%302bp%promoter%into%pYPQ143%(Lowder et#al.#2015)%using%
Type%II%restriction%reaction
Step%5:%3NWay%Multisite%Gateway%reaction%
LB RB
attR1 attR2 GFP:GUS Kanamycin&resistance2x35S&promoter
attL1 dCas9?VP64 attR5&
Gateway&entry&vector&pYPQ152&(Lowder et2al.22015) pYPQ143&+&Bs4&302bp
attL5 Bs4&min&prom attL2
pKGWFS7&+&2X35S&
302bp&Bs4&promoter
GACCACTCTTCTCACTAT +
Figure 3.3. K-AR cloning strategy. First, I amplified 2X35S promoter from pYL156 and 
inserted it into pKGWFS7 using restriction cloning (Steps 1-2). Next, I amplified Bs4 302bp 
promoter from pGWB19-300 and performed Type II Restriction with BsaI to insert it into 
pYPQ143 (Steps 3-4). The cloning culminated in a multisite Gateway reaction with 
pYPQ152, pYPQ143+Bs4 302, and pKGWFS7 + 2X35S (Step 5). Image in Step 4 modified 
from Lowder et al. (2015). 
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3.3.2 gRNA vector 
The gRNA construct needed to be a binary vector that would allow the gRNA to be 
transiently expressed or stably transformed into N. benthamiana separately from K-AR. pEN-
Chimera (Fauser et al. 2014) is a Gateway entry vector designed for gRNA expression. It 
includes the AtU6-26 promoter upstream of a BbsI Type II restriction site where the gRNA is 
inserted and the gRNA scaffold sequence downstream of the insertion site (see Figure 3.4 Step 
1).  
Following the protocol in Schiml et al. (2016), I generated three separate pEN-Chimera 
gRNA constructs. I then used Gateway cloning to insert the gRNA construct from pEN-
Chimera into pGWB401 (Nakagawa et al. 2007), an empty binary Gateway destination vector 
with Kanamycin resistance in plants. The final binary vector construct would allow 
transcription in planta of the gRNA driven by the AtU6-26 promoter. The full gRNA cloning 
strategy is illustrated in Figure 3.4 and is described in Chapter 2. gRNA oligos are listed in 
Appendix I.  
 
A summary of the constructs in my CRISPRa system can be found in Figure 3.5. 
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Step%1:%Digest%pEN.Chimera%(Fauser et#al.#2014)%with%BbsI and%
purify%the%product
Step%2:%Anneal%gRNA%oligos
Step%3:%Ligate%restricted%pEN.Chimera%with%annealed%gRNA%
oligos,%transform%into%E.coli#and%select%positive%clones%of%pEN.
Chimera+gRNA
Step%4:%Single%site%Gateway%reaction%between%pEN.
Chimera+gRNA and%pGWB401%(Nakagawa%et#al.#2007)
attL1 AtU6(26*promoter attL2gRNA
Gateway*entry*vector*pEN(Chimera+gRNA
LB RB
attR1 attR2Kanamycin*resistance
Gateway*destination*binary*vector*pGWB401
Fig. S5. Sequence information for pEn-Chimera. pEn-Chimera can be adapted to any 
target site of interest as described for pChimera (Figure S4). In contrast, the customised 
sgRNA can be transferred to pDe-CAS9 via Gateway® cloning (LR reaction).!
!
gRNA
gRNA*F
gRNA*R
Figure 3.4. gRNA cloning strategy. First, pEN-Chimera (Fauser et al. 2014) was digested 
with BbsI (Step 1). Next, gRNA oligos were annealed and ligated into the restricted pEN-
Chimera. Positive clones were selected (Steps 2-3). The final step was a Gateway reaction 
between pEN-Chimera+gRNA and pGWB401 (Nakagawa et al. 2007) (Step 4). Images in 
Steps 1 and 3 modified from Fauser et al. (2014). 
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+
GFP:GUSpromoter
gRNA
dCas9
VP64
GFP:GUS
fusion
Bs4 minimal 
promoter
LB RB
2x35S
promoter
dCas9:VP64 
fusion
Kanamycin 
resistance Nos promoter
K-AR A. tumefaciens expression construct
LB RB
Kanamycin 
resistance
Nos promoter gRNA U6promoter
gRNA A. tumefaciens expression construct
Figure 3.5. Schematic of activator-reporter system. When gRNA is co-expressed with K-
AR, the dCas9-VP64 forms a complex with the gRNA and sits on the Bs4 302bp minimal 
promoter, inducing the increased expression of the downstream reporter.  
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3.4 Transient expression assays demonstrate functionality of constructs 
After assembling the constructs, I transformed them into A. tumefaciens GV3101 pSoup 
and tested their functionality using transient assays in wild type N. benthamiana. Constructs 
transformed into A. tumefaciens are depicted in Figure 3.6A and full methods of transient 
infiltration can be found in Chapter 2. I infiltrated four spots per leaf (Figure 3.6B): 1) 35S 
GUS positive control + empty A. tumefaciens 2) K-AR + gRNA 3) K-AR + empty A. 
tumefaciens 4) gRNA+ empty A. tumefaciens. I expected K-AR + gRNA to show activation 
compared to the basal level of GUS expression present in the spot containing the K-AR + 
empty A. tumefaciens. In the spots where only one experimental construct was used, it was 
mixed in a 1:1 ratio with empty A. tumefaciens in order to maintain equal concentration of 
individual constructs compared to the K-AR and gRNA mixture. Three days post infiltration 
(dpi), I sampled the tissue for analysis of GUS expression. 
I used ImageJ to quantify the pixel intensity of scanned images of the GUS 
histochemical assay (Figure 3.6C) to test for GUS activation using gRNA1. There was a 
statistically significant activation of GUS level in the K-AR + gRNA1 spot compared to the K-
AR + empty A. tumefaciens (Figure 3.6D). While this was a promising result, it appeared the 
levels of activation would be quite low. I therefore used the more quantitative and sensitive 
GUS fluorometric assay in the rest of the activation experiments. 
The GUS fluorometric assay at 3dpi (for method see Chapter 2) showed significant 
increases in GUS expression when a mixture of K-AR + gRNA was co-infiltrated compared to 
K-AR + empty A. tumefaciens for all three gRNAs (Figure 3.7). gRNA2 and gRNA3 showed 
considerably higher levels of activation than gRNA1.  
In order to test the background reading of a non-infiltrated wild type leaf compared to 
the gRNA + empty A. tumefaciens control I had been using as a negative control, I performed 
a separate experiment to test the readouts of these two conditions. This assay showed no 
difference in GUS measurement between non-infiltrated wild type leaf and wild type leaf 
infiltrated with gRNA3+empty A. tumefaciens (Figure 3.8). 
These transient assays in wild type N. benthamiana served as proof of principle of my 
system, and therefore I was able to move forward with generating stably transformed lines. 
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Figure 3.6. Transient expression assays in wild type N. benthamiana leaves show 
activation of GUS reporter by gRNA1. A) All constructs transformed into A. tumefaciens 
for expression assays. B) Diagram of constructs co-infiltrated into leaf spots for transient 
expression assays. For infiltrations where only one experimental construct was used, it was 
mixed in a 1:1 ratio with empty A. tumefaciens so that there were equal concentrations of 
individual constructs in each leaf spot. C) Scans of GUS stained leaf discs from a transient 
expression assay using gRNA1. D) Quantification of the GUS stain in C) by pixel intensity 
using ImageJ. There were significant differences between K-AR + gRNA1 and K-AR + 
empty as well as between K-AR + empty and gRNA1 + empty (p=0.049, p=2.6*10-5, 
respectively). p-values measured by pairwise t-test. 
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Figure 3.7. GUS fluorometric quantification of transient expression assays in wild type N. 
benthamiana show activation by all three gRNAs. Wild type N. benthamiana leaves were infiltrated 
with 4 spots per leaf as shown in Figure 3.6B. Fluorometric assays revealed GUS levels resulting from 
co-expression of K-AR and gRNA were significantly higher than K-AR and empty A. tumefaciens for 
each of the 3 gRNAs. A), C), E) show fine scale to visualise activation. B), D), F) include GUS 
positive control. A)/B) Activation by gRNA1: n= 22 leaves; p = 2.2*10-7. C)/D) Activation by 
gRNA2: n= 10 leaves; p= 7.8*10-5 E)/F) Activation by gRNA3: n= 6 leaves; p=1.1*10-4. Reported p-
values represent the significance between “K-AR + gRNA” and “K-AR + empty” and were calculated 
by pairwise t-test. The difference between “K-AR + empty” and “gRNA1 + empty” was also 
significant in all cases but not relevant for demonstrating functional activation. 
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Figure 3.8. GUS fluorometric assay to determine background level of GUS 
fluorometric assay in wild type leaves. Wild type N. benthamiana leaves were infiltrated 
in one spot with gRNA3 + empty A. tumefaciens and the rest of the leaf was non-infiltrated. 
There was no significant difference between the two conditions. n=8 leaves, p=0.15, 
pairwise t-test. 
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3.5 Generation and characterisation of stably transformed lines 
The overall aim of this project was to test various methods of delivering gRNA in trans, 
so I needed to make stable transgenic lines for four separate constructs (one K-AR, one for 
each of three gRNAs) (see Chapter 2 for transformation protocol).  
The gRNA transformations produced 6 gRNA1 T0s, 11 gRNA2 T0s, and 8 gRNA3 
T0s. I genotyped 6 T0s from each group using primers located in the backbone of the binary 
vector, spanning the gRNA insertion site (M13_F and M13_R). All the gRNA T0s tested were 
positive. These six T0s from each gRNA construct were self-fertilised and seed was harvested.  
Transformation yielded 6 K-AR T0s. To determine whether the transgene was 
successfully integrated, I performed PCRs using primers that spanned the Bs4 minimal 
promoter and part of the GFP:GUS reporter gene (Bs4p_F and pK_R). 3 out of the 6 K-AR 
T0s tested positive for the transgene. It is known that transformations are likely to have 
“escapes,” false positive shoots that do not contain the transgene (Estopà et al. 2001, Rakosy-
Tican et al. 2007, Zale et al. 2009), so this result was not unexpected. I next checked for 
transgene expression in these three K-AR T0 lines using RT-PCR with primers in the sequence 
encoding the dCas9 (KRT_FWD and KRT_REV). Two out of the three were positive, likely 
due to transgene silencing in one of the lines. The positive line K-AR T0 #6 was self-fertilised. 
Its seed was collected and sown on soil as the T1 generation. 
Primer sequences are in Appendix I. 
 
3.6 Transient assays on K-AR T1 generation show activation ability 
To confirm that the K-AR construct could be activated in the T1 transgenic lines, I used 
transient expression assays on the T1 K-AR leaves with:  1) gRNA2; 2) gRNA3; 3) non-
infiltrated leaf; 4) empty A. tumefaciens. The GUS fluorometric assay at 3dpi showed 
activation by gRNA2 and gRNA3 in 4 out of 6 T1 plants (Figure 3.9A). Activation level could 
be categorised into three main groups: high activation, lower activation, and no activation 
(circled in Figure 3.9A). The leaf spot infiltrated with empty A. tumefaciens also exhibited mild 
activation compared to the non-infiltrated leaf, but the activation demonstrated by the addition 
of gRNA was far higher. Genotyping (primers: Bs4p_F and pK_R) revealed that the two plants 
(#44 and #52) that exhibited background values tested negative for the transgene (Figure 3.9B).  
The activation levels and segregation pattern suggest that the K-AR transgene was 
hemizygous in K-AR T0 #6 and the T1s were either homozygous, hemizygous, or null. T1 #21 
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exhibited the highest activation level of the T1s in this assay and was likely homozygous, so it 
was self-fertilised and seed was collected in order to use the T2 generation in later experiments.  
Agroinfiltration with gRNA2 showed consistent activation ability in the stable lines, 
and I therefore chose it as the gRNA used for the rest of the project. RT-PCRs using a primer 
pair specific to gRNA2 (gRNA2_RT_F and gRNA_RT_R) confirmed that the gRNA2 T0s that 
had genotyped positive also expressed the transgene. Seed from the positive gRNA2 #24 T0 
was sown on soil to produce the T1 generation. T1s were screened for expression with RT-
PCR and all tested individuals were positive. Plant gRNA2#24/#1 was self-fertilised and seed 
was harvested to be sown in the future as the T2 generation. 
 
3.7 Characterisation of K-AR T2 generation 
Genotyping and RT-PCR confirmed presence and expression of the transgene in all 
individual plants of the K-AR#6/21 T2 generation. This pattern further confirms that K-
AR#6/21 T1 was homozygous for the transgene, and therefore the T2 plants would also be 
homozygous.  
To confirm function of the activation system in the K-AR T2 generation, I performed 
transient expression with: 1) gRNA2; 2) 35S GUS; 3) non-infiltrated leaf; 4) empty A. 
tumefaciens. The GUS fluorometric assay showed activation by gRNA2, significantly higher 
than the slight activation exhibited by empty A. tumefaciens infiltration alone (Figure 3.10). I 
used two independent A. tumefaciens cultures for each construct and infiltrated two leaves per 
plant, one with each group of bacterial cultures, to ensure biological replication. This transient 
expression experiment demonstrated that the K-AR T2s were suitable for use in further 
experiments on gRNA delivery in trans. 
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Figure 3.9. GUS fluorometric assay and genotyping of K-AR T1 lines. A) GUS 
fluorometric assay 3dpi after agroinfiltrating spots of gRNA2, gRNA3, and empty A. 
tumefaciens show the transgene is able to be activated in 4 out of 6 lines. Two of the lines 
were unable to be activated. Circles are drawn around three groups of activation – high 
activation, lower activation, no activation. B) Genotyping revealed segregation of the K-AR 
transgene. The plants lacking the transgene are the plants that did not show GUS activation 
by the gRNA in the transient expression assay (A).  
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Figure 3.10. Transient expression assays in K-AR T2 lines demonstrated functionality 
of the system. Leaf spots of K-AR T2 lines agroinfiltrated with gRNA2 showed significant 
GUS activation compared to spots infiltrated with empty A. tumefaciens (p=1*10-5).  There 
was also significant activation due to empty A. tumefaciens alone compared to non-
infiltrated leaf (p=3.9*10-10).  A) shows fine scale to visualise activation while B) includes 
the GUS positive control which confirmed effective infiltration technique.  
Two independent A. tumefaciens cultures were used per construct and divided into 
infiltration groups to ensure biological replication. n=12 leaves (6 leaves per bacterial 
culture group). p-values were calculated by pairwise t-test. 
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Discussion 
3.8 Construct design and transient assays in wt N. benthamiana 
First, I successfully used molecular cloning to generate constructs for CRISPRa in 
plants. One construct contains a constitutively expressed dCas9-VP64 activator and a 
GFP:GUS reporter driven by the Bs4 minimal promoter. I chose to include both the activator 
and reporter in the same construct so that both components could be stably transformed into N. 
benthamiana in a single tissue culture process. The second construct contains the gRNA to 
target the Bs4 minimal promoter. When the two constructs are co-expressed, the gRNA-bound 
dCas9-VP64 targets the Bs4 minimal promoter and increases levels of GUS expression.  
Importantly, I needed to demonstrate that a single gRNA is able to activate the system, 
instead of requiring a multiplexed approach. While multiplexing has been shown to cause 
higher levels of activation (Maeder et al. 2013, Perez-Pinera et al. 2013, Piatek et al. 2015), 
the limitations of the future aims of my project (delivering a gRNA via a virus or grafting) 
required that only one gRNA be used at a time.  
The ability of each gRNA alone to activate the system was demonstrated in transient 
assays in wild type N. benthamiana (Figure 3.7). gRNA2 and gRNA3 showed much higher 
levels of activation than gRNA1. Piatek et al. (2015) also noticed variability in the effects of 
their gRNAs for CRISPRa. They observed that the gRNAs they designed to bind the sense-
strand of target DNA were more effective than those binding in the anti-sense direction. All 
three of my gRNAs are designed to target the sense-strand so this is not the cause of difference.  
One theory is that the sequence of the gRNA might affect its activation ability. It has 
been shown that Cas9 cutting efficiency is influenced by gRNA nucleotide composition 
(Doench et al. 2014), however the same sequence rules did not have a significant effect on 
CRISPRa (Doench et al. 2016). In one of the initial tests of CRISPRa using dCas9-VP64, 
Maeder et al. (2013) reported no correlation between gRNA nucleotide composition and 
activation level. More research needs to be done to better understand how to predict nucleotide 
sequences for effective CRISPRa gRNA design. 
It is most likely that target site location of my gRNAs affected their activation ability. 
Piatek et al. (2015) suggest that the distance from the TSS might have explained the behaviour 
of their gRNAs, but do not provide any support from the literature for this claim. This 
hypothesis has been more carefully considered in mammalian systems and large-scale studies 
have shown that the ideal target site locations of gRNAs for various CRISPR applications are 
different (Gilbert et al. 2014, Mohr et al. 2016). Konermann et al. (2015) found that the best 
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prediction of how effective a gRNA would be for CRISPRa was distance from the transcription 
start site (TSS), with the highest levels of activation occurring when the target site was within 
the -200bp to +1bp region of the promoter. Gilbert et al. (2014) observed a slightly different 
optimal window for CRISPRa activity within -400 to -50 bp upstream from the TSS.  
All three of my gRNAs are within the ranges suggested by Gilbert et al. (2014) and 
Konermann et al. (2015). Perhaps the location of the gRNA relative to various promoter 
elements might cause the difference in activation ability. For example, distance from a TATA 
box could be an indicator of activation potential. gRNA2 and gRNA3 are both closer to a 
TATA box than gRNA1 (Figure 3.2A). As CRISPRa becomes a more widely used technique, 
it might be useful to use the large data sets to zoom in on the high activation window of -400bp 
to +1bp to get better information on gRNA placement and promoter elements. In addition, 
continuing to improve gene annotations and precise locations of promoter elements and the 
TSS will facilitate designing the best gRNAs for CRISPRa (Mohr et al. 2016). It will be 
important in the future to build a data set for CRISPRa in plants instead of extrapolating 
observations from studies in mammalian cells. 
The activation levels observed in these assays were consistent with other studies using 
VP64 as an activator (Konermann et al. 2015, Li et al. 2017). I tested the background of the 
system in wild type plants comparing leaf spots agroinfiltrated with a mixture of gRNA3 and 
empty A. tumefaciens to non-infiltrated wt leaf spots. These two groups showed no difference 
in the GUS fluorometric assay confirming that the gRNA alone was not having any effect on 
the GUS level in wt plants (Figure 3.8).  
While the reporter used in this system is a GFP:GUS fusion, I chose only to assay the 
GUS activity. It has been shown that GFP in a protein fusion is less easily detected from low 
transcript levels (Martin et al. 2009). Since I was anticipating relatively small changes in the 
amount of reporter transcript, I thought that an enzymatic assay would provide a more reliable 
readout. In addition, Schornack et al. (2005) and Piatek et al. (2015) whose work formed a 
guide for my assays used a GFP:GUS fusion and also only assayed for GUS.  
The assays in this chapter used an equal-sized leaf punch as an approximation for an 
equal amount of protein per sample. There could be slightly different amounts of protein per 
sample due to conditions like leaf thickness, leaf age, and punch location, but the effects on the 
results would be random, not causing a clear pattern. Therefore, while there may be mild 
variability in the data that is not represented in my results, I am confident that the patterns of 
activation displayed using the leaf punch as an approximation are valid. Future experiments 
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could measure total protein per sample using the Bradford Assay to provide a more precise 
quantification.  
All the quantification of reporter levels in this chapter should be further confirmed by 
using qPCR to measure RNA expression. This method is complementary to the enzymatic 
assay because it measures mRNA instead of protein and would be a clear readout because there 
is no background level of expression of the GUS transgene in wild type plants.  
 
3.9 Stable transgenic lines showed functional CRISPRa  
After demonstrating proof of principle of the system, I generated and characterised 
stably transformed lines of N. benthamiana, transgenic with either the K-AR construct or one 
of three gRNAs. Piatek et al. (2015) did not make any stably transformed lines of their system, 
limiting them to only testing transient effects. Lowder et al. (2015) made stable transgenic lines 
using a single expression construct including the dCas9-VP64 and three gRNAs designed to 
target an endogenous gene of choice. Their system successfully activated the target gene, but 
was not designed for testing methods of gRNA delivery. Therefore, the goal of my 
transformation lines was to establish the first system in which gRNA could be delivered in 
trans to a stably transgenic activator-reporter system. 
When I agroinfiltrated the T1 generation of a K-AR transgenic line with gRNA 
targeting the Bs4 minimal promoter, there was significant activation of the GUS reporter 
compared to the non-infiltrated leaf or leaf infiltrated with empty A. tumefaciens (Figure 3.9). 
This result confirmed that the activator-reporter transgene was functional and able to be 
activated in my transgenic lines. The T1 plant exhibiting the highest activation and likely to be 
homozygous was self-fertilised and its progeny were used as the K-AR T2 generation.  
Transient expression assays in the T2 generation also displayed significant activation 
in leaf spots where gRNA had been infiltrated compared with leaf spots of non-infiltrated tissue 
or tissue infiltrated with empty A. tumefaciens (Figure 3.10). Establishing functional 
transactivation in these K-AR T2s was essential to being able to move forward with 
experiments exploring various methods of gRNA delivery. 
Interestingly, in both the T1 and T2 transient assays, I observed that the leaf spot 
infiltrated with empty A. tumefaciens showed increased GUS expression compared to the non-
infiltrated leaf spot. The earlier wild type N. benthamiana transient assays showed no 
difference between these two conditions (Figure 3.8). Additionally, the segregated plants in the 
T1 generation that were lacking the K-AR transgene did not show activation by A. tumefaciens 
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(Figure 3.9). Therefore, I concluded that the transgenic minimal Bs4 promoter may be slightly 
activated by the infiltration of A. tumefaciens, while significantly less than in the presence of 
gRNA.  
There is evidence to support that non-oncogenic A. tumefaciens used in biotechnology 
can trigger host plant immune responses in the infiltrated region (Pruss et al. 2008) and the Bs4 
gene is a known part of the disease resistance pathway in tomato (Schornack et al. 2004), 
specifically recognising the AvrBs4 avirulence protein from the bacterium Xanthomonas 
campestris pv. vesicatoria. No experiments have been done to show whether the Bs4 promoter 
or its truncated versions are activated upon infiltration of A. tumefaciens, so while the Bs4 
protein could be specific to targeting the AvrBs4 protein, the promoter activity could be 
increased upon signs of bacterial infection.  
This hypothesis is supported by the predicted W-box at the -171 position in the Bs4 
promoter (Schornack et al. 2005). The W-box is a conserved DNA sequence that acts as a 
binding site for WRKY transcription factors, which behave as regulators for plant pathogen 
defence (Pandey and Somssich 2009). The pathogen-associated molecular pattern (PAMP) of 
bacteria such as A. tumefaciens induces expression of WRKYs (Pandey and Somssich 2009). 
The PAMPs from A. tumefaciens are part of the bacteria’s virulence process (Djamei et al. 
2007), not restricted to the tumour-inducing genes that have been removed in the ‘disarmed’ 
strains used in biotechnology (Hellens et al. 2000). Van Verk et al. (2008) discovered a WRKY 
transcription factor (NtWRKY12) in N. tabacum that binds in the pathogenesis-related gene 
PR-1a promoter. They observed that when they infiltrated N. tabacum leaves with A. 
tumefaciens, expression of both PR-1a and NtWRKY12 increased. Pruss et al. (2008) did not 
mention WRKYs but also reported that A. tumefaciens infiltration induced expression of PR-1 
in N. tabacum.  
Therefore, it would be reasonable that the infiltration of A. tumefaciens into my K-AR 
T2 lines would induce the WRKY transcription factors, which would recognise the W-box in 
the Bs4 minimal promoter, and increase expression of the GUS reporter. If I were to redesign 
the construct, I would perhaps consider selecting a minimal promoter that is not involved in 
plant immune response, or check for the presence of a W-box. However, for my project, the 
important result was that the gRNA infiltrated spot showed significantly higher GUS 
expression than the activation exhibited in the leaf spot infiltrated with empty A. tumefaciens.  
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3.10 Conclusion 
The results in this chapter serve as the proof of principle of the activator-reporter system 
and demonstrate the functionality of the K-AR T2 stable transgenic lines. Therefore, I was 
confident moving forward with using these materials to test various non-transgenic gRNA 
delivery methods by CRISPRa.  
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Chapter 4: Transactivation using a viral vector 
Introduction 
4.1 Tobacco Rattle Virus in biotechnology 
Tobacco Rattle Virus (TRV) is frequently used in plant biotechnology as a delivery 
vector for engineered genetic sequences. It has a rod-shaped structure and the protein subunits 
are arranged in a helix (Hull 2002) (Figure 4.1A). TRV is an RNA virus with a genome 
comprised of two strands of positive sense RNA (Figure 4.1B). TRV RNA1 encodes for 
replicase proteins, a movement protein, and a 16K suppressor of silencing (Macfarlane 2010). 
This suppressor of silencing is one of the reasons TRV is so commonly used in biotechnology, 
because it is thought to allow the virus to invade plant meristems (Martin-Hernandez and 
Baulcombe 2008).  
TRV RNA2 encodes the viral coat protein and two non-structural proteins (2b and 2c) 
that are not essential for viral infection (Macfarlane 2010). The 2b non-structural protein is 
recorded either as 29.4K (Hernandez et al. 1995) or 40K (Visser et al. 1999). Sequencing 
differences established by Visser et al. (1999) that suggested the protein actually consists of 
additional amino acids caused the reclassification.  
Once in the plant cell, the RNA-dependent RNA polymerase (RdRP) encoded on TRV 
RNA1 is translated and replicates the viral genome (Newburn and White 2015). First it copies 
the genomic RNAs 3’ to 5’, generating negative sense genomic RNA molecules, which are 
then copied 3’ to 5’ to produce positive sense genomic RNA.  
Viral genomes include genes for several proteins. To ensure translation of internal open 
reading frames (ORFs) that do not begin at the 5’ end of the genomic RNA, TRV produces 
subgenomic RNAs (sgRNA). These sgRNAs can be thought of as 5’ deletion derivatives of the 
genomic RNA because they have the same 3’ end as genomic RNA, but different 5’ start sites 
(Miller and Koev 2000). There are two proposed mechanisms for the generation of sgRNA 
(Miller and Koev 2000, Sztuba-Solinska et al. 2011). “Internal initiation” involves the negative 
sense RNA acting as the template for both sgRNA transcription and genome replication. In this 
model, RdRp promoter sites exist both at the ends of the genomic RNA for replication and 
internally in the genomic RNA for sgRNA production (Miller et al. 1985).  
In an alternative “premature termination” model, the RdRP stops at a certain location 
on the genomic RNA as it transcribes the negative strand (Sit et al. 1998). This process results 
in a subgenomic length negative sense RNA strand which then serves as a template for positive 
sense sgRNA synthesis. These two models are summarised in Figure 4.2. 
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A)
B) Wild-type TRV1
Wild-type TRV2
Replicase MP
134KDa 194KDa 29KDa 16KDa
CP 29.4KDa 32.8KDa
Non-structural proteins
Silencing(
Suppressor
2b 2c
Figure 4.1. Physical and genomic structure of TRV. A) Electron microscopy image of 
TRV showing its helical, rod-shaped structure. Image from Offord (1966) B) Schematic of 
TRV genomic RNA structure. RNA1 contains replicases, a movement protein (MP), and a 
suppressor of silencing. RNA2 includes the coat protein (CP) and two non-structural 
proteins, “2b” and “2c.” Diagram modified from Senthil-Kumar and Mysore (2014). 
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A)
B)
Figure 4.2. Diagram of sgRNA production models. A) Shows “internal initiation” model 
in which a subgenomic promoter (SGP) causes the RNA-dependent RNA Polymerase 
(RdRP) to begin transcribing at a point in the middle of the viral genome instead of at the 
3’ end, generating a positive sense sgRNA strand. B) Shows “premature termination” model 
in which the SGP acts as a signal for the RdRP to stop reading, generating a negative sense 
sgRNA strand which is then read 3’ to 5’ to generate the final positive sense sgRNA. Figure 
from Sztuba-Solinska et al. (2011). 
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In plant RNA virus vectors, the inserted sequence is usually part of a sgRNA. In TRV 
RNA2, an engineered insert can replace the non-essential 2b and 2c sequences downstream of 
the RdRP promoter (MacFarlane 2010). The size limit for an insert sequence in TRV is around 
1.5kB (Burch-Smith et al. 2004). This size limitation means that TRV as a vector for CRISPR 
in plants can only accommodate the gRNA, while the 4kB Cas9 sequence has to be expressed 
separately.  
At the start of my PhD, there had been three attempts to perform Virus Induced Gene 
Editing (VIGE) in plants. Ali et al. (2015) showed that it is possible to use TRV as a vector to 
deliver gRNA and cause mutation in transgenic Cas9-expressing N. benthamiana. They 
reported the mutations were detected in two progeny lines. Yin et al. (2015) used cabbage leaf 
curl virus, a geminivirus with a DNA genome, to deliver gRNA into transgenic Cas9-
expressing N. benthamiana. While their system had a high efficiency of systemic genome 
editing in the infected plant, they were unable to show inheritance of the induced mutation, 
which the authors anticipated due to the limitations of the geminivirus used. Yin et al. (2015) 
also questioned the inheritance of Ali et al. (2015)’s system. Baltes et al. (2014) used bean 
yellow dwarf virus (BeYDV) lacking the coat and movement proteins as a vector to deliver the 
sequences for both the Cas9 and gRNA to N. tabacum. Gene editing mutations were 
successfully induced but limited only to the directly infected tissue because the virus could not 
spread cell-to-cell or systemically. 
Clearly, there is scope for further optimisation of VIGE as a reliable method for gRNA 
delivery for heritable CRISPR gene editing. My approach, described in this chapter, uses a 
modified TRV vector for delivery of a gRNA to my CRISPRa system (Chapter 3) because 
TRV has a high chance of invading the meristem and causing heritable mutations. The 
advantage of using a transactivation system for optimising the VIGE method is that even low 
activity can be detected and phenotypes can be observed without waiting for residual protein 
product to degrade.   
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Results 
4.2 Virus Design and Construct Generation 
4.2.1 Vector selection 
In order to infect N. benthamiana with TRV, binary Ti plasmid vectors for expression 
in plants containing the cDNA for TRV RNA1 and TRV RNA2 were generated first by Ratcliff 
et al. (2001) and later by Liu et al. (2002) based on TRV isolate PPK20. Direct infiltration of 
these vectors using A. tumefaciens causes the viral genomic RNA to be transcribed in the host 
plant so that the virus can then replicate and spread systemically. Both TRV RNA2 vectors 
include a multiple cloning site (MCS), designed for easy insertion of engineered sequences. In 
addition, the vector pair from Liu et al. (2002) includes a self-cleaving ribozyme at the 3’ end 
of the viral genomes to make sure there is a precise end for viral replication (Figure 4.3). For 
my project, I chose to use the vector pair from Liu et al. (2002) due to their demonstrated higher 
virulence (Liu et al. 2002). These vectors are “pYL192” encoding TRV RNA1 and “pYL156” 
encoding TRV RNA2. Since only TRV RNA2 needs to be engineered with synthetic sequence, 
I left pYL192 unchanged. I modified pYL156 in order to efficiently express my gRNA. 
 
 
 
B
pTRV1
2X35S
Replicase MP
134KDa 194KDa 29KDa 16KDa NOSt
Rz
Silencing(
Suppressor
pYL192'(RNA1)
pTRV2 (conventional cloning)
CP2X35S NOSt
Rz
MCS
EcoRI, Xbal, Stul, Ncol, BamHl, Kpnl, Sacl, Mlul, Xhol, Srfl, Smal
pYL156'(RNA2)
Figure 4.3. TRV cDNA regions of pYL192 and pYL156. pYL192 and pYL156, generated 
by Liu et al. (2002), include a 2X35S promoter driving the viral cDNA and a self-cleaving 
ribozyme sequence at the 3’ end of the viral genomic cDNA. pYL156 was engineered with 
a multiple cloning site for insertion of desired sequence fragments. Diagram adapted from 
Senthil-Kumar and Mysore (2014). 
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4.2.2 TRV RNA2 modifications 
I had two main considerations when designing my TRV RNA2 construct to deliver 
gRNA. First, I wanted to have as few non-essential bases as possible since it is known that 
smaller inserts are more stable in plant virus vectors (Avesani et al. 2007, Bruun-Rasmussen 
et al. 2007, Burch-Smith et al. 2004). The second main consideration was to ensure that the 
gRNA sequence started as close to the viral transcription start site (TSS) as possible in order 
for the gRNA to have an accurate 5’ end. The 5’ sequence of the gRNA aligns with the 
complementary target DNA and additional sequence could interfere with the targeting 
mechanism. 
The TRV subgenomic RdRP promoter is not precisely defined (Miller and Koev 2000), 
but is generally thought of as the regions between ORFs on a viral genomic RNA. pYL156 
includes the region in between the coat protein and 2b non-structural protein as the subgenomic 
RdRP promoter before the engineered MCS. Based on the findings of Hernández et al. (1995) 
and the reporting of Goulden et al. (1990), I located the transcription start site of TRV RNA2 
sgRNA in strain ppk20 (Figure 4.4). I then analysed the sequence of pYL156 to find any non-
essential bases between the TSS of the sgRNA and the MCS where my gRNA would be 
inserted. 
There was a region of 303 bp in between the TSS and the MCS that corresponded to 
residual bases from the 5’ end of the 2b non-structural protein gene, which could interfere with 
the processing of the gRNA. It has been shown that the 2b protein can increase the ability of 
TRV to invade roots and meristems (Valentine et al. 2004) so I thought that could be a possible 
reason for its sequence being present in the vector. However, Valentine et al. (2004) make it 
clear that the construct from Liu et al. (2002) lacks the 2b gene. Analysis of the plasmid 
confirmed that the residual bases corresponded to a severely truncated fragment of the 2b gene 
that would not have been functional. Removing them would therefore reduce the amount of 
additional sequence at the 5’ end of my gRNA.  
In order to remove the non-essential bases in between the TRV promoter and the MCS, 
I used an overlap PCR deletion approach (Figure 4.5). The resulting plasmid was called 
“pYL_DEL.” I then inserted the gRNA into the multiple cloning site of pYL_DEL via 
restriction and ligation. I chose to use gRNA2 because of its consistent ability to activate the 
system in transient assays (see Chapter 3). The final TRV2 construct with the proper deletion 
of bases and insertion of gRNA2 was called “pYDg2.” 
The complete cloning method is outlined in Figure 4.5 and described in Chapter 2. 
Primers are in Appendix I and the map and sequence of pYDg2 can be found in Appendix II.  
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Figure 4.4. Annotated sequence of TRV ppk20 RNA2. Yellow boxes mark the 
sequence indicative of transcription start site, and black arrows deliniate 5’ termini of 
sgRNAs. Pink boxes indicate translation start sites of ORFs. Blue represents the region 
thought of as an RdRP subgenomic promoter, the sequence in between the end of the 
coat protein and the next ORF. Sequence from Hernandez et al. (1995). Annotations by 
me, partially based on information in Goulden et al. (1990).  
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Figure 4.5. Cloning schematic to generate pYDg2, a gRNA2 TRV RNA2 vector. First, I 
used overlap PCR to delete a 303 bp non-essential fragment. Then I used restriction cloning 
to insert gRNA2. Schematics generated using Snapgene.  
 Chapter 4 
 
69 
4.3 gRNA TRV activates GUS expression in directly infiltrated tissue 
With the pYDg2 construct complete, I could test transactivation of my reporter system 
using gRNA delivered via TRV. Direct infiltration of viral constructs in A. tumefaciens into N. 
benthamiana is a commonly used method in plant biotechnology for virus inoculation 
(Macfarlane 2010). I transformed the viral constructs pYL192, pYL156, and pYDg2 into A. 
tumefaciens strain GV3101 and cultured them appropriately to prepare for direct infiltration 
into N. benthamiana K-AR T2s (Chapter 3). I used a 1:1 mixture of pYL192 and pYDg2 as 
“gRNA2 virus” and a 1:1 mixture of pYL192 and pYL156 as “wt TRV virus.” I used two 
independent bacterial cultures of each construct to ensure biological replication. I infiltrated 
two leaves per plant of 4-week old N. benthamiana K-AR T2s with either gRNA2 virus (8 
plants) or wt virus (8 plants). Experimental procedure is outlined in Figure 4.6 and infiltration 
methods can be found in Chapter 2. 
 At 3 days post infiltration (dpi) into the K-AR T2s, I harvested one infiltrated leaf for 
analysis. I used a 2mL microcentrifuge tube to punch an equal disc out of each leaf to be used 
in the GUS fluorometric assay and saved the rest of the leaf for RNA extraction. The GUS 
fluorometric assay shows significant activation of GUS in the gRNA2 virus infiltrated leaves 
compared with the wt virus infiltrated leaves (Figure 4.7).  
RT-PCRs on RNA from the infiltrated leaves using primers located in the TRV RNA2 
viral genome spanning the insertion site showed that each experimental group contained the 
correct virus and the single strong band indicates that at 3dpi in the infiltrated leaf, the insert is 
stably expressed in the gRNA2 virus (Figure 4.8). Primers for RT-PCR can be found in 
Appendix I. 
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Figure 4.6. Diagram of virus infiltration and sampling method. First, I cultured viral 
vectors in A. tumefaciens GV3101 to OD 1.0. I used 1:1 ratio combinations to make a 
gRNA2 virus and a wt virus for infiltration into 4 week old N. benthamiana K-AR T2s. I 
sampled infiltrated leaves at 3dpi and systemic leaves at 14dpi to use for GUS fluorometric 
and RNA assays. 
 Chapter 4 
 
71 
 
 
  
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
0
10
20
30
40
gRNA2 virus wt virus
variable
va
lue
variable
●
●
gRNA2 virus
wt virus
Sample'type
M
U
'p
er
's
am
pl
e'
(n
m
ol
)
*
Figure 4.7. GUS fluorometric assay of directly infiltrated leaves 3dpi. The leaves 
agroinfiltrated with gRNA2 virus constructs showed significantly increased levels of GUS 
expression compared to leaves agroinfiltrated with wt virus constructs (p=8*10-4, pairwise 
t-test). gRNA2 virus n=8 leaves, wt virus n=8 leaves.  
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Figure 4.8. RT-PCR of virus infiltrated leaves 3dpi. A) Primers were used that span the 
insertion site on RNA2 to be able to distinguish between gRNA2 virus and wt virus. The 
expected band for the wt virus was 517bp and for the gRNA2 virus 317bp. The reason the 
gRNA2 virus is a smaller size, despite it having an insert is because the wt virus is the 
undeleted version of pYL156. 517bp - 303bp deletion = 214bp. 214bp + 103bp gRNA2 = 
317bp. Schematics generated using Snapgene. B) RT-PCR shows the bands are of the 
correct size and show no insert loss at this time point.  
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4.4. gRNA TRV activates GUS expression in mildly symptomatic systemic 
leaves but not in very symptomatic systemic leaves 
 The next question was whether the gRNA2 virus could activate in systemic (not directly 
infiltrated) leaves. At 14 dpi, I collected tissue from “less symptomatic” and “very 
symptomatic” systemic leaves. The “less symptomatic” leaves were always the newest leaves 
on the plant, while the “very symptomatic leaves” were closer to the position of the leaves that 
had been directly infiltrated. As in the previous assay, I used a 2mL microcentrifuge tube to 
punch an equal disc out of each leaf to be used in the GUS fluorometric assay and saved the 
rest of the leaf for RNA extraction. 
 The GUS fluorometric assay (Figure 4.9) showed that in the “less symptomatic” leaves, 
there is still a pattern that the plants infected with the gRNA2 virus exhibit higher GUS 
expression than the plants infected with the wt TRV. In contrast, in the “very symptomatic” 
leaves, there is no difference between the two conditions but background GUS expression 
levels are much higher than previously observed activation.  
RT-PCRs on the RNA from the systemic leaves (Figure 4.10) revealed instability of 
the insert in the virus vector. In the “less symptomatic” leaves there was a band of the correct 
size for the gRNA2 virus, but at a lower abundance than the signal from the wt virus. The “very 
symptomatic leaves” showed degradation of the gRNA insert, with weak bands of many 
different sizes in the gRNA2 virus samples, while the wt virus samples still resulted in a single, 
strong band of the correct size.  
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Figure 4.9. GUS fluorometric assay of systemic leaves 14dpi. LS = Less Symptomatic, 
VS = Very Symptomatic. In the LS condition, the systemic leaves infected with gRNA2 
virus seem to show increased levels of GUS expression compared to systemic leaves 
infected with wt virus, but the difference is not statistically significant (p=0.078, pairwise t-
test). Any pattern of activation is lost in VS leaves (p=0.79) and the level of GUS is much 
higher than anticipated. LS gRNA2 virus n=8 leaves, VS gRNA2 virus n=8 leaves, LS wt 
virus n=8 leaves, VS wt virus n=8 leaves.  
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
0
25
50
75
100
125
LS gRNA2 virus LS wt virus VS gRNA2 virus VS wt virus
variable
va
lue
variable
●
●
●
●
LS gRNA2 virus
LS wt virus
VS gRNA2 virus
VS wt virus
M
U
#p
er
#s
am
pl
e#
(n
m
ol
)
Sample#type
 Chapter 4 
 
75 
 
 
 
 
 
  
“Less symptomatic” 
100    101    102    103    104    105     106     109   110     111     112    113    114    115             K-AR   YDg2  YL156  H2O 
gRNA2 virus infected plants wt virus infected plants 
“Very symptomatic” 
100     102      104      105      106      107       108       109      110      112       113      114     115 
gRNA2 virus infected plants wt virus infected plants 
A) 
B) 
250bp 
500bp 
500bp 
250bp 
Figure 4.10. RT-PCR of virus infected systemic leaves 14dpi. Primers were used that 
span the insertion site on RNA2 to be able to distinguish between gRNA2 virus and wt 
virus, as in Figure 4.8. A) Less symptomatic systemic leaves. B) Very symptomatic leaves. 
Controls shown are a non-infected K-AR transgenic plant, the two TRV RNA2 plasmids to 
show correct size, and water.  
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4.5 Discussion 
I have described the design, construction, and testing of a TRV vector for CRISPR 
gRNA delivery. In this section, I will discuss the preliminary evidence showing that these 
gRNAs are effective for transactivation of the reporter in my CRISPRa system (Chapter 3) and 
suggest future directions for validation and optimisation.  
 
4.5.1 TRV assays in N. benthamiana 
My preliminary evidence indicates that the GUS reporter gene in my CRISPRa system 
was able to be transactivated by gRNA delivered in a TRV vector. The directly infiltrated 
leaves of N. benthamiana K-AR T2s showed clear activation of the GUS reporter when 
infected with my gRNA2 TRV compared to leaves infected with wt TRV (Figure 4.7). 
In systemic “less symptomatic” leaves, there was also activation of the GUS reporter 
(Figure 4.9). In contrast, “very symptomatic” systemic leaves showed unexpectedly high levels 
of GUS with both the wt and gRNA constructs. This observation suggests that the GUS gene 
was somehow activated by a mechanism other than the gRNA guiding dCas9-VP64 to the 
minimal promoter. 
The RT-PCRs from these samples show intact gRNA2 virus and wt virus in the 
respective infiltrated leaves (Figure 4.8). However, in more symptomatic leaves, there was 
instability of the gRNA2 virus (Figure 4.10). Even wild type TRV is known to recombine to 
modify the ORFs on RNA2 (Hernandez et al. 1996) so I propose that my engineered TRV 
recombined to negatively select against the gRNA2 insert. The instability of the gRNA2 insert 
explains why the less symptomatic leaves showed less GUS activation than infiltrated leaves. 
Recombination, however, does not explain why the GUS transgene driven by the 
minimal promoter was overexpressed in the “very symptomatic” leaves. One potential reason 
is that the GUS reporter transgene was silenced in the K-AR T2 plants. It is known that 
transgenes are frequently subjected to epigenetic silencing in plants (Rajeevkumar et al. 2015) 
and there is direct evidence of GUS transgene silencing in N. tabacum (Day et al. 2000). In 
this scenario, in the absence of the virus, the transgene expression was low. Upon infection 
with either wt or gRNA TRV, the RNA1-encoded suppressor of silencing released this 
transgene silencing and caused high background levels of GUS. The TRV 16K suppressor of 
silencing has been shown to interfere with silencing of endogenous genes during viral infection 
in addition to its role of reducing the immune response to the virus (Ghazala et al. 2008, 
Martínez-Priego et al. 2008) so this is a likely explanation.  
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The “less symptomatic” leaves were farther away from the initial infiltration, while the 
“very symptomatic” leaves were close to the infiltrated leaves on the plant. Therefore, in the 
“very symptomatic” samples, the virus probably had a longer amount of time to replicate, 
recombine to select for the preferred version without intact gRNA, and cause symptoms of 
viral infection including suppression of transgene silencing.  
 
4.5.1.1 Preliminary activation results require further confirmation 
These GUS activation and insert stability data are preliminary and further experiments 
are needed to confirm the results. Repeat assays should include the infection of wt N. 
benthamiana with both wt and gRNA2 virus constructs alongside the K-AR T2 N. 
benthamiana. This additional control would investigate the hypothesis that the viral release of 
transgene silencing caused the increased level of GUS in very symptomatic systemic leaves. If 
this theory is correct, it would be expected that very symptomatic wild type leaves would show 
no difference compared to less symptomatic non-infected wild type leaves in the GUS 
fluorometric assay, with both conditions exhibiting background levels. In contrast, the K-AR 
T2 very symptomatic leaves would show the same pattern as the results in this chapter, with 
very high GUS levels in both wt virus and gRNA2 virus infected tissue. 
GUS RNA expression data determined by qPCR is necessary to serve as a confirmation 
of the activation observed in the fluorometric assays. Using qPCR, the system could also be 
tested using a gRNA targeting an endogenous gene. Demonstrating activation of a non-silenced 
endogenous gene would avoid the issue of the viral infection’s potential effect on transgene 
silencing.  
 
4.5.1.2 Preliminary viral gRNA2 insert stability results require further confirmation 
The RT-PCRs presented in this chapter were originally intended as a diagnostic test to 
confirm that the leaf samples were infected with the correct virus. Unfortunately, these 
experiments are lacking a no-RT control. The no-RT control is essential to validate the 
observations because in the infiltrated leaves, any residual DNA from the pYDg2 plasmid used 
in the agroinfiltrations would amplify during PCR and give a false result. The samples were 
treated with DNase during RNA extraction, but a no-RT reaction would confirm that the bright 
single bands representing a stable gRNA virus in the infiltrated leaves was indeed from viral 
RNA and not residual plasmid DNA.  
The systemic leaves were in theory never exposed to agroinfiltration, but the no-RT is 
still necessary to ensure that the result is purely from viral RNA and not from plasmid 
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contamination. A non-infected plant as a negative control did demonstrate that the signal was 
coming from the virus and not an endogenous location. (Figure 4.10). The RNA from the non-
infected plant was good quality based on quantification, but testing that an endogenous gene 
(e.g. GAPDH) is able to be amplified from the sample would verify its reliability as a negative 
control for the virus assay. 
Another improvement would be to change the RT-PCR primer pair spanning the 
gRNA2 insertion site in order to amplify from the negative sense strand of RNA2. The primers 
used in this chapter were designed to amplify the positive sense strand of RNA. Therefore, in 
infiltrated leaves, it cannot be concluded whether the amplification signal is a product of viral 
replication or merely the initial RNA transcript from the pYDg2 plasmid. Negative sense viral 
RNA is a fundamental part of the TRV replication process (explained in Section 4.1). 
Therefore, testing for its presence would illustrate whether the virus is actively replicating in 
infected tissue.  
The relative replication competence of the different viral constructs should also be 
assessed. Using a second primer pair spanning a region of the conserved coat protein sequence 
would show relative amounts of TRV RNA2 accumulation in tissues infected with wt or 
gRNA2 TRV. This control could be measured by analysing band strength in RT-PCR or 
performing qPCR. It would also be interesting to include the intermediate TRV RNA2 
construct pYL_DEL in this analysis to determine whether the viral replication ability is 
affected by the deletion of bases in between the subgenomic promoter and the MCS or only 
once the gRNA2 insert has been added in pYDg2, if there are any differences at all.  
 
4.5.2 Virus optimisation and future directions 
I aimed to generate an improved TRV vector for delivering gRNA to my CRISPRa 
system. With the knowledge that plant viral vectors are more stable with smaller inserts 
(Avesani et al. 2007, Bruun-Rasmussen et al. 2007, Burch-Smith et al. 2004), I removed 303 
unnecessary bases before the MCS in the pYL156 TRV RNA2 vector. This deletion also meant 
that my gRNA would start immediately after the viral TSS, ensuring a precise 5’ start to the 
gRNA. I considered engineering a ribozyme sequence at the 3’ end of the gRNA so that there 
would be a precise cut-off, but this strategy would interrupt viral replication so it was not 
possible to be sure of the 3’ end. The gRNA was functional even without 3’ cleavage so it does 
not seem like an essential modification. 
I considerably reduced the size of insert compared with Ali et al. (2015), who kept the 
non-essential bases before the MCS and on top of that inserted a subgenomic RdRP promoter 
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sequence from Pea Early Browning Virus, which was not needed because the TRV subgenomic 
promoter was already present in the construct. When they tested for viral presence in the 
infiltrated and systemic leaves of their plants via RT-PCR, their TRV RNA2 amplicon was 
located in the coat protein sequence, and not related to the gRNA insertion site. Therefore, they 
would not have been able to detect insert stability. My results suggest that while the wild type 
parts of their virus may have been intact, they probably had substantial insert removal before 
the virus even reached a meristem to invade. Therefore, it is unsurprising that their reported 
inheritance efficiency was so low, and potentially not even valid (Yin et al. 2015). 
The preference of the virus to remove gRNA inserts is problematic for the use of viral 
vectors to deliver gRNA for CRISPR gene editing. When I first saw the results from Ali et al. 
(2015) which suggest that VIGE in plants would be possible using TRV, I assumed that their 
extremely low efficiency of mutation inheritance was caused by the virus not being able to act 
efficiently in the meristem, where the germ line cells are formed. Even TRV, which has a 
suppressor of silencing that allows meristem invasion, is only able to remain in the meristem 
for a short amount of time, and the plant defences are high to try to eliminate the virus (Martin-
Hernandez and Baulcombe 2008).  
I therefore initially thought my transactivation system would be useful to study and 
optimise the spatial aspects of gRNA delivery via a virus, dissecting out the meristem to 
measure GUS activation level. While my system still would allow this assay, I think the 
problem with the method lies before invasion of the meristem. If the virus with the gRNA insert 
is already being selected against in the leaves, only a small fraction of the virus with intact 
insert would ever reach the meristem.  
It still could be possible to use viral gRNA delivery for CRISPR gene editing, but my 
results indicate that optimisation should probably focus on stability of the insert in the virus, 
because proper and precise editing will not occur if the virus successfully invades the meristem 
but is no longer carrying an intact gRNA. One strategy for improving stability would be to 
examine the structure of the insert instead of only the length. Ding et al. (2018) found that 
modifying the secondary structure of their insert in BMV led to increased insert stability. This 
outcome makes sense because the RNA structure could be important in the template switching 
mechanism that is the cause of many types of viral recombination (Bujarski 2013, Sztuba-
Solinska et al. 2011).  
Further optimisation strategies and relevant new improvements to VIGE are discussed 
in Chapter 6. My positive readout strategy will be a useful tool for future analysis; even at low 
efficiency, activation is easily assayed and quantified.  
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Chapter 5: Graft delivery of gRNA 
5.1 Introduction 
Grafting is frequently used in both crop production and basic research to obtain desired 
phenotypic traits and study long distance systemic movement of signalling molecules through 
the plant vasculature. N. benthamiana is able to be grafted, even to other species in heterografts 
(Notaguchi et al. 2015, Xia et al. 2018). There are previous demonstrations of movement of 
siRNA, miRNA, and mRNAs across graft junctions in N. benthamiana (Voinnet et al. 1998, 
Bai et al. 2011, Kasai et al. 2010, Xu et al. 2013). 
Typically, mobile RNA follows the direction of phloem flow from photosynthetic 
source tissues like mature leaves to sink tissues like roots and flowers (Kehr and Kragler 2018). 
In grafting experiments, the RNA of interest is expressed in source tissue and movement across 
the graft junction is demonstrated by sampling the destination sink tissue (Figure 5.1). 
Normally the sink tissues in the scion are in meristems and flowers, but a technique 
called mentor grafting (Figure 5.2) can force additional sinks in the shoot, encouraging 
movement from the rootstock into the scion (Goldschmidt 2014). This method involves 
removing all mature leaves of the scion after the graft has healed, forcing the scions to rely 
completely on the rootstock for nutrients. The mentor grafting procedure switches the role of 
the scion from source tissue into sink tissue. New developing leaves that grow from the scion 
are nutrient sinks and are sampled for RNA assays. Mentor grafting has been previously used 
successfully in N. benthamiana (Kasai et al. 2011). 
 The aim of the experiments in this chapter was to explore whether grafting could be a 
potential method for delivering CRISPR gRNA in trans. I based my work on the questions: 1) 
Can a gRNA enter the phloem channel and move systemically? 2) If gRNA is mobile, is it still 
functional when it reaches its destination tissue?  
There is no information on whether gRNA can move systemically in a plant which 
therefore makes it an exciting concept to investigate for both basic science and future 
applications. 
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Figure 5.1 Grafting to test for RNA mobility. Plants of two types, here represented by 
genotypes, are grafted together in order to observe movement of molecules like RNA from 
source tissue to sink tissue. Figure from Kehr and Kragler (2018). 
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A) 
B) 
Figure 5.2 Mentor grafting schematic. A) The direction of phloem flow normally moves 
from photosynthetic source tissues in the shoot to sink tissues in the root. B) The technique 
of mentor grafting involves cutting off the leaves of the shoot in order to induce new growth, 
forcing a sink in the scion. 
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5.2 Results 
 Grafting experiments were carried out to test whether gRNA could move systemically 
in plants. I also performed crosses intended to be a control for function of gRNA produced 
from a transgene.  
 
5.2.1 Grafting design  
Reciprocal experimental and control grafts were designed in order to test for gRNA 
movement (Figure 5.3). Experimental grafts consisted of T2 transgenic gRNA2 N. 
benthamiana grafted to T2 transgenic K-AR N. benthamiana. Detail about the generation of 
these T2 transgenic lines is in Chapters 2 and 3. Before grafting, I confirmed transgene presence 
in each individual plant via PCR. Control grafts followed the same set up, but with wild type 
N. benthamiana grafted to T2 transgenic K-AR plants. 
It is known that RNA generally moves systemically from source to sink (Kehr and 
Kragler 2018). Therefore, for grafts containing gRNA2 plants as the scion and K-AR as the 
stock, it would be expected that gRNA2 would move from shoot to root, following the source 
to sink gradient (Figure 5.3). In the controls, no gRNA2 should be detected in the sink tissue 
because there would be no gRNA2 being produced in the wild type scion. The strategy of 
reciprocal grafting was used in order to make it possible to force a sink in the scion via mentor 
grafting, changing the direction of gRNA2 movement from root to shoot. The control grafts 
would not show any gRNA2 in the shoot sink tissue because it would not be present in the root 
source. 
Figure 5.3. Grafting design. Reciprocal grafts between K-AR and gRNA2 T2s, and K-AR 
T2s and wild type plants were designed to allow assaying gRNA movement in both 
directions across the graft junction. 
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5.2.2 RT-PCR results from graft roots inconclusive about gRNA mobility 
I expected that mobile gRNA2 would be in low abundance in destination sink tissues. 
Therefore, I chose to test for the presence of gRNA2 by RT-PCR because the amplification is 
highly sensitive. In order to detect a mobile version of gRNA2, I designed RT-PCR primers 
within its sequence (Figure 5.4A). Primer sequences can be found in Appendix I. 
I started by testing the roots of grafts in which K-AR was the stock because it would be 
more likely to detect movement from the shoot to the naturally strong sink tissue of the root 
than via a mentor grafting approach. The expected result from the RT-PCR was to find a 95 bp 
fragment representing gRNA2 in the roots of experimental grafts that had gRNA2 scions, but 
not in the roots of control grafts that had wild type scions. Eleven wt/K-AR grafts and eight 
gRNA2/K-AR grafts were sampled and root RNA was extracted. Positive control samples 
(gRNA2 transgenic roots) showed a clear band for gRNA2 (Figure 5.4B), demonstrating that 
gRNA2 can be detected in roots via this method when it is in high enough abundance. There 
was no indication of mobile gRNA2 in any of the grafted root samples (Figure 5.4B). 
 
5.2.3 Crossing of T1 lines intended as a positive control for activation  
 gRNA would be produced transgenically in the T2 plants used for grafting. As a control 
for this type of expression, I crossed a stable K-AR T1 line with a stable gRNA2 T1 line (Figure 
5.5) in order to validate the functionality of my CRISPRa system when the gRNA is expressed 
via a transgene. Plants expressing both K-AR and gRNA2 were expected to exhibit GUS 
activation compared to uncrossed K-AR T2 lines. My full N. benthamiana crossing method 
(found in Chapter 2) required development to establish correct timing for the flower to be 
mature enough to develop properly, but not already have been self-pollinated. I was able to 
collect seeds from 14 of the cross attempts.  
 I sowed F1 seeds from 7 of the 14 crosses alongside K-AR T2s to be able to compare 
plants of the same age and used OneStep RT-PCR to confirm expression of both transgenes in 
6 of the 7 progeny sets (Figure 5.6). Three of the progeny sets were generated with K-AR as 
male and three as female. I selected 4 plants from each of the 6 successful crosses that were 
positive for both transgenes to be sampled for GUS expression. I punched equal leaf discs with 
a 2mL microcentrifuge tube to be used in the GUS fluorometric assay. At the same time, I 
harvested leaf punches from the 8 K-AR T2s of the same age. The fluorometric assay did not 
show any difference in GUS expression between the crosses and the K-AR T2s (Figure 5.7).  
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G1     G2    G3     G16  G17  G19    wt   K-AR    g2r   g2p   H2O    G2    G3     G16   G17    wt   K-AR  g2r   H2O 
gRNA2 primers, RT gRNA2 primers, no-RT GAPDH primers, RT 
100bp 
200bp 
G15$$G16$$G17$$G18$$G19wt K,AR$$g2r$$g2p$$H2O$$G1$$$G2$$$G3$$$$G4$$$G5$$$ G6$$$G7$$$G8$$$$G9$$$G10$$G11$G12$G13$G14
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C) 
gRNA2 primers, RT GAPDH primers, RT GAPDH primers, RT 
Figure 5.4. gRNA2 primer design and graft root RT-PCR results. A) RT-PCR primers 
were designed to only amplify inside the gRNA in order to be able to detect it in its potential 
mobile form. B) RT-PCRs were carried out on graft root RNA to test for gRNA2 movement 
from shoot to root. This gel shows samples which are representative of all the grafts tested. 
G1, G2, G3 = wt shoot/K-AR root grafts. G16, G17, G19 = gRNA2 shoot/K-AR root grafts. 
wt = non-grafted wt root. K-AR= non-grafted K-AR T2 root. g2r = gRNA2 T2 root. g2p = 
gRNA2 plasmid. Using the gRNA2 primers (shown in A), RT-PCR did not show a gRNA2 
band in roots of either control grafts or experimental grafts. wt and K-AR samples were 
negative controls, and did not have a gRNA2 band as expected. g2r was a positive control 
and the clear band demonstrates gRNA2 is detectable via RT-PCR in gRNA2 transgenic 
roots. g2p has the same clear band which is a positive control for primer function and band 
size. No-RT controls for the grafts also did not show a band. GAPDH testing confirmed that 
the lack of gRNA2 bands was a true result and not due to insufficient RNA quality. GAPDH 
results for wt, K-AR, and g2r samples is included in B). The GAPDH results for all the 
grafts are on the gels shown in C) along with repeated results for control samples (wt, K-
AR, g2r, g2p, H2O) with gRNA2 primers.  
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Figure 5.5. Crossing scheme. K-AR T1 P21 and gRNA2 T1 P1 plants were crossed 
multiple times, in both directions (as the male and as the female). The progeny were sown 
and compared to K-AR T2s for GUS level. 
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Figure 5.6. RT-PCRs show successful crossing of F1 transgenic lines. Progeny sets from 
six individual crosses were tested for expression of both K-AR and gRNA2 transgenes. 
Crosses 1-4 (X1-X4) were performed using K-AR#6/21 as the male and gRNA2#24/1 as 
the female. X5-X7 were performed in the opposite direction. K-AR primers: + = K-AR 
plasmid, – = H2O. gRNA2 primers: + = gRNA2 plasmid, – = H2O. For the fluorometric 
assay (see Figure 5.7), the following were the cross progeny plants used: X2 #3,4,5,6/X3 
#1,2,3,5/X4 #2,4,5,6/X5 #1,2,5,6/X6 #1,2,3,4/X7 #1,4,5,6. 
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Figure 5.7 GUS fluorometric assays of K-AR T2 lines compared to crosses. There is no 
significant difference (p=0.095) between the GUS level in the crosses compared to the K-
AR T2s. K-AR T2s n=8. Crosses n=24. 6 cross progeny sets are represented, 4 plants per 
set.  
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5.3 Discussion 
The aim of the work presented in this chapter was to explore the use of grafting as a 
method of gRNA delivery by investigating the questions 1) Is gRNA mobile across a graft 
junction? and 2) If gRNA is systemically mobile, is it still functional upon reaching its 
destination tissue?  
RT-PCR results from grafting experiments were unable to demonstrate movement of 
gRNA2 across a graft junction (Figure 5.4). However, the possibility of gRNA mobility should 
not yet be eliminated. Crosses which were meant to act as a positive control for gRNA2 
activation from a transgene did not produce the desired effect (Figure 5.7). It is likely that there 
was not enough gRNA2 produced in the transgenic gRNA2 lines to activate the system 
(discussed below), and therefore it probably also would not have been in high enough 
abundance to be detected in its mobile form. 
In retrospect, I should have focused first on functionality of transgenic and mobile 
gRNA2 instead of testing for movement. Ensuring functionality of the gRNA2 transgenic lines 
before using them for grafting would have increased the potential to detect gRNA2 systemic 
movement. Additionally, GUS assays could have been used to determine whether mobile 
gRNA2 is able to activate the system. Even if gRNA is mobile, lack of function post-movement 
would discard this strategy for gene editing applications.  
 
5.3.1 Crosses were unable to function as a control 
In order to focus on functionality, it would be important to confirm that gRNA produced 
from a transgene is able to activate the system. The crosses presented in this chapter were meant 
to act as that control, but they were ineffective. 
The crosses performed between K-AR and gRNA2 T2 lines were successful in the 
sense of both transgenes being expressed in F1 progeny (Figure 5.6). However, the GUS 
fluorometric assay showed no difference in GUS expression between un-crossed K-AR T2 
plants and the crossed F1s (Figure 5.7). The anticipated result was clear activation due to both 
transgenes being constitutively expressed in each cell, so this observation was surprising. 
It is unlikely that the K-AR transgenes were no longer able to be activated after crossing 
because their functionality had been tested by transient assay (Chapter 3). A more likely 
explanation is that the transgene in the gRNA2 T2 line was not functional perhaps because the 
expression level was too low. I characterised the gRNA2 lines for expression of the gRNA with 
RT-PCR, but did not test them for function. Therefore, the selected gRNA T2 line could be 
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non-functional in the system. This could be tested by doing transient expression assays in the 
parental gRNA line, following the same strategy used to test function in the K-AR lines 
(Chapter 3). First, a modified K-AR construct containing only the minimal promoter driven 
reporter would need to be generated by removing the dCas9-VP64. When infiltrated separately 
into wt N. benthamiana, spots infiltrated with the original K-AR construct and the modified K-
AR construct (K-R) should show the same level of GUS expression because there would be no 
gRNA present. In contrast, on gRNA transgenic lines, the K-AR infiltration should show 
increased levels of GUS compared to the K-R infiltration. A confirmed functional gRNA line 
could then be used for crossing with K-AR.  
Expression level of the transgenes could also have played a role in the result of the 
crosses. Previous demonstration of the functional CRISPRa system in stable K-AR transgenic 
lines (Chapter 3) was via agroinfiltration assays, in which very high copy number of the 
gRNA was introduced to each cell of the infiltrated spot. The integrated transgene is likely 
not transcribed as abundantly, and may even be partially silenced. To test this hypothesis, I 
would use qPCR to measure the gRNA expression level in the gRNA transgenic lines 
compared to gRNA expression level in wt or K-AR leaves agroinfiltrated with the gRNA 
construct. If the transgenic lines show lower expression levels, the role of silencing could be 
explored by transiently expressing a silencing suppressor such as P19 (Voinnet et al. 1999, 
Silhavy et al. 2002, Voinnet et al. 2003: retracted) in gRNA2 transgenic lines and comparing 
gRNA transcript abundance in the infiltrated spots and non-infiltrated leaf. 
In addition to lower expression level of the gRNA transgene in stably transformed lines 
compared to agroinfiltration, the crosses also cause the dosage of each transgene to be reduced. 
Dosage effect describes how copy number of a gene can proportionally affect the quantity of 
the gene’s product (Birchler and Veitia 2012). Therefore, after crossing the F1 transgenic lines 
there would be fewer copies of the gene producing gRNA2 and fewer copies of the K-AR gene 
to be activated. In order to cause the observed result, the amount of activation caused by the 
gRNA would have to make up for the different dosage amount.  
This phenomenon could be tested by sampling the cross F1s that express K-AR but are 
lacking the gRNA transgene and comparing them to the F1s from the same cross that do express 
both transgenes. In my experiment, there were too few of these plants to have been able to draw 
any conclusions. In the future, I would choose one cross and sow out many F1s to have a large 
enough sample size to test for dosage effect. 
 
 
 Chapter 5 
 
92 
5.3.2 Testing the function of mobile gRNA using CRISPRa  
After validating that gRNA can activate the GUS reporter in a crossing situation, my 
CRISPRa system would also allow mobile gRNA functionality to be easily assayed. Even a 
low abundance of gRNA moving across a graft junction could have a measurable activation 
effect. To test for this, I would do qPCR for GUS, comparing the expression levels in K-AR 
sink tissues with mobile gRNA and the K-AR sink tissues that had been grafted to wt plants. 
If the GUS level is increased, it would show that the gRNA is able to transactivate the system, 
and therefore is functional after movement.  
 
 
5.3.3 Improved grafting method for higher throughput  
I reciprocally grafted six-week old transgenic K-AR N. benthamiana lines with either 
transgenic gRNA2 lines or wt plants in order to determine if gRNA can systemically move 
through the phloem. In the future, I would design these experiments to be done via 
micrografting and hydroponic growth. This method has been successfully used in N. 
benthamiana (Xu et al. 2013) and would allow for a much higher throughput. In addition, the 
suspension of roots in water would provide an easier sampling system than soil-grown mature 
plants.  
 
5.3.4 Conclusion 
Functional gRNA T2 lines and successfully activated crosses should be established 
before continuing grafting experiments. Further suggestions for how to improve the 
effectiveness of crosses and grafts are discussed in Chapter 6. In the future, my positive readout 
assay will still be useful in investigating grafting as a gRNA delivery method because of the 
ability to identify activity caused by low amounts of systemically mobile gRNA.   
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Chapter 6: General Discussion 
 
Developing gene editing technology in plants is useful for both crop improvement and 
basic research; knock-out lines for most genes exist for Arabidopsis, but are not available for 
other model species like N. benthamiana and important crop plants (Bally et al. 2018). The 
work presented in this thesis aimed to address the challenges of efficient delivery mechanisms 
for CRISPR gene editing in plants. In this chapter, I will recapitulate the project goals, discuss 
my findings, suggest future directions in context with recent advancement, and mention the 
policy implications for new CRISPR technology. 
 
6.1 Summary of Thesis Aims 
The first goal of the work in this thesis was to set up a system to facilitate optimisation 
of CRISPR component delivery to plants, especially as a research tool. The protein components 
in this system would be expressed transgenically and the gRNA introduced into the plant in 
trans. I then aimed to test the system by delivering gRNA via a virus or by grafting. Since 
gRNA is the only variable part of the CRISPR system, this strategy would reduce the amount 
of tissue culture required to produce plants with the desired traits. 
My approach was based on the recognition that new delivery systems might only 
operate at a low efficiency and that loss of function of a target gene function might be difficult 
to observe phenotypically. For that reason, I developed a system based on gene activation in 
which low activity might be easier to detect, especially if histochemical methods could be 
performed as an initial screen. Using the activation system to optimise a delivery method would 
then allow future application of efficient external gRNA delivery for gene editing.  
 
6.2 Discussion of findings 
6.2.1 Developing a CRISPRa system for testing gRNA delivery methods 
 First, I generated a CRISPRa system designed for introducing gRNA in trans, 
separately from the activator-reporter construct. I validated the proof of principle by using 
fluorometric assays to demonstrate gRNA-induced transactivation of the GUS reporter gene in 
transient expression experiments (Figure 3.7). I generated stable transgenic lines of my 
constructs and confirmed that the CRISPRa system was functional in the T1 and T2 generation 
stable activator-reporter lines by transiently expressing gRNA (Figures 3.9, 3.10). 
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6.2.2 Demonstration of TRV gRNA delivery for CRISPRa  
 My CRISPRa system was designed to be used for optimising various VIGE methods 
by providing an easy assay to determine functional gRNA delivery. Of the previously 
attempted methods (Ali et al. 2015, Yin et al. 2015, Baltes et al. 2014), a TRV vector has the 
highest chance of causing gene edited progeny by seed due to its ability to invade plant 
meristems (Martìn-Hernàndez and Baulcombe 2008). The first demonstration of VIGE with 
TRV struggled to show sufficient inheritance (Ali et al. 2015, Yin et al. 2015), so I focused 
my work on identifying the system’s obstacles in order to improve it for the future. 
I tested viral delivery of gRNA for CRISPRa by inoculating N. benthamiana K-AR T2 
plants with TRV carrying gRNA2 in its genomic RNA2. Quantitative GUS assays showed 
activation in those plants infected with gRNA2 virus compared to plants infected with 
unmodified wild type TRV. This effect was significant in directly infiltrated leaves (Figure 
4.7). There was a pattern in mildly symptomatic systemic leaves (Figure 4.9), but the activation 
was reduced. RNA analysis showed instability of the gRNA2 insert in these systemic leaves 
compared to intact wild type TRV (Figure 4.10A). Very symptomatic systemic leaves located 
closely to the infiltrated leaves entirely lost the pattern of activation and showed almost 
complete removal of the correct size gRNA2 insert (Figures 4.9, 4.10B).  
This thesis is the first demonstration that viral gRNA delivery can be used for the 
purpose of CRISPRa. Using the CRISPRa system allowed easy analysis of the efficiency of 
viral delivery as the gRNA insert was recombined out of the viral genome and preferentially 
selected against in systemic leaves.  
This observation suggests that more work needs to be done on viral insert stability. 
Even if the virus is indeed reaching the germline cells, there may be low abundance of the virus 
containing the correct gRNA insert. Not only does this make the intended effect minimal, but 
there could also be recombination variants that cause unintended editing effects, which 
damages the precision reliability of CRISPR edits. Therefore, my results question whether 
VIGE is an accurate and efficient delivery mechanism. 
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6.2.3 Inconclusive Graft Delivery of gRNA 
I also began to explore gRNA delivery via grafting. T2 generation gRNA2 lines were 
grafted with K-AR T2 lines and sink tissue was sampled to test for long distance gRNA 
movement through the phloem. The results are currently inconclusive due the negative results 
from RT-PCRs of graft roots (Figure 5.4) in which mobile gRNA was not found. Starting with 
a focus on function instead of trying to find movement would have more directly determined 
if graft delivery of gRNA would be a useful tool for biotechnology. 
As a control to understand whether gRNA produced from a transgene was functional 
for my CRISPRa system, I performed crosses between K-AR and gRNA2 T1s. GUS 
fluorometric assays revealed no difference in expression level between the cross F1 progeny 
and K-AR T2 lines (Figure 5.7). I expect that further experiments, described in Chapter 5, 
would show that the amount of gRNA produced from the transgene was not enough to function 
in the CRISPRa system. Lowder et al. (2015) were able to quantify activation in stably 
transformed lines using the AtU6 promoter to drive gRNA expression; however, they used 
multiplexing of three gRNAs simultaneously and therefore the activation was likely amplified 
compared to the effect from one gRNA.  
 
6.3 Recent developments in CRISPRa and VIGE 
6.3.1 Second generation CRISPRa for enhanced activation 
 The increased expression resulting from my CRISPRa system was effectively 
quantified by fluorometric assays, but a higher level of activation would be beneficial for even 
quicker analysis of transactivation by only GUS histochemical staining. Over the course of my 
PhD, second generation CRISPRa systems have been developed that result in higher levels of 
activation (Figure 6.1). These systems rely on the recruitment of multiple activation domains 
by one dCas9/gRNA complex. Tanenbaum et al. (2014) modified the dCas9 component of the 
system to achieve this result. They developed a system in which dCas9 fused to a repeating 
peptide array called SunTag carries multiple copies of VP64-antibody fusions to the target 
location when in complex with a gRNA. Papikian et al. (2019) applied the SunTag-VP64 
activation system to Arabidopsis, successfully activating genes and transposable elements. 
Instead of changing the dCas9, it is also possible to alter the gRNA structure for 
increased activation technology. Zalatan et al. (2015) designed scaffold RNA (scRNA), adding 
RNA aptamers that recruit specific RNA-binding proteins (RBPs). Transcriptional regulators 
are fused to the RBPs that attach to the scRNA, achieving multiplexed activator or repressor 
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activity at the target site. The synergistic activation mediator (SAM) method is also based on 
modified gRNA. A dCas9-VP64 fusion forms a complex with gRNA containing two stem 
loops associated with the bacteriophage coat protein MS2 (Konermann et al. 2015). Additional 
VP64 fused to the MS2 protein is also expressed from the system and links to the stem loops, 
causing the dCas9 to be attached to many copies of VP64 instead of one. Lowder et al. (2018) 
demonstrated the use of SAM in plants, showing three to four fold higher transcriptional 
activation compared to their first study of CRISPRa using first generation dCas9-VP64 
(Lowder et al. 2015). 
Alternate approaches engineered fusions of multiple activator domains in order to 
achieve increased activation. The dCas9-VPR technique (Chavez et al. 2015) augments 
activation compared to dCas9-VP64 by using dCas9 fused to a tripartite activator composed of 
VP64, the activator domain of nuclear factor kappa B (p65), and Epstein-Barr virus R 
transactivator (Rta).  An even larger activator was developed by Li et al. (2017), who combined 
six TALE activation domains with VP128 (8 times VP16) to create dCas9-6TAL-VP128, 
renamed as dCas9-TV. Their activator showed vast improvement over dCas9-VP64 (Figure 
6.2), for which their reported activity was similar to what I observed in my own dCas9-VP64 
assays.  
 Strategies for epigenome engineering are also being developed using second generation 
dCas9-based strategies. For example, instead of recruiting activator domains to the SunTag 
system, the catalytic domain of demethylase TET1 has been fused to dCas9, causing increased 
expression of targeted genes. This technique was first used in animals, but was recently applied 
to plants by Gallego-Bartolomé et al. (2018) who showed activated expression of a highly 
methylated epiallele and methylated regions of a transposon in Arabidopsis when targeted with 
the SunTag-TET1 system. 
Incorporating these stronger activation techniques into my system would provide a 
more robust result that could be used for rapid assessment of gRNA delivery methods.   
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10.2.1 The dCas9–VP64 CRISPRa System
The dCas9–VP64 CRISPRa system, first reported in 2013 as being able to activate
targeted endogenous genes, represents the first-generation CRISPRa system, while
all the other further improved versions are generally considered as second-
generation activation systems. When dCas9 is genetically fused with a C-terminal
VP64 acidic transactivation domain (four copies of Herpes simplex virus protein
16), it can activate both reporter gene and endogenous genes with a single sgRNA
by transient delivery into mammalian cells (Fig. 10.2a). In addition, the use of
multiple sgRNAs was able to achieve synergistic activation of a broad range of
selected genes (interleukin 1 receptor antagonist, IL1RN), achaete-scute family
bHLH transcription factor 1 (ASCL1), nanog homeobox (NANOG), myogenic
differentiation 1 (MYOD1), hemoglobin subunit gamma ½ (HBG1/2), vascular
endothelial growth factor A (VEGFA), and neurotrophin 3 (NTF3). Furthermore,
RNA sequencing demonstrated that targeted gene activation was quite specific with
no detectable off-target gene activation [21, 23].
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Figure 6.1. Second generation CRISPRa systems for nhanced activat o  level. The 
SunTag system uses small peptide repeats fused to dCas9 to recruit multiple copies of 
antibody single chain variable fragment (ScFV) fused to VP64. SAM uses stem loops on 
the gRNA to cause binding with bacteriophage coat protein MS2 fused to transcriptional 
activators. In plants, it was applied to bind to multiple copies of VP64 (Lowder et al. 2018). 
VPR uses a tripartite activator of VP64, p65, and Rta fused to dCas9 to initiate activation. 
Figure modified from Chen and Qi (2017).  
 Chapter 6 
 
98 
 
  
A) B)
C)
Figure 6.2 dCas9-TV is able to activate target genes at a much higher level than dCas9-
VP64. A) and B) are Luciferase measurement assays in Arabidopsis protoplasts in which 
gRNA is targeted to the AtWRKY30 promoter driving LUC. RLU = relative luciferase unit 
A) Reveals VP128 to be the VP16 repeat with the highest level of activation, 5.1 times 
higher than the control. In contrast VP64 only showed a 2 fold increase. B) dCas9-6TAL-
VP128 (dCas9-TV) shows a 55.6 fold activation. C) When targeted to activate endogenous 
genes, qPCR quantification shows dCas9-TV exhibits high activation levels compared to 
dCas9-VP64. Figures modified from Li et al. (2017) 
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6.3.2 Advancement in vectors available for VIGE  
During the course of my PhD, other groups continued to experiment with VIGE. Ali et 
al. (2018) expanded upon their original work (Ali et al. 2015) with TRV in N. benthamiana by 
applying their vector to Arabidposis and showing successful CRISPR mutations in infected 
plants. They also demonstrated the use of PEBV-mediated gRNA delivery in N. benthamiana 
and observed that it had higher rates of mutation compared to their first generation TRV vector. 
Unlike their original TRV VIGE publication, they did not test for inheritance in their follow 
up work, instead only mentioning the theoretical possibility of edited progeny due to the fact 
that PEBV and TRV are known to be able to infect meristematic tissues (Wang et al. 1997). 
They suggest that modified tissue from the infected plant could be placed in tissue culture and 
regenerated plants could be screened for the mutation. 
Other groups focused on local gRNA delivery using viral vectors instead of attempting 
to achieve systemic spread into meristematic tissues. For example, Cody et al. (2017) used 
tobacco mosaic virus (TMV) RNA-based overexpression (TRBO) to develop a transient 
screening tool. TRBO is a mutant form of TMV lacking the coat protein (Lindbo 2007). It is 
therefore unable to move systemically but can still move cell-to-cell. This vector was chosen 
for gRNA delivery because of its previously demonstrated ability to produce high amounts of 
desired protein and stay localised to the infected regions (Lindbo 2007, Cody et al. 2017). The 
VIGE method using TRBO aimed to saturate the infiltrated cells with gRNA to increase editing 
efficiency. The experiments showed high editing rates (60-70%). Since the method was 
developed only for local expression, inheritance was not a priority and was not tested. 
Gil-Humanes et al. (2017) built on the work of Baltes et al. (2014), using geminivirus-
based replicons to deliver both gRNA and Cas9 using wheat dwarf virus (WDV) to induce 
targeted mutations in cereals. They were also able to cause specific insertions by homologous 
recombination (HR) by including the repair template in the viral replicon with the Cas9 and 
gRNA. As in the work of Baltes et al. (2014), their approach is based on localised infection, 
using vectors lacking the movement protein and coat protein in order to allow for large insert 
size. The study was carried out mainly in protoplasts which would be subjected to tissue culture 
in order to generate the desired edited plant, but the method eliminates the need for any stable 
integration of transgenes for editing cereals. Geminiviral delivery of CRISPR components has 
also been demonstrated in tomato (Dahan-Meir et al. 2018) and rice (Wang et al. 2017), 
establishing it as a method that can be used for many valuable crop species. 
Jiang et al. (2019) used beet necrotic yellow vein virus (BNYVV) which has a genome 
comprised of four or five single-stranded RNAs. Only RNA1 and RNA2 are essential for viral 
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replication and therefore the other RNAs can be engineered to express genes of interest. This 
study successfully demonstrated BNYVV delivery of gRNA for causing CRISPR mutations in 
infected plants Cas9 transgenic N. benthamiana.  
BNYVV RNA2, RNA3, RNA4, and RNA5 can exhibit internal deletions (Jiang et al. 
2019), similar to what has been observed in TRV RNA2 (Hernandez et al. 1996). My work 
suggests that insert stability in RNAs that undergo recombination may be a limitation of using 
viral delivery (Chapter 4). However, Jiang et al. (2019) observed intact gRNA via RT-PCR in 
systemic leaves 5 weeks post infiltration. While it is possible that the two viruses naturally 
behave differently, there is also a notable difference in the construction of the gRNA expression 
strategy. My strategy was to place the gRNA downstream of a subgenomic RdRP promoter in 
order to ensure the correct 5’ sequence. In contrast, Jiang et al. (2019) designed their construct 
so the gRNA is directly after the sequence encoding the BNYVV RNA4 protein p31. This 
approach may be useful in future VIGE design, if indeed attaching the gRNA to a viral protein 
sequence increases insert stability.  
Perhaps the most promising result from Jiang et al. (2019) for the future of VIGE is 
their demonstration of simultaneous expression multiple reporters from one viral vector due to 
the many RNA strands of the BNYVV genome. The largest size insert they tested was 2650nt, 
which is larger than most viruses are able to tolerate, but still not enough to carry Cas9 (~4kb). 
However, as bacteria continue to be screened for orthologs of Cas9, there could be potential 
for introducing both parts of the CRISPR machinery with BYNVV if a small enough ortholog 
is found. The BYNVV system would still hold advantages over other plant viral vectors 
because it could accommodate both components in a single vector, while there can be 
complications caused by the use of multiple vectors at once or co-infection of the same vector 
backbone with different inserts (Cody et al. 2017, Jiang et al. 2019). Inheritence of mutations 
were not tested in this study, but BYNVV is transmitted by the fungus Polymyxa betae (Hull 
2002) and not by seed, therefore it is unlikely that components delivered by BYNVV would be 
able to enter the germline. 
 Hu et al. (2019) demonstrated the use of barley stripe mosaic virus (BSMV) for gene 
editing in N. benthamiana, wheat, and maize. BSMV has a tripartite RNA genome consisting 
of RNAa, RNAb, and RNAg. Two versions of the gRNA delivery vector were tested in N. 
benthamiana – one inserting the gRNA in the place of the coat protein on RNAb and one 
inserting the gRNA directly after the sequence of protein gb on the RNAg strand (Figure 6.3). 
Successful editing occurred when the viral constructs were agroinfiltrated in conjunction with 
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a Cas9 expression plasmid. At 14dpi, systemic leaves were agroinfiltrated with the Cas9 
construct and displayed targeted mutations when sampled 4 days later.    
Interestingly, the results showed higher editing efficiency from the latter vector design 
in systemic leaves. This is consistent with my observation from the work of Jiang et al. (2019) 
where gRNA inserted immediately following a viral protein sequence may be better maintained 
than when it is downstream of a subgenomic RdRP promoter. The study did not include RT-
PCRs of the gRNA site from systemic leaves, but it would be useful to investigate whether the 
insert was partially lost when using the RNAb vector design. 
 The BSMV-induced mutations in N. benthamiana were passed to the next generation 
when plants were regenerated from edited leaf tissues via tissue culture (Hu et al. 2019). BSMV 
is known to be seed transmitted (Carroll 1972), so there is potential for BSMV VIGE to create 
heritable mutations when used with a Cas9 expressing transgenic line in the future.  
 
 
  
Figure 6.3 Schematic of BSMV vector constructs. A) The vector constructs for the 
expression of wild type BSMV tripartite genome. B) Vector design in which gRNA is 
inserted following a subgenomic RdRP promoter (sgg promoter) in the place of the coat 
protein on RNAb  C) Vector design in which gRNA is inserted on RNAg directly 
downstream of the sequence encoding protein gb. Figure from Hu et al. (2019). 
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6.4 Future work to further advance project aims 
6.4.1 Potential modifications to the CRISPRa system for testing gRNA delivery in trans 
Reverting to the native RNA organisation of CRIPSR, the crRNA and the tracrRNA 
could be separated, with the tracrRNA included in the activator-reporter construct. If the 
tracrRNA sequence is already transgenic in the plant along with the dCas9-VP64, the only 
component that needs to be added is the 20nt crRNA. The short length of the crRNA could 
allow it to be more stable in a viral vector. Alternatively, it may be possible to spray 20nt 
crRNA onto plants as is done with siRNAs in spray-induced gene silencing (SIGS) (Koch et 
al. 2016). 
 It could be useful in future work to use a gain of function system for heritable gene 
editing using out of frame reporters. When a gRNA is targeted to the out of frame portion of 
the reporter, the editing event causes a frame shift allowing the reporter to be expressed (Yin 
et al. 2015). This method relies on mutations, and not all mutations would cause the necessary 
frame shift. However, it would not require any currently existing protein to degrade, and 
correctly mutated lines could be quickly screened. The frame shift, and therefore the reporter 
expression, would be inherited in the next generation allowing for easy determination of 
inheritance. 
 
6.4.2 Future optimisation of viral gRNA delivery for CRISPRa 
The recent advances to the VIGE method are promising, but overcoming meristem 
exclusion to enter the germline and avoiding extra tissue culture are still challenges. The 
modified geminiviral vectors have the advantage of being able to deliver all components non-
transgenically but are unable to invade the meristem. TRV, PEBV, and BSMV vectors have 
the potential to enter the germline, but inheritance has not yet been solidly demonstrated. In 
addition, my work indicated that insert stability may be an issue that should be addressed in 
order to ensure precise editing events.  
All the recent publications have tested VIGE by screening for phenotypes caused by 
mutation. CRISPRa provides distinct advantages for method optimisation. It delivers a 
quantifiable gain of function result, allowing detection of even very low activity.  In addition, 
it is not necessary to wait for the degradation of residual gene product in order to observe the 
phenotype. In this section, I will describe potential VIGE optimisation strategies using 
CRISPRa. 
 
 Chapter 6 
 
103 
6.4.2.1 Multiplexing gRNAs for increased activation and multiple edit sites 
The system I developed provided preliminary evidence that CRISPRa can be achieved 
through viral delivery of gRNA. In order to fulfil the potential of being a powerful screening 
tool, the activation level could be further enhanced. One strategy is to combine viral delivery 
with second generation CRISPRa methods. Another possibility is to increase activation by 
gRNA multiplexing within the viral vector. 
Multiplexing of gRNAs has been shown to increase activation level (Cheng et al. 2013, 
Maeder et al. 2013, Perez-Pinera et al. 2013, Piatek et al. 2015), but currently the TRV 
technology has only been used with one gRNA at a time to ensure proper viral replication. 
Introducing components like self-cleaving ribozymes or tRNA precursors that are cleaved post 
transcription (Xie et al. 2015) would interrupt the RNA genome and impede replication. Hu et 
al. (2019) engineered a BSMV RNAg to carry two gRNAs without any space between them 
and demonstrated multiplexed editing of the targets. Cody et al. (2017) successfully applied 
the same approach in their TMV-based TRBO system. This strategy of simply adding gRNAs 
back to back would theoretically be possible in the TRV system, and could be a way to increase 
activation of CRISPRa, in addition to achieving multiplexed targeted mutations when applied 
for gene editing. 
 
6.4.2.2 Using gene silencing knock down lines to promote viral infection  
Weakening the plant’s immune response would make it easier for the virus to access 
the meristem and could lead to greater insert stability because of decreased selection pressure. 
N. benthamiana knock down lines deficient in essential RNA silencing machinery such as DCL 
proteins already exist and have been shown to exhibit increased levels of TRV infection 
compared to wt plants (Katsarou et al. 2019). RDR6 seems like another likely knock down 
target for decreasing silencing ability, but it has been shown previously that using RDR6 knock 
down lines for infection does not increase level of TRV accumulation (Schwach et al. 2005) 
and the process of TRV meristem invasion is independent of RDR6 (Martìn-Hernàndez and 
Baulcombe 2008).  
Crossing N. benthamiana DCL knock down lines (Katsaurou et al. 2019) with my K-
AR T2 lines would generate a hyper-susceptible host plant in which the virus would have a 
better chance of invading the meristem with an intact gRNA insert. Testing reporter activation 
levels in dissected meristems of plants infected with gRNA TRV compared to wild type TRV 
would be a simple indicator of the spatial aspects of the delivery method. The method optimised 
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with CRISPRa could be applied with catalytically active Cas9 to cause mutations in the 
germline cells for edited progeny.  
 
6.4.2.3 Placement of gRNA in viral vector could affect insert stability 
Stability of the gRNA insert could also be addressed by experimenting with placement 
of the gRNA in the viral genome. The results from BSMV (Hu et al. 2019) and BNYVV (Jiang 
et al. 2019) have shown gRNA insert stability when it is placed immediately following the 
sequence for a viral protein on a non-essential strand of the vector’s RNA genome. In contrast, 
the current work in tobraviruses (this thesis, Ali et al. 2015, Ali et al. 2018) designed the gRNA 
to follow a subgenomic RdRP promoter, in the place of where a viral protein would natively 
be. My results suggested recombination to remove the insert, leading to a mixture of insert 
fragment sizes in very symptomatic systemic leaves (Figure 4.10). Perhaps engineering my 
TRV vector to include the gRNA insert directly following the coat protein sequence on RNA2 
would enhance stability in the future. 
 
6.4.3 Future work for grafting 
Transgenic lines should be screened for the highest gRNA expression, which would 
reveal differences transgene silencing may play on the amount of gRNA available to the 
system. It is also possible that using a stronger promoter would produce higher levels of gRNA. 
Pol III promoters are usually used for gRNA expression because of their specific transcription 
start site allowing a clean 5’ end of the gRNA and known termination sequence (Gao et al. 
2018). Unfortunately, there is a limited amount of characterised Pol III promoters (Gao and 
Zhao 2014), restricting the variety of expression levels possible. In contrast, many 
characterised Pol II promoters exist, but RNAs derived from them are subjected to post-
transcriptional processing that is not useful for gRNA which needs a precise 5’ end to match 
the target gene sequence (Gao and Zhao 2014).  
Recently, a method allowing gRNA to be expressed transgenically from any promoter 
was developed (Gao and Zhao 2014). The study demonstrated that gRNA flanked by two self-
cleaving ribozymes on either side and driven by a Pol II promoter is able to be transcribed and 
then processed to the desired length. Therefore, use of a well-characterised strong promoter for 
expression of gRNA may be possible to ensure there is enough produced by the transgene in 
order to function in crossing and grafting. Using one of the second generation CRISPRa 
systems which increase the efficiency of the gRNA combined with expressing the gRNA from 
a stronger promoter could further boost the system. 
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6.5 Future applications of gRNA delivered to CRISPRa system in trans 
6.5.1 Uses for virus induced CRISPRa 
Beyond an optimisation tool for gene editing, virus induced CRISPRa could have its 
own applications. One use of CRISPRa could be for screening regions of the genome that are 
amenable to editing via VIGE to aid in better experiment design. Instead of mutation screens, 
qPCR for endogenous gene activation would be an indicator of whether the editing location is 
able to be targeted.  
Viral CRISPRa could also be used for gene function assays. Similar to the use of VIGS 
for gene repression, using a viral delivery for CRISPRa using either transcriptional activators 
(e.g. dCas9-VP64) or epigenetic modifiers (e.g. dCas9-Tet1) would allow for temporal control 
of gene activation. This method would be particularly useful for experimenting with genes for 
which improper regulation during development would be lethal. Additionally, viral CRISPRa 
could be used as a transient way to activate certain genes in the meristem to induce desired 
traits in the progeny caused by overexpression at a specific developmental time point. 
 
6.5.2 Potential use of graft delivery of gRNA 
Grafting is used frequently in crop production, including on the industrial scale 
(Haroldsen et al. 2012). Therefore, it is reasonable to imagine that introducing gRNA for 
CRISPR via grafting would be a technique that is attractive to the food production industry. It 
would reduce some of the uncertainty caused by repeated tissue culture because the genome of 
the end product is from the consistent Cas9/dCas9 line, not the variable gRNA line. However, 
in terms of time required, graft delivery is not the most efficient because of the constraint of 
generating stably transformed gRNA lines.  
If gRNA introduction by grafting is not functional, testing for gRNA mobility could 
still have valuable implications for basic research. A sensitive assay such as RNA sequencing 
would be able to establish RNA movement even if it is at very low abundance and is not 
functional upon reaching destination tissue. If mobility is established, determining exactly how 
the gRNA moves could provide information on trafficking processes for many classes of 
RNAs. 
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6.6 Tissue culture-free systems for CRISPR gene editing in plants 
Due to the importance of efficient plant gene editing technology for both basic research 
and agricultural applications, many groups are focused on alternate CRISPR delivery methods 
in plants. In addition to the development of VIGE, other non-transgenic delivery strategies for 
CRISPR exist such as injecting the assembled Cas9/gRNA RNPs into protoplasts (Woo et al. 
2015). Similar to geminiviral VIGE, this method eliminates initial tissue culture to introduce 
transgenes, but still requires plant regeneration after delivery of the CRISPR components. 
Three recently established techniques stand out as having high potential because they do not 
require any tissue culture and are possible in a wide variety of plant species.  
 
6.6.1 Induction of de novo meristems for CRISPR gene editing 
Originally developed to aid genetic transformation in recalcitrant species (Lowe et al. 
2016), overexpression of morphogenic genes to induce meristem formation has now been 
applied for gene editing. Existing shoot meristems were removed from transgenic N. 
benthamiana plants expressing Cas9. T-DNA constructs containing combinations of 
developmental regulation genes and gRNA in A. tumefaciens were then perfused into the cut 
sites (Figure 6.4) (Maher et al. under review, communication with Voytas lab). A proportion 
of the resulting de novo meristems produced CRISPR-edited shoots that did not contain 
transgenes for the developmental regulators or gRNA. Progeny from these shoots exhibited the 
edited mutations, demonstrating inheritance without the use of tissue culture.  
The main benefit of this approach is the reduced time required to produce a gene edited 
plant. However, while repeated traditional tissue culture using hormone-containing media is 
not used, cells are still induced into an un-differentiated callus state before new meristems are 
formed. The de-differentiation process may still cause epigenetic mutations, and therefore this 
method does not yet fully overcome the tissue culture bottleneck.  
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Figure 6.4. Induction of de novo meristems for gene editing. Shoot meristems are 
removed from transgenic plants expressing Cas9. Developmental regulators and gRNA are 
delivered to the cut site in A. tumefaciens. The shoot from the induced meristem has 
undergone gene editing and the mutation is inherited to the next generation. Figure from 
Maher et al. (under review). 
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6.6.2 Haploid induction for CRISPR gene editing 
The natural process of haploid induction has also been harnessed for gene editing 
(Kelliher et al. 2019). The study demonstrated that when pollen of a plant transgenic for Cas9 
and gRNA is crossed to the egg of a haploid inducer line, the resulting haploid progeny contain 
the desired mutation and are lacking both CRISPR transgenes. This process is possible because 
the two genomes form a transient zygotic state, during which time the editing occurs. The male 
genome is then eliminated during the haploid induction step of reproduction. Kelliher et al. 
(2019) first performed this method in maize (Figure 6.5A), then showed it was possible in 
dicots by experiments in Arabidopsis. Finally, they demonstrated that pollen from maize 
expressing the CRIPSR components could edit an elite wheat variety (Figure 6.5B), based on 
the knowledge that when maize pollen fertilises wheat ovules, the maize chromosomes are 
eliminated (Laurie et al. 1988, Mochida et al. 2004). The wheat haploid embryos therefore had 
undergone CRISPR editing, and were free of the Cas9 and gRNA transgenes that were only 
carried in the maize pollen. 
This haploid induction method is a considerable step forward for efficient gene editing 
in two very valuable crop species and the demonstration in Arabidopsis showed that it can be 
applied to many more plants in the future. The edited plant line has never been exposed to the 
tissue culture process, but the necessity to generate a transgenic editor line containing the Cas9 
and gRNA for each new genomic target is still a limitation to the throughput of the method.  
 
6.6.3 Nanoparticle DNA delivery for CRISPR gene editing 
Another exciting advance has been in the field of nanoparticle delivery. Nanoparticle 
introduction of biomolecules to plants is a growing area of research due to the method’s 
demonstrated success in animal systems (Cunningham et al. 2018). Demirer et al. (2019) 
showed successful delivery of plasmid and linear DNA into mature plants using carbon 
nanotubes (CNT), which are below the size exclusion limit of the cell wall and therefore able 
to diffuse into plant cells. They suggest that CNT delivery of CRISPR components would allow 
transient expression, inducing transgene-free targeted gene edits.  
The proposed nanoparticle-mediated CRISPR in plants is tissue culture-free, transgene-
free, and gRNAs can be easily interchanged for high throughput editing. The technique has 
high potential, but a key outcome that is currently unknown is whether the method can 
successfully target germline cells, generating heritable mutations. Nanopoarticle DNA delivery 
to plants is still in its infancy, and further optimisation will likely yield substantial 
developments for biotechnology. 
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A)
B)
Figure 6.5. Haploid induction gene editing method. A) Haploid-inducing maize pollen 
transgenic for Cas9 and gRNA fertilises the egg of an elite maize line resulting in CRISPR 
edited, transgene-free haploid progeny. B) Maize pollen transgenic for Cas9 and gRNA 
fertilises the egg of an elite wheat variety, yielding haploid, edited, transgene-free wheat 
progeny. Figure modified from Kelliher et al. (2019). 
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6.7 Policy implications of gene editing in plants 
6.7.1 Implications of VIGE for biosafety 
The United States Defense Advanced Research Projects Agency (DARPA) released a 
plan for a programme called “Insect Allies” in which insect vectors such as aphids carrying 
engineered plant viruses would be released into a field for the purpose of rapid gene editing of 
crops in order to respond to potential threats to the national food supply (DARPA, 2016). This 
strategy caused recent uproar in the scientific community regarding containment concerns and 
worry that the technology could turn into a bioweapon (Reeves et al. 2018). The DARPA 
project is an extreme example of how innovation in viral delivery is full of potential, but each 
development must proceed with caution when entering the field.  
The VIGE technology discussed in this thesis would be performed in laboratory 
biocontainment. Additionally, even though it can invade the meristem, TRV is not seed 
transmissible in N. benthamiana (Martìn-Hernàndez and Baulcombe 2008) so progeny plants 
from my system would not carry the virus. However, the viruses that have the highest chance 
of effectively inducing heritable mutations in the meristem are seed transmissible. Therefore, 
future strategies could show inherited CRISPR mutations, but the progeny may be infected 
with the virus. Even other researchers focused on VIGE highlight the consideration required 
when using functional viruses in biotechnology (Cody et al. 2017). It will be important to check 
the seed transmissibility of the viral vector for each proposed technology before allowing the 
offspring plants to be grown in the field. It may be possible to treat infected progeny in order 
to remove viruses with methods like thermotherapy (Wang et al. 2018) to ensure safe 
containment.  
 
6.7.2 Implications for crop biotechnology regulation 
I have described how the use of transgene-free CRISPR methods are scientifically 
useful for increasing efficiency of gene editing. They also carry with them important 
implications for crop biotechnology policy.  
The use of genetically modified crops is highly contested around the world (Huang et 
al. 2016). First generation genetically modified organisms (GMOs) involved stably integrating 
a transgene into the plant to confer a desired trait and most of the regulation of crop 
biotechnology regulation is based on this method (Voytas and Gao 2014). The rapid 
development of CRISPR has sparked the question of how gene edited plants should be 
regulated. 
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For example, a recent case brought before the European Court of Justice (Case 
C-528/16) was on the topic of whether gene edited crops should be regulated in the same 
strict manner as transgenic GMOs, set out in the GMO Directive (Directive 2001/18). There 
is an exemption in the GMO Directive for products derived from mutagenesis techniques. To 
date, this has been applied to varieties developed from methods such as chemical and 
radiation induced mutagenesis. Proponents for CRISPR crops argued that a gene edited 
product is indistinguishable from one derived from other types of mutagenesis and therefore 
should fall under the mutagenesis exemption. The Court ruled in the opposite direction, citing 
that the mutagenesis exemption does not apply to products that have been generated via a 
process that includes a transgenic step. This is indeed the ruling consistent with the regulation 
laid out in the GMO Directive, based on the necessity to stably transform the Cas9 and gRNA 
to induce the edit before removing the transgenes via crossing to yield the final product.  
In this chapter, I have discussed multiple new methods of performing CRISPR gene 
editing in plants that do not involve a transgenic step, such as geminiviral VIGE, haploid 
induction, and nanoparticle diffusion. These technologies all have the potential to circumvent 
this ruling and all other regulation worldwide that is based on transgenic methods. As plant 
biotechnology advances away from relying on transgenic processes, policy in many countries 
will need to be redefined. 
 
6.8 Conclusion 
Developing sustainable agricultural practices is an urgent global priority as we are 
confronted with the effects of climate change, pest migration, and population increase (FAO 
2016). The majority of the scientific community feels that gene editing in plants is a key 
technology for defending crops against impending threats and ensuring food security for 
humans (Huang et al. 2016). The research presented in this thesis contributes to the fast-paced 
work being done around the world on improving CRISPR delivery to a wide variety of plant 
species by providing a tool for method optimisation and insight into the potential of VIGE.  
Each step in the evolution of efficient CRISPR in plants brings the technology closer to being 
able to reliably and rapidly serve the needs of global agricultural systems. 
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Appendix I: List of primers  
 
Primer sequences are printed 5’ to 3’. 
 
Chapter 3 
Primers used to amplify 2x25S from pYL156 with SacI and SpeI overhangs 
2x35S F GATCGAGCTCCTTGCATGCCTGCAGGTCAAC 
2x35S R GATCACTAGTCCTCTCCAAATGAAATGAACTTCC 
 
Primers used to amplify Bs4 302bp promoter with flanking BsaI and overlaps 
Bs4 302 F GGGGTCTCACTATATTTTCAAGTTTTTATTATTTTAATCTTTTGATGGCTTTTG 
Bs4 302 R GGGGTCTCACCAGAGATTCGATTAAAAATAAATTGTATGGATGAGATC 
 
gRNA annealing oligos 
gRNA1F ATTGGTTATTATTTTAATCTTTTGA 
gRNA1R AAACTCAAAAGATTAAAATAATAAC 
gRNA2F ATTGGTGTTAGTGGAAAAAGGGCAA 
gRNA2R AAACTTGCCCTTTTTCCACTAACAC 
gRNA3F ATTGGACAAGCTTTCACGTTTCAAG 
gRNA3R AAACCTTGAAACGTGAAAGCTTGTC 
 
pK-AR Sequencing primers 
Seq1 CGCGGCTGAGTGGCTCCTTCA 
Seq2 GATGACGCACAATCCCACT 
Seq3 GCACGAGAGACACCCAATCTTCGG 
Seq4 AGATACGATGAGCACCACCAGG 
Seq5 GTTGATAAGGGAGCTTCTGCTCAG 
Seq6 CTCTTACCTTCAAGGAGGACATCC 
Seq7 GCTTGTTGAGACCAGACAGATC 
Seq8 GGAGGATTCGATTCTCCAACCGT 
Seq9 CCACCAGTCTATCACCGGACTT 
Seq10 GCGTTCCCTCTAGATAACGCA 
 
 
Genotyping of gRNA T0 transformants 
M13_F GTAAAACGACGGCCAGT 
M13_R CAGGAAACAGCTATGAC 
 
 
Genotyping of K-AR T0 transformants 
Bs4p_F GCAGGATCCCCAAGTGGTGGCTA 
pK_R GCCGTCCAGCTCGACCAGGAT 
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RT-PCR of gRNA2 T0 transformants 
gRNA2_RT_F GTGATTGGTGTTAGTGGAAAAAGGGCAAG 
gRNA_RT_R CACCGACTCGGTGCCACT 
 
 
RT-PCR of K-AR T0 transformants 
KRT_FWD CGGAGGATTCGATTCTCCAACCGTTG 
KRT_REV GCCTGTCCAGCCTTCTTGGTAGC 
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Primers used in overlap PCR and gRNA2 restriction cloning 
DP_A GCAGCTGCTAGTTCATCTGCACCG 
DP_B AGAGAATTCTGCGAAACTCAAATGCTA 
DP_C AGTTTCGCAGAATTCTCTAGAAGGCCT 
DP_D CGCCGATCTCAAACAGTCTATACAC 
gRNA2_F_EcoRI GATCGAATTCGTGTTAGTGGAAAAAGGGCAAGTTTTAGAGCTAG 
gRNA_R_XbaI GCCAACTTTGTACAAGAAAGCTGGGTC 
 
Primers used for TRV RNA2 insertion site RT-PCR 
VT_F CACTGATGCCATTAGCGACATCT 
VT_R CAGACACGGATCTACTTAAAGAACCG 
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GAPDH_F AGCTCAAGGGAATTCTCGATG 
GAPDH_R AACCTTAACCATGTCATCTCCC 
K_F ATCCACCAGTCTATCACCGGACTTTACGAG 
K_R GCCTGTCCAGCCTTCTTGGTAGCAG 
gRNA2_FWD GTGTTAGTGGAAAAAGGGCAAG 
gRNA_REV ACCGACTCGGTGCCAC 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Appendix II 
 
113 
Appendix II: Construct maps and sequences 
 
 
pK-AR 
Binary vector with 2X35S driven pcodCas9-VP64 and Bs4 minimal promoter driven GFP:GUS 
 
 
 
2X35S, pcodCas9, VP64, Bs4 302bp, GFP:GUS 
 
tgatcacaggcagcaacgctctgtcatcgttacaatcaacatgctaccctccgcgagatcatccgtgtttcaaacccggcagcttagt
tgccgttcttccgaatagcatcggtaacatgagcaaagtctgccgccttacaacggctctcccgctgacgccgtcccggactgatgg
gctgcctgtatcgagtggtgattttgtgccgagctgccggtcggggagctgttggctggctggtggcaggatatattgtggtgtaaac
aaattgacgcttagacaacttaataacacattgcggacgtttttaatgtactgaattaacgccgaattgaattatcagcttgcatgcc
ggtcgatctagtaacatagatgacaccgcgcgcgataatttatcctagtttgcgcgctatattttgttttctatcgcgtattaaatgtat
aattgcgggactctaatcataaaaacccatctcataaataacgtcatgcattacatgttaattattacatgcttaacgtaattcaaca
gaaattatatgataatcatcgcaagaccggcaacaggattcaatcttaagaaactttattgccaaatgtttgaacgatctgcttgact
ctagctagagtccgaaccccagagtcccgctcagaagaactcgtcaagaaggcgatagaaggcgatgcgctgcgaatcgggagc
ggcgataccgtaaagcacgaggaagcggtcagcccattcgccgccaagctcttcagcaatatcacgggtagccaacgctatgtcct
gatagcggtccgccacacccagccggccacagtcgatgaatccagaaaagcggccattttccaccatgatattcggcaagcaggca
tcgccgtgggtcacgacgagatcctcgccgtcgggcatccgcgccttgagcctggcgaacagttcggctggcgcgagcccctgatgc
tcttcgtccagatcatcctgatcgacaagaccggcttccatccgagtacgtgctcgctcgatgcgatgtttcgcttggtggtcgaatgg
gcaggtagccggatcaagcgtatgcagccgccgcattgcatcagccatgatggatactttctcggcaggagcaaggtgagatgaca
ggagatcctgccccggcacttcgcccaatagcagccagtcccttcccgcttcagtgacaacgtcgagcacagctgcgcaaggaacg
cccgtcgtggccagccacgatagccgcgctgcctcgtcttggagttcattcagggcaccggacaggtcggtcttgacaaaaagaac
cgggcgcccctgcgctgacagccggaacacggcggcatcagagcagccgattgtctgttgtgcccagtcatagccgaatagcctct
T35S
2x35S	promoter
attB1
pcodCas9
5XGS	linker
VP64
NOS	term
attB5
Bs4	302	promoter
attB2
pK-AR
17,071	bp
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ccacccaagcggccggagaacctgcgtgcaatccatcttgttcaatcatgcctcgatcgagttgagagtgaatatgagactctaatt
ggataccgaggggaatttatggaacgtcagtggagcatttttgacaagaaatatttgctagctgatagtgaccttaggcgacttttga
acgcgcaataatggtttctgacgtatgtgcttagctcattaaactccagaaacccgcggctgagtggctccttcaacgttgcggttctg
tcagttccaaacgtaaaacggcttgtcccgcgtcatcggcgggggtcataacgtgactcccttaattctcatgtataattcgagctcct
tgcatgcctgcaggtcaacatggtggagcacgacactctcgtctactccaagaatatcaaagatacagtctcagaagaccagaggg
ctattgagacttttcaacaaagggtaatatcgggaaacctcctcggattccattgcccagctatctgtcacttcatcgaaaggacagt
agaaaaggaagatggcttctacaaatgccatcattgcgataaaggaaaggctatcgttcaagatgcctctaccgacagtggtccca
aagatggacccccacccacgaggaacatcgtggaaaaagaagacgttccaaccacgtcttcaaagcaagtggattgatgtgatgg
tcaacatggtggagcacgacactctcgtctactccaagaatatcaaagatacagtctcagaagaccagagggctattgagacttttc
aacaaagggtaatatcgggaaacctcctcggattccattgcccagctatctgtcacttcatcgaaaggacagtagaaaaggaagat
ggcttctacaaatgccatcattgcgataaaggaaaggctatcgttcaagatgcctctaccgacagtggtcccaaagatggaccccca
cccacgaggaacatcgtggaaaaagaagacgttccaaccacgtcttcaaagcaagtggattgatgtgatatctccactgacgtaag
ggatgacgcacaatcccactatccttcgcaagacccttcctctatataaggaagttcatttcatttggagaggactagtgatatcaca
agtttgtacaaaaaagcaggctccgaattcgcccttcaccatggattacaaggatgatgatgataaggattacaaggatgatgatg
ataagatggctccaaagaagaagagaaaggttggaatccacggagttccagctgctgataagaagtactctatcggacttgCcatc
ggaaccaactctgttggatgggctgttatcaccgatgagtacaaggttccatctaagaagttcaaggttcttggaaacaccgataga
cactctatcaagaagaaccttatcggtgctcttcttttcgattctggagagaccgctgaggctaccagattgaagagaaccgctaga
agaagatacaccagaagaaagaacagaatctgctaccttcaggaaatcttctctaacgagatggctaaggttgatgattctttcttc
cacagacttgaggagtctttccttgttgaggaggataagaagcacgagagacacccaatcttcggaaacatcgttgatgaggttgct
taccacgagaagtacccaaccatctaccaccttagaaagaagttggttgattctaccgataaggctgatcttagacttatctaccttg
ctcttgctcacatgatcaagttcagaggacacttccttatcgagggagaccttaacccagataactctgatgttgataagttgttcatc
cagcttgttcagacctacaaccagcttttcgaggagaacccaatcaacgcttctggagttgatgctaaggctatcctttctgctagact
ttctaagtctcgtagacttgagaaccttatcgctcagcttccaggagagaagaagaacggacttttcggaaaccttatcgctctttctc
ttggacttaccccaaacttcaagtctaacttcgatcttgctgaggatgctaagttgcagctttctaaggatacctacgatgatgatctt
gataaccttcttgctcagatcggagatcagtacgctgatcttttccttgctgctaagaacctttctgatgctatccttctttctgacatcc
ttagagttaacaccgagatcaccaaggctccactttctgcttctatgatcaagagatacgatgagcaccaccaggatcttaccctttt
gaaggctcttgttagacagcagcttccagagaagtacaaggaaatcttcttcgatcagtctaagaacggatacgctggatacatcg
atggaggagcttctcaggaggagttctacaagttcatcaagccaatccttgagaagatggatggaaccgaggagcttcttgttaagt
tgaacagagaggatcttcttagaaagcagagaaccttcgataacggatctatcccacaccagatccaccttggagagcttcacgct
atccttcgtagacaggaggatttctacccattcttgaaggataacagagagaagatcgagaagatccttaccttcagaatcccatac
tacgttggaccacttgctagaggaaactctcgtttcgcttggatgaccagaaagtctgaggagaccatcaccccttggaacttcgag
gaggtaagtttctgcttctacctttgatatatatataataattatcattaattagtagtaatataatatttcaaatatttttttcaaaata
aaagaatgtagtatatagcaattgcttttctgtagtttataagtgtgtatattttaatttataacttttctaatatatgaccaaaatttgtt
gatgtgcaggttgttgataagggagcttctgctcagtctttcatcgagagaatgaccaacttcgataagaaccttccaaacgagaag
gttcttccaaagcactctcttctttacgagtacttcaccgtttacaacgagcttaccaaggttaagtacgttaccgagggaatgagaa
agccagctttcctttctggagagcagaagaaggctatcgttgatcttcttttcaagaccaacagaaaggttaccgttaagcagttgaa
ggaggattacttcaagaagatcgagtgcttcgattctgttgaaatctctggagttgaggatagattcaacgcttctcttggaacctac
cacgatcttttgaagatcatcaaggataaggatttccttgataacgaggagaacgaggacatccttgaggacatcgttcttaccctta
cccttttcgaggatagagagatgatcgaggagagactcaagacctacgctcaccttttcgatgataaggttatgaagcagttgaaga
gaagaagatacaccggatggggtagactttctcgtaagttgatcaacggaatcagagataagcagtctggaaagaccatccttgat
ttcttgaagtctgatggattcgctaacagaaacttcatgcagcttatccacgatgattctcttaccttcaaggaggacatccagaagg
ctcaggtttctggacagggagattctcttcacgagcacatcgctaaccttgctggatctccagctatcaagaagggaatccttcagac
cgttaaggttgttgatgagcttgttaaggttatgggtagacacaagccagagaacatcgttatcgagatggctagagagaaccaga
ccacccagaagggacagaagaactctcgtgagagaatgaagagaatcgaggagggaatcaaggagcttggatctcaaatcttga
aggagcacccagttgagaacacccagcttcagaacgagaagttgtacctttactaccttcagaacggaagagatatgtacgttgat
caggagcttgacatcaacagactttctgattacgatgttgatGCcatcgttccacagtctttcttgaaggatgattctatcgataaca
aggttcttacccgttctgataagaacagaggaaagtctgataacgttccatctgaggaggttgttaagaagatgaagaactactgg
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agacagcttcttaacgctaagttgatcacccagagaaagttcgataaccttaccaaggctgagagaggaggactttctgagcttgat
aaggctggattcatcaagagacagcttgttgagaccagacagatcaccaagcacgttgctcagatccttgattctcgtatgaacacc
aagtacgatgagaacgataagttgatcagagaggttaaggttatcaccttgaagtctaagttggtttctgatttcagaaaggatttcc
agttctacaaggttagagagatcaacaactaccaccacgctcacgatgcttaccttaacgctgttgttggaaccgctcttatcaagaa
gtacccaaagttggagtctgagttcgtttacggagattacaaggtttacgatgttagaaagatgatcgctaagtctgagcaggagat
cggaaaggctaccgctaagtacttcttctactctaacatcatgaacttcttcaagaccgagatcacccttgctaacggagagatcag
aaagagaccacttatcgagaccaacggagagaccggagagatcgtttgggataagggaagagatttcgctaccgttagaaaggtt
ctttctatgccacaggttaacatcgttaagaaaaccgaggttcagaccggaggattctctaaggagtctatccttccaaagagaaac
tctgataagttgatcgctagaaagaaggattgggacccaaagaagtacggaggattcgattctccaaccgttgcttactctgttcttg
ttgttgctaaggttgagaagggaaagtctaagaagttgaagtctgttaaggagcttcttggaatcaccatcatggagcgttcttctttc
gagaagaacccaatcgatttccttgaggctaagggatacaaggaggttaagaaggatcttatcatcaagttgccaaagtactctctt
ttcgagcttgagaacggaagaaagagaatgcttgcttctgctggagagcttcagaagggaaacgagcttgctcttccatctaagtac
gttaacttcctttaccttgcttctcactacgagaagttgaagggatctccagaggataacgagcagaagcagcttttcgttgagcagc
acaagcactaccttgatgagatcatcgagcaaatctctgagttctctaagagagttatccttgctgatgctaaccttgataaggttctt
tctgcttacaacaagcacagagataagccaatcagagagcaggctgagaacatcatccaccttttcacccttaccaaccttggtgct
ccagctgctttcaagtacttcgataccaccatcgatagaaaaagatacacctctaccaaggaggttcttgatgctacccttatccacc
agtctatcaccggactttacgagaccagaatcgatctttctcagcttggaggagataagagaccagctgctaccaagaaggctgga
caggctaagaagaagaagggagacggctctggatcggggtcgggttctggctcagtcgacgatgctcttgacgattttgacctcgat
atgctcgacgctcttgatgattttgatctcgacatgctcgatgcacttgatgactttgaccttgacatgctcgacgcactcgatgacttc
gacctcgacatgctttaggacgtccgatcgttcaaacatttggcaataaagtttcttaagattgaatcctgttgccggtcttgcgatga
ttatcatataatttctgttgaattacgttaagcatgtaataattaacatgtaatgcatgacgttatttatgagatgggtttttatgattag
agtcccgcaattatacatttaatacgcgatagaaaacaaaatatagcgcgcaaactaggataaattatcgcgcgcggtgtcatctat
gttactagatcgggaattgatcccccctcgacagcttccggaaagggcgaattcgcaactttgtatacaaaagttgccccatggcgtt
ccctctagataacgcaggatccccaagtggtggctatattttcaagtttttattattttaatcttttgatggcttttgttagtggaaaaag
ggcaacggtaaacaaataaattaatttgtcaactcttctttgttgtcctttgacaaagtcagctttcattagtgtgacagagaattttat
ttagattattttttattgttgaagactgatcaaagcgaatgttaatacaagctttcacgtttcaagtggtacttgtttaattcttctttctt
gtatataactttgtccaaaatatcatcaattgatctcatccatacaatttatttttaatcgaatctccagactagtaagggcaaattcg
acccagctttcttgtacaaagtggtgatatcccgcggatggtgagcaagggcgaggagctgttcaccggggtggtgcccatcctggt
cgagctggacggcgacgtaaacggccacaagttcagcgtgtccggcgagggcgagggcgatgccacctacggcaagctgaccctg
aagttcatctgcaccaccggcaagctgcccgtgccctggcccaccctcgtgaccaccctgacctacggcgtgcagtgcttcagccgc
taccccgaccacatgaagcagcacgacttcttcaagtccgccatgcccgaaggctacgtccaggagcgcaccatcttcttcaaggac
gacggcaactacaagacccgcgccgaggtgaagttcgagggcgacaccctggtgaaccgcatcgagctgaagggcatcgacttca
aggaggacggcaacatcctggggcacaagctggagtacaactacaacagccacaacgtctatatcatggccgacaagcagaaga
acggcatcaaggtgaacttcaagatccgccacaacatcgaggacggcagcgtgcagctcgccgaccactaccagcagaacacccc
catcggcgacggccccgtgctgctgcccgacaaccactacctgagcacccagtccgccctgagcaaagaccccaacgagaagcgc
gatcacatggtcctgctggagttcgtgaccgccgccgggatcactctcggcatggacgagctgtacaagcccggcatgttacgtcct
gtagaaaccccaacccgtgaaatcaaaaaactcgacggcctgtgggcattcagtctggatcgcgaaaactgtggaattgatcagcg
ttggtgggaaagcgcgttacaagaaagccgggcaattgctgtgccaggcagttttaacgatcagttcgccgatgcagatattcgtaa
ttatgcgggcaacgtctggtatcagcgcgaagtctttataccgaaaggttgggcaggccagcgtatcgtgctgcgtttcgatgcggtc
actcattacggcaaagtgtgggtcaataatcaggaagtgatggagcatcagggcggctatacgccatttgaagccgatgtcacgcc
gtatgttattgccgggaaaagtgtacgtatcaccgtttgtgtgaacaacgaactgaactggcagactatcccgccgggaatggtgat
taccgacgaaaacggcaagaaaaagcagtcttacttccatgatttctttaactatgccggaatccatcgcagcgtaatgctctacac
cacgccgaacacctgggtggacgatatcaccgtggtgacgcatgtcgcgcaagactgtaaccacgcgtctgttgactggcaggtgg
tggccaatggtgatgtcagcgttgaactgcgtgatgcggatcaacaggtggttgcaactggacaaggcactagcgggactttgcaa
gtggtgaatccgcacctctggcaaccgggtgaaggttatctctatgaactgtgcgtcacagccaaaagccagacagagtgtgatatc
tacccgcttcgcgtcggcatccggtcagtggcagtgaagggccaacagttcctgattaaccacaaaccgttctactttactggctttg
gtcgtcatgaagatgcggacttacgtggcaaaggattcgataacgtgctgatggtgcacgaccacgcattaatggactggattggg
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gccaactcctaccgtacctcgcattacccttacgctgaagagatgctcgactgggcagatgaacatggcatcgtggtgattgatgaa
actgctgctgtcggctttaacctctctttaggcattggtttcgaagcgggcaacaagccgaaagaactgtacagcgaagaggcagtc
aacggggaaactcagcaagcgcacttacaggcgattaaagagctgatagcgcgtgacaaaaaccacccaagcgtggtgatgtgg
agtattgccaacgaaccggatacccgtccgcaagtgcacgggaatatttcgccactggcggaagcaacgcgtaaactcgacccga
cgcgtccgatcacctgcgtcaatgtaatgttctgcgacgctcacaccgataccatcagcgatctctttgatgtgctgtgcctgaaccgt
tattacggatggtatgtccaaagcggcgatttggaaacggcagagaaggtactggaaaaagaacttctggcctggcaggagaaac
tgcatcagccgattatcatcaccgaatacggcgtggatacgttagccgggctgcactcaatgtacaccgacatgtggagtgaagagt
atcagtgtgcatggctggatatgtatcaccgcgtctttgatcgcgtcagcgccgtcgtcggtgaacaggtatggaatttcgccgatttt
gcgacctcgcaaggcatattgcgcgttggcggtaacaagaaagggatcttcactcgcgaccgcaaaccgaagtcggcggcttttct
gctgcaaaaacgctggactggcatgaacttcggtgaaaaaccgcagcagggaggcaaacaatgaccatggcggccgggagcatg
cggccatgctagagtccgcaaaaatcaccagtctctctctacaaatctatctctctctatttttctccagaataatgtgtgagtagttcc
cagataagggaattagggttcttatagggtttcgctcatgtgttgagcatataagaaacccttagtatgtatttgtatttgtaaaatac
ttctatcaataaaatttctaattcctaaaaccaaaatccagtgacctgcaggcatgcgacgtcgagcttagcttgagcttggatcaga
ttgtcgtttcccgccttcagtttaaactatcagtgtttgacaggatatattggcgggtaaacctaagagaaaagagcgtttattagaat
aacggatatttaaaagggcgtgaaaaggtttatccgttcgtccatttgtatgtgcatgccaaccacagggttcccctcgggatcaaa
gtactttgatccaacccctccgctgctatagtgcagtcggcttctgacgttcagtgcagccgtcttctgaaaacgacatgtcgcacaa
gtcctaagttacgcgacaggctgccgccctgcccttttcctggcgttttcttgtcgcgtgttttagtcgcataaagtagaatacttgcga
ctagaaccggagacattacgccatgaacaagagcgccgccgctggcctgctgggctatgcccgcgtcagcaccgacgaccaggac
ttgaccaaccaacgggccgaactgcacgcggccggctgcaccaagctgttttccgagaagatcaccggcaccaggcgcgaccgcc
cggagctggccaggatgcttgaccacctacgccctggcgacgttgtgacagtgaccaggctagaccgcctggcccgcagcacccgc
gacctactggacattgccgagcgcatccaggaggccggcgcgggcctgcgtagcctggcagagccgtgggccgacaccaccacgc
cggccggccgcatggtgttgaccgtgttcgccggcattgccgagttcgagcgttccctaatcatcgaccgcacccggagcgggcgcg
aggccgccaaggcccgaggcgtgaagtttggcccccgccctaccctcaccccggcacagatcgcgcacgcccgcgagctgatcga
ccaggaaggccgcaccgtgaaagaggcggctgcactgcttggcgtgcatcgctcgaccctgtaccgcgcacttgagcgcagcgag
gaagtgacgcccaccgaggccaggcggcgcggtgccttccgtgaggacgcattgaccgaggccgacgccctggcggccgccgag
aatgaacgccaagaggaacaagcatgaaaccgcaccaggacggccaggacgaaccgtttttcattaccgaagagatcgaggcgg
agatgatcgcggccgggtacgtgttcgagccgcccgcgcacgtctcaaccgtgcggctgcatgaaatcctggccggtttgtctgatg
ccaagctggcggcctggccggccagcttggccgctgaagaaaccgagcgccgccgtctaaaaaggtgatgtgtatttgagtaaaac
agcttgcgtcatgcggtcgctgcgtatatgatgcgatgagtaaataaacaaatacgcaaggggaacgcatgaaggttatcgctgta
cttaaccagaaaggcgggtcaggcaagacgaccatcgcaacccatctagcccgcgccctgcaactcgccggggccgatgttctgtt
agtcgattccgatccccagggcagtgcccgcgattgggcggccgtgcgggaagatcaaccgctaaccgttgtcggcatcgaccgcc
cgacgattgaccgcgacgtgaaggccatcggccggcgcgacttcgtagtgatcgacggagcgccccaggcggcggacttggctgt
gtccgcgatcaaggcagccgacttcgtgctgattccggtgcagccaagcccttacgacatatgggccaccgccgacctggtggagct
ggttaagcagcgcattgaggtcacggatggaaggctacaagcggcctttgtcgtgtcgcgggcgatcaaaggcacgcgcatcggc
ggtgaggttgccgaggcgctggccgggtacgagctgcccattcttgagtcccgtatcacgcagcgcgtgagctacccaggcactgcc
gccgccggcacaaccgttcttgaatcagaacccgagggcgacgctgcccgcgaggtccaggcgctggccgctgaaattaaatcaa
aactcatttgagttaatgaggtaaagagaaaatgagcaaaagcacaaacacgctaagtgccggccgtccgagcgcacgcagcag
caaggctgcaacgttggccagcctggcagacacgccagccatgaagcgggtcaactttcagttgccggcggaggatcacaccaag
ctgaagatgtacgcggtacgccaaggcaagaccattaccgagctgctatctgaatacatcgcgcagctaccagagtaaatgagca
aatgaataaatgagtagatgaattttagcggctaaaggaggcggcatggaaaatcaagaacaaccaggcaccgacgccgtggaa
tgccccatgtgtggaggaacgggcggttggccaggcgtaagcggctgggttgtctgccggccctgcaatggcactggaacccccaa
gcccgaggaatcggcgtgacggtcgcaaaccatccggcccggtacaaatcggcgcggcgctgggtgatgacctggtggagaagtt
gaaggccgcgcaggccgcccagcggcaacgcatcgaggcagaagcacgccccggtgaatcgtggcaagcggccgctgatcgaat
ccgcaaagaatcccggcaaccgccggcagccggtgcgccgtcgattaggaagccgcccaagggcgacgagcaaccagattttttc
gttccgatgctctatgacgtgggcacccgcgatagtcgcagcatcatggacgtggccgttttccgtctgtcgaagcgtgaccgacga
gctggcgaggtgatccgctacgagcttccagacgggcacgtagaggtttccgcagggccggccggcatggccagtgtgtgggatta
cgacctggtactgatggcggtttcccatctaaccgaatccatgaaccgataccgggaagggaagggagacaagcccggccgcgtg
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ttccgtccacacgttgcggacgtactcaagttctgccggcgagccgatggcggaaagcagaaagacgacctggtagaaacctgcat
tcggttaaacaccacgcacgttgccatgcagcgtacgaagaaggccaagaacggccgcctggtgacggtatccgagggtgaagcc
ttgattagccgctacaagatcgtaaagagcgaaaccgggcggccggagtacatcgagatcgagctagctgattggatgtaccgcg
agatcacagaaggcaagaacccggacgtgctgacggttcaccccgattactttttgatcgatcccggcatcggccgttttctctaccg
cctggcacgccgcgccgcaggcaaggcagaagccagatggttgttcaagacgatctacgaacgcagtggcagcgccggagagttc
aagaagttctgtttcaccgtgcgcaagctgatcgggtcaaatgacctgccggagtacgatttgaaggaggaggcggggcaggctgg
cccgatcctagtcatgcgctaccgcaacctgatcgagggcgaagcatccgccggttcctaatgtacggagcagatgctagggcaaa
ttgccctagcaggggaaaaaggtcgaaaaggtctctttcctgtggatagcacgtacattgggaacccaaagccgtacattgggaac
cggaacccgtacattgggaacccaaagccgtacattgggaaccggtcacacatgtaagtgactgatataaaagagaaaaaaggc
gatttttccgcctaaaactctttaaaacttattaaaactcttaaaacccgcctggcctgtgcataactgtctggccagcgcacagccg
aagagctgcaaaaagcgcctacccttcggtcgctgcgctccctacgccccgccgcttcgcgtcggcctatcgcggccgctggccgct
caaaaatggctggcctacggccaggcaatctaccagggcgcggacaagccgcgccgtcgccactcgaccgccggcgcccacatca
aggcaccctgcctcgcgcgtttcggtgatgacggtgaaaacctctgacacatgcagctcccggagacggtcacagcttgtctgtaag
cggatgccgggagcagacaagcccgtcagggcgcgtcagcgggtgttggcgggtgtcggggcgcagccatgacccagtcacgtag
cgatagcggagtgtatactggcttaactatgcggcatcagagcagattgtactgagagtgcaccatatgcggtgtgaaataccgcac
agatgcgtaaggagaaaataccgcatcaggcgctcttccgcttcctcgctcactgactcgctgcgctcggtcgttcggctgcggcga
gcggtatcagctcactcaaaggcggtaatacggttatccacagaatcaggggataacgcaggaaagaacatgtgagcaaaaggc
cagcaaaaggccaggaaccgtaaaaaggccgcgttgctggcgtttttccataggctccgcccccctgacgagcatcacaaaaatcg
acgctcaagtcagaggtggcgaaacccgacaggactataaagataccaggcgtttccccctggaagctccctcgtgcgctctcctgt
tccgaccctgccgcttaccggatacctgtccgcctttctcccttcgggaagcgtggcgctttctcatagctcacgctgtaggtatctcag
ttcggtgtaggtcgttcgctccaagctgggctgtgtgcacgaaccccccgttcagcccgaccgctgcgccttatccggtaactatcgtc
ttgagtccaacccggtaagacacgacttatcgccactggcagcagccactggtaacaggattagcagagcgaggtatgtaggcggt
gctacagagttcttgaagtggtggcctaactacggctacactagaaggacagtatttggtatctgcgctctgctgaagccagttacct
tcggaaaaagagttggtagctcttgatccggcaaacaaaccaccgctggtagcggtggtttttttgtttgcaagcagcagattacgc
gcagaaaaaaaggatctcaagaagatcctttgatcttttctacggggtctgacgctcagtggaacgaaaactcacgttaagggattt
tggtcatgcatgatatatctcccaatttgtgtagggcttattatgcacgcttaaaaataataaaagcagacttgacctgatagtttggc
tgtgagcaattatgtgcttagtgcatctaatcgcttgagttaacgccggcgaagcggcgtcggcttgaacgaatttctagctagacat
tatttgccgactaccttggtgatctcgcctttcacgtagtggacaaattcttccaactgatctgcgcgcgaggccaagcgatcttcttct
tgtccaagataagcctgtctagcttcaagtatgacgggctgatactgggccggcaggcgctccattgcccagtcggcagcgacatcc
ttcggcgcgattttgccggttactgcgctgtaccaaatgcgggacaacgtaagcactacatttcgctcatcgccagcccagtcgggcg
gcgagttccatagcgttaaggtttcatttagcgcctcaaatagatcctgttcaggaaccggatcaaagagttcctccgccgctggacc
taccaaggcaacgctatgttctcttgcttttgtcagcaagatagccagatcaatgtcgatcgtggctggctcgaagatacctgcaaga
atgtcattgcgctgccattctccaaattgcagttcgcgcttagctggataacgccacggaatgatgtcgtcgtgcacaacaatggtga
cttctacagcgcggagaatctcgctctctccaggggaagccgaagtttccaaaaggtcgttgatcaaagctcgccgcgttgtttcatc
aagccttacggtcaccgtaaccagcaaatcaatatcactgtgtggcttcaggccgccatccactgcggagccgtacaaatgtacggc
cagcaacgtcggttcgagatggcgctcgatgacgccaactacctctgatagttgagtcgatacttcggcgatcaccgcttcccccatg
atgtttaactttgttttagggcgactgccctgctgcgtaacatcgttgctgctccataacatcaaacatcgacccacggcgtaacgcgc
ttgctgcttggatgcccgaggcatagactgtaccccaaaaaaacatgtcataacaagaagccatgaaaaccgccactgcgccgtta
ccaccgctgcgttcggtcaaggttctggaccagttgcgtgacggcagttacgctacttgcattacagcttacgaaccgaacgaggctt
atgtccactgggttcgtgcccgaat  
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pYDg2 
Binary TRV RNA2 vector containing gRNA2 
 
 
 
TRV Coat Protein, TRV RdRP promoter, gRNA2, gRNA scaffold 
 
ataaaacattgcacctatggtgttgccctggctggggtatgtcagtgatcgcagtagaatgtactaattgacaagttggagaatacg
gtagaacgtccttatccaacacagcctttatccctctccctgacgaggtttttgtcagtgtaatatttctttttgaactatccagcttagt
accgtacgggaaagtgactggtgtgcttatctttgaaatgttactttgggtttcggttctttaggttagtaagaaagcacttgtcttctc
atacaaaggaaaacctgagacgtatcgcttacgaaagtagcaatgaaagaaaggtggtggttttaatcgctaccgcaaaaacgat
ggggtcgttttaattaacttctcctacgcaagcgtctaaacggacgttggggttttgctagtttctttagagaaaactagctaagtcttt
aatgttatcattagagatggcataaatataatacttgtgtctgctgataagatcattttaatttggacgattagacttgttgaactaca
ggttactgaatcacttgcgctaatcaacatgggagatatgtacgatgaatcatttgacaagtcgggcggtcctgctgacttgatggac
gattcttgggtggaatcagtttcgtggaaagatctgttgaagaagttacacagcataaaatttgcactacagtctggtagagatgag
atcactgggttactagcggcactgaatagacagtgtccttattcaccatatgagcagtttccagataagaaggtgtatttccttttaga
ctcacgggctaacagtgctcttggtgtgattcagaacgcttcagcgttcaagagacgagctgatgagaagaatgcagtggcgggtg
ttacaaatattcctgcgaatccaaacacaacggttacgacgaaccaagggagtactactactaccaaggcgaacactggctcgact
ttggaagaagacttgtacacttattacaaattcgatgatgcctctacagctttccacaaatctctaacttcgttagagaacatggagtt
gaagagttattaccgaaggaactttgagaaagtattcgggattaagtttggtggagcagctgctagttcatctgcaccgcctccagc
gagtggaggtccgatacgtcctaatccctagggatttaaggacgtgaactctgttgagatctctgtgaaattcagagggtgggtgat
accatattcactgatgccattagcgacatctaaatagggctaattgtgactaatttgagggaatttcctttaccattgacgtcagtgtc
gttggtagcatttgagtttcgcagaattcGTGTTAGTGGAAAAAGGGCAAGTTTTAGAGCTAGAAATAGCAAG
TTAAAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCGGTGCTTTTTTtctagaaggcc
tccatggggatccggtaccgagctcacgcgtctcgaggcccgggcatgtcccgaagacattaaactacggttctttaagtagatccg
tgtctgaagttttaggttcaatttaaacctacgagattgacattctcgactgatcttgattgatcggtaagtcttttgtaatttaattttct
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ttttgattttattttaaattgttatctgtttctgtgtatagactgtttgagatcggcgtttggccgactcattgtcttaccataggggaacg
gactttgtttgtgttgttattttatttgtattttattaaaattctcaacgatctgaaaaagcctcgcggctaagagattgttggggggtga
gtaagtacttttaaagtgatgatggttacaaaggcaaaaggggtaaaacccctcgcctacgtaagcgttattacgcccgtctgtactt
atatcagtacactgacgagtccctaaaggacgaaacgggagaacgctagccaccaccaccaccaccacgtgtgaattacaggtga
ccagctcgaatttccccgatcgttcaaacatttggcaataaagtttcttaagattgaatcctgttgccggtcttgcgatgattatcatat
aatttctgttgaattacgttaagcatgtaataattaacatgtaatgcatgacgttatttatgagatgggtttttatgattagagtcccgc
aattatacatttaatacgcgatagaaaacaaaatatagcgcgcaaactaggataaattatcgcgcgcggtgtcatctatgttactag
atcgggaattaaactatcagtgtttgacaggatatattggcgggtaaacctaagagaaaagagcgtttattagaataacggatattt
aaaagggcgtgaaaaggtttatccgttcgtccatttgtatgtgcatgccaaccacagggttcccctcgggatcaaagtactttgatcc
aacccctccgctgctatagtgcagtcggcttctgacgttcagtgcagccgtcttctgaaaacgacatgtcgcacaagtcctaagttac
gcgacaggctgccgccctgcccttttcctggcgttttcttgtcgcgtgttttagtcgcataaagtagaatacttgcgactagaaccgga
gacattacgccatgaacaagagcgccgccgctggcctgctgggctatgcccgcgtcagcaccgacgaccaggacttgaccaacca
acgggccgaactgcacgcggccggctgcaccaagctgttttccgagaagatcaccggcaccaggcgcgaccgcccggagctggcc
aggatgcttgaccacctacgccctggcgacgttgtgacagtgaccaggctagaccgcctggcccgcagcacccgcgacctactgga
cattgccgagcgcatccaggaggccggcgcgggcctgcgtagcctggcagagccgtgggccgacaccaccacgccggccggccgc
atggtgttgaccgtgttcgccggcattgccgagttcgagcgttccctaatcatcgaccgcacccggagcgggcgcgaggccgccaag
gcccgaggcgtgaagtttggcccccgccctaccctcaccccggcacagatcgcgcacgcccgcgagctgatcgaccaggaaggcc
gcaccgtgaaagaggcggctgcactgcttggcgtgcatcgctcgaccctgtaccgcgcacttgagcgcagcgaggaagtgacgccc
accgaggccaggcggcgcggtgccttccgtgaggacgcattgaccgaggccgacgccctggcggccgccgagaatgaacgccaa
gaggaacaagcatgaaaccgcaccaggacggccaggacgaaccgtttttcattaccgaagagatcgaggcggagatgatcgcgg
ccgggtacgtgttcgagccgcccgcgcacgtctcaaccgtgcggctgcatgaaatcctggccggtttgtctgatgccaagctggcgg
cctggccggccagcttggccgctgaagaaaccgagcgccgccgtctaaaaaggtgatgtgtatttgagtaaaacagcttgcgtcat
gcggtcgctgcgtatatgatgcgatgagtaaataaacaaatacgcaaggggaacgcatgaaggttatcgctgtacttaaccagaaa
ggcgggtcaggcaagacgaccatcgcaacccatctagcccgcgccctgcaactcgccggggccgatgttctgttagtcgattccgat
ccccagggcagtgcccgcgattgggcggccgtgcgggaagatcaaccgctaaccgttgtcggcatcgaccgcccgacgattgaccg
cgacgtgaaggccatcggccggcgcgacttcgtagtgatcgacggagcgccccaggcggcggacttggctgtgtccgcgatcaag
gcagccgacttcgtgctgattccggtgcagccaagcccttacgacatatgggccaccgccgacctggtggagctggttaagcagcgc
attgaggtcacggatggaaggctacaagcggcctttgtcgtgtcgcgggcgatcaaaggcacgcgcatcggcggtgaggttgccga
ggcgctggccgggtacgagctgcccattcttgagtcccgtatcacgcagcgcgtgagctacccaggcactgccgccgccggcacaa
ccgttcttgaatcagaacccgagggcgacgctgcccgcgaggtccaggcgctggccgctgaaattaaatcaaaactcatttgagtta
atgaggtaaagagaaaatgagcaaaagcacaaacacgctaagtgccggccgtccgagcgcacgcagcagcaaggctgcaacgtt
ggccagcctggcagacacgccagccatgaagcgggtcaactttcagttgccggcggaggatcacaccaagctgaagatgtacgcg
gtacgccaaggcaagaccattaccgagctgctatctgaatacatcgcgcagctaccagagtaaatgagcaaatgaataaatgagt
agatgaattttagcggctaaaggaggcggcatggaaaatcaagaacaaccaggcaccgacgccgtggaatgccccatgtgtgga
ggaacgggcggttggccaggcgtaagcggctgggttgtctgccggccctgcaatggcactggaacccccaagcccgaggaatcgg
cgtgacggtcgcaaaccatccggcccggtacaaatcggcgcggcgctgggtgatgacctggtggagaagttgaaggccgcgcagg
ccgcccagcggcaacgcatcgaggcagaagcacgccccggtgaatcgtggcaagcggccgctgatcgaatccgcaaagaatccc
ggcaaccgccggcagccggtgcgccgtcgattaggaagccgcccaagggcgacgagcaaccagattttttcgttccgatgctctat
gacgtgggcacccgcgatagtcgcagcatcatggacgtggccgttttccgtctgtcgaagcgtgaccgacgagctggcgaggtgat
ccgctacgagcttccagacgggcacgtagaggtttccgcagggccggccggcatggccagtgtgtgggattacgacctggtactga
tggcggtttcccatctaaccgaatccatgaaccgataccgggaagggaagggagacaagcccggccgcgtgttccgtccacacgtt
gcggacgtactcaagttctgccggcgagccgatggcggaaagcagaaagacgacctggtagaaacctgcattcggttaaacacca
cgcacgttgccatgcagcgtacgaagaaggccaagaacggccgcctggtgacggtatccgagggtgaagccttgattagccgcta
caagatcgtaaagagcgaaaccgggcggccggagtacatcgagatcgagctagctgattggatgtaccgcgagatcacagaagg
caagaacccggacgtgctgacggttcaccccgattactttttgatcgatcccggcatcggccgttttctctaccgcctggcacgccgc
gccgcaggcaaggcagaagccagatggttgttcaagacgatctacgaacgcagtggcagcgccggagagttcaagaagttctgtt
tcaccgtgcgcaagctgatcgggtcaaatgacctgccggagtacgatttgaaggaggaggcggggcaggctggcccgatcctagtc
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atgcgctaccgcaacctgatcgagggcgaagcatccgccggttcctaatgtacggagcagatgctagggcaaattgccctagcagg
ggaaaaaggtcgaaaaggtctctttcctgtggatagcacgtacattgggaacccaaagccgtacattgggaaccggaacccgtaca
ttgggaacccaaagccgtacattgggaaccggtcacacatgtaagtgactgatataaaagagaaaaaaggcgatttttccgcctaa
aactctttaaaacttattaaaactcttaaaacccgcctggcctgtgcataactgtctggccagcgcacagccgaagagctgcaaaaa
gcgcctacccttcggtcgctgcgctccctacgccccgccgcttcgcgtcggcctatcgcggccgctggccgctcaaaaatggctggcc
tacggccaggcaatctaccagggcgcggacaagccgcgccgtcgccactcgaccgccggcgcccacatcaaggcaccctgcctcg
cgcgtttcggtgatgacggtgaaaacctctgacacatgcagctcccggagacggtcacagcttgtctgtaagcggatgccgggagc
agacaagcccgtcagggcgcgtcagcgggtgttggcgggtgtcggggcgcagccatgacccagtcacgtagcgatagcggagtgt
atactggcttaactatgcggcatcagagcagattgtactgagagtgcaccatatgcggtgtgaaataccgcacagatgcgtaagga
gaaaataccgcatcaggcgctcttccgcttcctcgctcactgactcgctgcgctcggtcgttcggctgcggcgagcggtatcagctca
ctcaaaggcggtaatacggttatccacagaatcaggggataacgcaggaaagaacatgtgagcaaaaggccagcaaaaggcca
ggaaccgtaaaaaggccgcgttgctggcgtttttccataggctccgcccccctgacgagcatcacaaaaatcgacgctcaagtcag
aggtggcgaaacccgacaggactataaagataccaggcgtttccccctggaagctccctcgtgcgctctcctgttccgaccctgccg
cttaccggatacctgtccgcctttctcccttcgggaagcgtggcgctttctcatagctcacgctgtaggtatctcagttcggtgtaggtc
gttcgctccaagctgggctgtgtgcacgaaccccccgttcagcccgaccgctgcgccttatccggtaactatcgtcttgagtccaacc
cggtaagacacgacttatcgccactggcagcagccactggtaacaggattagcagagcgaggtatgtaggcggtgctacagagttc
ttgaagtggtggcctaactacggctacactagaaggacagtatttggtatctgcgctctgctgaagccagttaccttcggaaaaaga
gttggtagctcttgatccggcaaacaaaccaccgctggtagcggtggtttttttgtttgcaagcagcagattacgcgcagaaaaaaa
ggatctcaagaagatcctttgatcttttctacggggtctgacgctcagtggaacgaaaactcacgttaagggattttggtcatgcattc
taggtactaaaacaattcatccagtaaaatataatattttattttctcccaatcaggcttgatccccagtaagtcaaaaaatagctcg
acatactgttcttccccgatatcctccctgatcgaccggacgcagaaggcaatgtcataccacttgtccgccctgccgcttctcccaag
atcaataaagccacttactttgccatctttcacaaagatgttgctgtctcccaggtcgccgtgggaaaagacaagttcctcttcgggct
tttccgtctttaaaaaatcatacagctcgcgcggatctttaaatggagtgtcttcttcccagttttcgcaatccacatcggccagatcgt
tattcagtaagtaatccaattcggctaagcggctgtctaagctattcgtatagggacaatccgatatgtcgatggagtgaaagagcc
tgatgcactccgcatacagctcgataatcttttcagggctttgttcatcttcatactcttccgagcaaaggacgccatcggcctcactc
atgagcagattgctccagccatcatgccgttcaaagtgcaggacctttggaacaggcagctttccttccagccatagcatcatgtcct
tttcccgttccacatcataggtggtccctttataccggctgtccgtcatttttaaatataggttttcattttctcccaccagcttatatacc
ttagcaggagacattccttccgtatcttttacgcagcggtatttttcgatcagttttttcaattccggtgatattctcattttagccattta
ttatttccttcctcttttctacagtatttaaagataccccaagaagctaattataacaagacgaactccaattcactgttccttgcattct
aaaaccttaaataccagaaaacagctttttcaaagttgttttcaaagttggcgtataacatagtatcgacggagccgattttgaaacc
gcggtgatcacaggcagcaacgctctgtcatcgttacaatcaacatgctaccctccgcgagatcatccgtgtttcaaacccggcagc
ttagttgccgttcttccgaatagcatcggtaacatgagcaaagtctgccgccttacaacggctctcccgctgacgccgtcccggactg
atgggctgcctgtatcgagtggtgattttgtgccgagctgccggtcggggagctgttggctggctggtggcaggatatattgtggtgt
aaacaaattgacgcttagacaacttaataacacattgcggacgtttttaatgtactgaattaacgccgaattaattcctaggccacca
tgttgggcccggcgcgccaagcttgcatgcctgcaggtcaacatggtggagcacgacactctcgtctactccaagaatatcaaagat
acagtctcagaagaccagagggctattgagacttttcaacaaagggtaatatcgggaaacctcctcggattccattgcccagctatc
tgtcacttcatcgaaaggacagtagaaaaggaagatggcttctacaaatgccatcattgcgataaaggaaaggctatcgttcaaga
tgcctctaccgacagtggtcccaaagatggacccccacccacgaggaacatcgtggaaaaagaagacgttccaaccacgtcttca
aagcaagtggattgatgtgatggtcaacatggtggagcacgacactctcgtctactccaagaatatcaaagatacagtctcagaag
accagagggctattgagacttttcaacaaagggtaatatcgggaaacctcctcggattccattgcccagctatctgtcacttcatcga
aaggacagtagaaaaggaagatggcttctacaaatgccatcattgcgataaaggaaaggctatcgttcaagatgcctctaccgac
agtggtcccaaagatggacccccacccacgaggaacatcgtggaaaaagaagacgttccaaccacgtcttcaaagcaagtggatt
gatgtgatatctccactgacgtaagggatgacgcacaatcccactatccttcgcaagacccttcctctatataaggaagttcatttcat
ttggagagg 
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